Live-Cell Tracking of Apoptosis-Induced Proliferation (AiP): Mechanisms, Imaging, and Therapeutic Implications

Abstract

This article provides a comprehensive overview of live-cell tracking technologies for studying Apoptosis-Induced Proliferation (AiP), a paradoxical process where dying cells stimulate division in their neighbors. We explore the foundational mechanisms of AiP, highlighting the critical roles of caspases, JNK signaling, and reactive oxygen species (ROS). The content details advanced methodological approaches, including fluorescent biosensors and deep-learning segmentation tools, for real-time AiP visualization in 2D and 3D models. We address common troubleshooting challenges in live-cell imaging and data analysis, and present validation strategies to distinguish AiP from other proliferation forms. Aimed at researchers and drug development professionals, this review synthesizes current knowledge to underscore AiP's dual role in tissue regeneration and tumor repopulation, offering insights for therapeutic innovation.

Understanding Apoptosis-Induced Proliferation: From Paradoxical Concept to Key Biological Process

Apoptosis-induced proliferation (AiP) is a sophisticated compensatory process where apoptotic cells, rather than being passively cleared, actively stimulate mitosis in nearby surviving cells by releasing mitogenic signals [1]. This process ensures that tissues can continue to develop or regenerate even when a significant proportion of cells undergo apoptosis, playing a crucial role in maintaining tissue homeostasis and facilitating repair after injury, damage, or in pathological conditions such as cancer [1]. A defining feature of AiP is the involvement of apoptotic caspases, which not only execute cell death but also contribute to AiP by actively releasing growth-promoting signals [1]. This dual role highlights the paradoxical nature of apoptosis, where death signals can contribute to life by promoting regeneration and tissue renewal.

Key Mechanisms and Signaling Pathways in AiP

The molecular machinery of AiP involves specific signaling molecules and pathways that are activated during apoptosis.

The Role of Caspases

Initiator caspases, such as Dronc in Drosophila, are activated early in the apoptotic process and are instrumental in triggering mitogenic signaling from apoptotic cells [1]. These caspases cleave specific substrates that lead to the production and release of mitogens.

Key Mitogenic Signals

Apoptotic cells release several signaling molecules that stimulate proliferation in neighboring cells. The key mitogens involved in AiP include [1]:

• Wnt family proteins
• Hedgehog (Hh)
• Prostaglandin E2 (PGE2)

The table below summarizes the core components of the AiP signaling mechanism:

Table 1: Core Components of AiP Signaling

Component Type	Key Elements	Primary Function in AiP
Initiating Signal	Apoptotic stimulus (e.g., damage, stress)	Triggers the apoptotic cascade and caspase activation.
Key Executors	Initiator caspases (e.g., Dronc)	Cleave substrates to initiate release of mitogenic signals.
Mitogenic Signals	Wnt, Hedgehog (Hh), Prostaglandin E2 (PGE2)	Activate proliferation pathways in nearby surviving cells.
Cellular Outcome	Proliferation of neighboring surviving cells	Restores tissue mass and maintains homeostasis.

Diagram 1: AiP Signaling Pathway. This diagram illustrates the core mechanism where an apoptotic stimulus triggers caspases in dying cells, leading to the release of mitogens that promote proliferation in neighboring cells.

Experimental Models for Studying AiP

AiP has been extensively studied in various model systems, which provide insights into its fundamental mechanisms and pathological implications.

Table 2: Experimental Models in AiP Research

Model System	Key Experimental Readouts	Applications and Insights
Drosophila Imaginal Discs	Caspase activation (e.g., Dronc), tissue overgrowth, mitogen signal measurement.	Fundamental discovery of AiP; distinction between "genuine" and "undead" AiP [1].
Mammalian Cell Cultures	Real-time caspase activity, proliferation markers (EdU), surface calreticulin exposure [2].	Validation of AiP in mammalian systems; study of AiP in cancer and immunogenic cell death [2].
3D Culture Systems (Spheroids, Organoids)	Spatial localization of apoptosis and proliferation, viability loss in a tissue-like context [2].	Investigation of AiP in a more physiologically relevant, complex tissue environment [2].

"Genuine" vs. "Undead" AiP Models

Research in Drosophila has led to the characterization of two distinct AiP models [1]:

• "Genuine" AiP: Apoptotic cells complete the death process but release mitogenic signals before their clearance.
• "Undead" AiP: Apoptotic execution is experimentally blocked (e.g., by inhibiting effector caspases), leading to immortalized cells that continuously secrete mitogenic signals, often resulting in excessive overgrowth rather than balanced tissue recovery. This model is useful for amplifying signals for study but does not represent the physiologically normal process.

Application Notes: Protocols for Live-Cell Tracking of AiP

The following protocols leverage modern live-cell imaging technologies to dynamically capture AiP, enabling researchers to move beyond static endpoint analyses.

Protocol: Real-Time Visualization of Apoptosis and AiP in 2D Monolayers

This protocol uses a stable fluorescent reporter system to track caspase activation and subsequent proliferation simultaneously [2] [3].

I. Materials and Cell Preparation

• Stable Reporter Cell Line: Generate or obtain cells expressing a caspase-3/7 biosensor (e.g., ZipGFP) and a constitutive viability marker (e.g., mCherry).
• Culture Labware: Black-walled, clear-bottom 96- or 384-well microplates.
• Live-Cell Imaging System: An automated microscope (e.g., ImageXpress Pico) with integrated environmental control (37°C, 5% CO₂, humidity).
• Reagents:
  • Apoptosis inducers: e.g., Carfilzomib (1-10 µM), Oxaliplatin (varies by cell line).
  • Pan-caspase inhibitor: e.g., Z-VAD-FMK (zVAD, 20-50 µM) for control experiments.
  • Proliferation dye: e.g., CellTrace dyes or 5-Ethynyl-2'-deoxyuridine (EdU).

II. Staining and Treatment Procedure

• Plate cells into the microplate and incubate overnight under standard conditions to allow adherence.
• Treat with compounds: Add the apoptosis-inducing agent alone or in combination with the caspase inhibitor.
• Stain for proliferation: According to the manufacturer's protocol, add the proliferation dye to the culture medium either at the time of treatment or at a later time point to label dividing cells.

III. Image Acquisition and Analysis

• Configure the imager: Place the microplate in the live-cell imaging system and activate environmental controls.
• Set acquisition parameters:
  • For a 24-hour assay, configure the system to capture images every 2-4 hours from multiple sites per well.
  • Fluorescence channels: GFP (caspase activation), RFP/mCherry (cell presence/viability), and the channel corresponding to the proliferation dye.
  • Include brightfield imaging.
• Analyze data using high-content analysis software (e.g., CellReporterXpress):
  • Quantify apoptosis: Measure GFP fluorescence intensity over time to track caspase-3/7 activation kinetics.
  • Quantify proliferation: Identify mCherry-positive cells that have incorporated the proliferation dye.
  • Correlate events: Analyze the spatial and temporal relationship between apoptotic cells (GFP-positive) and proliferating neighboring cells.

Protocol: Monitoring AiP in 3D Spheroid and Organoid Models

This protocol adapts the AiP tracking method for more complex 3D cultures, which better recapitulate in vivo tissue physiology [2].

I. 3D Model Generation and Treatment

• Generate Spheroids/Organoids: Culture reporter cells in low-attachment plates or embed them in an extracellular matrix (e.g., Cultrex) to form 3D structures.
• Treat with compounds: Add apoptosis inducers to the culture medium. Ensure proper diffusion into the core of the 3D structure.
• Stain with proliferation dye.

II. Image Acquisition and Analysis for 3D Models

• Acquire z-stacks: Use confocal or high-content imaging systems to capture z-stack images through the entire depth of the spheroid/organoid at regular intervals.
• Perform 3D analysis: Use software capable of 3D image analysis to:
  • Segment individual cells or regions within the structure.
  • Quantify the GFP signal (apoptosis) and proliferation dye signal in a spatially resolved manner.
  • Identify "hotspots" of apoptosis and correlate them with zones of subsequent proliferation.

Diagram 2: AiP Experimental Workflow. This flowchart outlines the key steps for a live-cell imaging experiment designed to track apoptosis-induced proliferation.

The Scientist's Toolkit: Essential Reagents and Materials

The table below lists key reagents and tools essential for conducting AiP research, as featured in the protocols and literature.

Table 3: Research Reagent Solutions for AiP Studies

Reagent / Tool	Function in AiP Research	Example Products / Specifications
Caspase-3/7 Reporter	Real-time, specific detection of executioner caspase activity.	ZipGFP-based biosensor (DEVD cleavage site), stable cell lines [2].
Constitutive Fluorescent Marker	Normalization for cell presence and transduction efficiency.	Constitutively expressed mCherry or similar FP [2].
Proliferation Trackers	Label and track dividing cells.	EdU Click-iT kits, CellTrace dyes (e.g., CFSE) [2].
Apoptosis Inducers	Trigger the apoptotic cascade to initiate AiP.	Carfilzomib, Oxaliplatin, other chemotherapeutic agents [2].
Caspase Inhibitors	Control for caspase-specificity in reporter assays.	Z-VAD-FMK (pan-caspase inhibitor), Q-VD-OPh [2].
Live-Cell Imaging System	Maintain cell health and acquire kinetic data.	Automated microscope with environmental control (CO₂, temp, humidity) [3].
Key Mitogen Assays	Detect and quantify mitogenic signals from apoptotic cells.	ELISA/Western for Wnt, Hh, PGE2 [1].

Implications and Applications of AiP Research

Understanding AiP has significant translational implications, particularly in the field of oncology. After cancer treatments like chemotherapy or irradiation, apoptotic tumor cells can release AiP signals such as PGE2, which stimulates the proliferation of surviving tumor cells, potentially leading to tumor regrowth and contributing to therapy resistance [1]. Furthermore, the "undead" cell model shares similarities with certain tumor cell behaviors, where apoptotic signals paradoxically promote further growth [1]. This creates a complex dynamic that challenges traditional cancer therapeutics and underscores the need for strategies that can simultaneously induce cell death and block compensatory proliferative signaling. The development of real-time imaging platforms also opens avenues for investigating immunogenic cell death (ICD) alongside AiP, as these processes can be interconnected in the tumor microenvironment [2].

Caspases (cysteine-dependent aspartate-specific proteases) represent a conserved family of cysteine proteases that function as critical signaling hubs in cellular homeostasis, coordinating both cell death and non-death signaling pathways. Historically characterized as mere executioners of programmed cell death (PCD), emerging research reveals their functionality extends well beyond apoptosis into complex regulatory roles in cellular signaling, immune response, and tissue homeostasis [4] [5]. These enzymes achieve this functional diversity through dynamic gradients of enzymatic activity and precise spatiotemporal localization, forming a "functional continuum" from molecular to system levels [5]. In the specific context of apoptosis-induced proliferation (AiP), caspases demonstrate a paradoxical role where they not only execute cell death but also actively trigger mitogenic signaling to stimulate tissue repair and regeneration, a process with significant implications for cancer therapy resistance and regenerative medicine [2] [6].

The traditional classification system categorizes caspases simplistically into apoptotic initiators (caspase-2, -8, -9, -10), apoptotic executioners (caspase-3, -6, -7), and inflammatory caspases (caspase-1, -4, -5, -11) [7] [8]. However, contemporary research indicates this view is insufficient to capture their multifaceted roles. A more nuanced classification based on a functional continuum has been proposed, grouping caspases into homeostatic (low activity, physiological regulation), defensive (intermediate activity, immune surveillance), and remodeling (high activity, structural changes including death) types [5]. This refined framework better explains how caspases can participate in diverse processes ranging from synaptic plasticity to immunogenic cell death, all governed by their activity intensity and subcellular localization.

Molecular Mechanisms: Caspase Functions Across Cell Death and Signaling Pathways

Caspase Roles in Programmed Cell Death Pathways

Caspases are integral components across multiple PCD pathways, often determining the mode of cell death through specific substrate cleavage and molecular interactions.

• Apoptosis: This non-lytic, generally non-inflammatory form of cell death proceeds through extrinsic and intrinsic pathways. The extrinsic pathway is initiated by caspase-8, while the intrinsic pathway involves caspase-9 and mitochondrial components [4]. These initiator caspases activate executioner caspases-3 and -7, which systematically cleave structural and regulatory proteins like PARP, leading to cellular dismantling into apoptotic bodies [4] [2]. Caspase-3 also cleaves gasdermin E (GSDME), which can shift the cell death mode toward lytic outcomes under certain conditions [4].

• Pyroptosis: This lytic, inflammatory cell death is primarily mediated by gasdermin family proteins. Inflammatory caspases (caspase-1, -4, -5, -11) directly cleave GSDMD, releasing its N-terminal fragment that oligomerizes to form plasma membrane pores, leading to cell swelling, lysis, and release of inflammatory mediators [4] [8]. Notably, apoptotic caspases including caspase-3 and -8 can also cleave other gasdermins (GSDMB, GSDMC, GSDME), contributing to pyroptosis under specific contexts [4].

• Necroptosis: This programmed necrosis occurs when caspase-8 activity is inhibited. Caspase-8 normally cleaves RIPK1 and RIPK3 to prevent necrosome assembly. When caspase-8 is inactive, RIPK1 and RIPK3 phosphorylate MLKL, which integrates into the plasma membrane causing membrane rupture [4]. Thus, caspase-8 serves as a crucial molecular switch between apoptosis and necroptosis.

• PANoptosis: Emerging evidence reveals an integrated cell death pathway called PANoptosis, which incorporates components from pyroptosis, apoptosis, and necroptosis. Multiple caspases, including caspase-1, -3, -7, and -8, are key components of PANoptosomes, molecular complexes that drive this inflammatory lytic cell death [8].

Non-Death Signaling Functions and Apoptosis-Induced Proliferation (AiP)

Beyond their classical roles in cell death, caspases regulate vital non-lethal processes through sublethal activity levels. In neuronal synapses, sublethal caspase-3 mediates dendritic spine remodeling by selectively cleaving the synaptic scaffold protein SynGAP1 [5]. In immune regulation, sublethal caspase-3 processes specific IL-18 fragments that activate immune surveillance signals [5].

The most paradoxical non-death function is AiP, where apoptotic caspases actively stimulate proliferation of neighboring surviving cells. AiP is distinct from compensatory proliferation (CP), which is initiated by surviving cells responding to tissue loss independently of apoptotic signaling [6]. In AiP, apoptotic cells—through their activated caspases—release growth-promoting signals like Wnt, Hedgehog (Hh), and Prostaglandin E2 (PGE2) that trigger nearby cells to proliferate [6]. This process has been extensively studied in Drosophila, where initiator caspase Dronc triggers mitogenic signaling from apoptotic cells [6].

Two AiP models exist: "genuine" AiP, where apoptotic cells complete death while releasing mitogenic signals, and "undead" models, where apoptotic cells are immortalized by blocked effector caspase activity but still secrete mitogenic signals causing excessive overgrowth [6]. This dual role of caspases highlights their functional complexity, where death signals paradoxically promote life through tissue regeneration, with significant implications for cancer therapy resistance where apoptotic tumor cells stimulate regrowth of surviving cells [2] [6].

Table 1: Caspase Functions in Programmed Cell Death Pathways

Caspase	Primary Classification	Key Functions in PCD	Specific Roles & Substrates
Caspase-1	Inflammatory	Pyroptosis, PANoptosis	Cleaves GSDMD, IL-1β, IL-18; induces apoptosis in GSDMD absence [4]
Caspase-2	Apoptotic Initiator	Apoptosis, Ferroptosis inhibition	DNA damage response; cleaves BID; stabilizes GPX4 to inhibit ferroptosis [4]
Caspase-3	Apoptotic Executioner	Apoptosis, Pyroptosis, PANoptosis	Primary executioner; cleaves PARP, lamin; activates DNA fragmentation; cleaves GSDME to induce pyroptosis [4] [8]
Caspase-6	Apoptotic Executioner	Apoptosis	Activates caspase-8; leads to BID-dependent apoptosis; regulates GSDMB [4]
Caspase-7	Apoptotic Executioner	Apoptosis	Cleaves PARP; suppresses pyroptosis via non-canonical GSDMD cleavage [4]
Caspase-8	Apoptotic Initiator	Extrinsic Apoptosis, Pyroptosis, Necroptosis inhibition	Molecular switch between death pathways; cleaves BID, GSDMC; inhibits necroptosis by cleaving RIPK1/RIPK3 [4]
Caspase-9	Apoptotic Initiator	Intrinsic Apoptosis	Mitochondrial pathway; cleaves/activates caspases-3/7; inhibits necroptosis via RIPK1 cleavage [4]
Caspase-4/5/11	Inflammatory	Pyroptosis	Non-canonical pathway; directly cleave GSDMD [4]

Experimental Protocols: Live-Cell Tracking of Caspase Dynamics and AiP

Real-Time Imaging of Executioner Caspase Activity

Advanced live-cell imaging enables real-time visualization of caspase activation dynamics, providing kinetic data superior to endpoint measurements. The following protocol utilizes a stable fluorescent reporter system for monitoring caspase-3/7 activity:

Principle: A lentiviral-delivered biosensor incorporates a DEVD cleavage motif (caspase-3/7 recognition site) within a split-GFP system. Under basal conditions, fluorescence is minimal due to prevented GFP folding. Upon caspase-3/7 activation during apoptosis, DEVD cleavage allows GFP reassembly and fluorescence recovery, providing an irreversible, time-accumulating apoptotic signal [2]. A constitutively expressed mCherry marker serves as a normalization control for cell presence.

Procedure:

• Cell Preparation: Generate stable cell lines expressing the ZipGFP-based caspase-3/7 reporter with constitutive mCherry expression using lentiviral transduction [2].
• Experimental Setup:
  • Seed reporter cells in appropriate culture vessels (2D monolayers, 3D spheroids, or patient-derived organoids).
  • For 3D cultures, embed spheroids/organoids in extracellular matrix substitutes like Cultrex [2].
  • Apply experimental treatments (e.g., chemotherapeutic agents like carfilzomib or oxaliplatin) with appropriate controls (DMSO vehicle) [2].
  • Include control wells with pan-caspase inhibitor (zVAD-FMK) to confirm caspase-dependent signal [2].
• Live-Cell Imaging:
  • Use an automated live-cell analysis system (e.g., IncuCyte) placed in a standard cell culture incubator.
  • Acquire time-lapse images every 1-2 hours over 48-120 hours, capturing both GFP (caspase activity) and mCherry (cell presence) channels alongside phase-contrast images [2].
• Image Analysis:
  • Use integrated software to automatically segment fluorescent objects and quantify GFP signal intensity normalized to mCherry.
  • Correlate caspase activation with morphological changes (membrane blebbing, nuclear condensation) visible in phase-contrast [2] [9].
  • Apply AI-based cell health modules to quantify viable cell counts concurrently [2].

Validation: Confirm system specificity via Western blot for cleaved PARP and cleaved caspase-3, and flow cytometric Annexin V/propidium iodide staining [2].

Multiplexed Detection of Apoptosis-Induced Proliferation

To simultaneously track caspase activation and subsequent proliferative responses in neighboring cells:

Principle: Combine the caspase-3/7 reporter with a proliferation tracking dye. The caspase reporter identifies apoptotic cells, while the dye dilution in daughter cells reveals proliferation kinetics [2].

Procedure:

• Cell Labeling:
  • Generate caspase-3/7 reporter cells stably expressing a nuclear label (e.g., IncuCyte Nuclight NIR Lentivirus) [2].
  • Alternatively, use a non-fluorescent, cell-permeable dye like carboxyfluorescein diacetate succinimidyl ester (CFSE), which is cleaved by intracellular esterases to fluorescent CFSE that dilutes with each cell division [10].
• Treatment & Imaging:
  • Treat labeled cells with apoptotic inducers (e.g., camptothecin serial dilutions) in the presence of the caspase-3/7 reagent.
  • Perform live-cell imaging as described in Section 3.1, acquiring images in multiple channels: GFP (caspase activity), NIR/CFSE (cell proliferation/number), and phase-contrast [2] [9].
• Quantitative Analysis:
  • Measure kinetic caspase activation (GFP object count/intensity).
  • Track proliferation through reduction in nuclear fluorescence intensity (NIR) or CFSE dilution in daughter cells.
  • Quantify AiP by correlating spatial localization of caspase-active cells with subsequent proliferative events in adjacent cells [2].

Integrated Immunogenic Cell Death (ICD) Assessment

Caspase activation can lead to ICD, which stimulates adaptive immunity. A key ICD marker is surface exposure of calreticulin (CALR), an "eat me" signal [2].

Endpoint Protocol:

• After live-cell imaging, harvest cells and stain with fluorescently labeled anti-calreticulin antibody.
• Analyze CALR surface exposure using flow cytometry.
• Correlate the percentage of CALR-positive cells with the kinetic caspase activity and AiP data obtained from live-cell imaging [2].

Visualization of Caspase Signaling Networks

Caspase-Mediated Signaling in Death and Proliferation

Diagram 1: Caspase-Mediated Signaling in Death and Proliferation. This diagram illustrates the central role of caspases as molecular switches between different cell death pathways (apoptosis, pyroptosis, necroptosis) and their paradoxical role in triggering proliferation through apoptosis-induced proliferation (AiP) via sublethal signaling. The pathway highlights how caspase-8 inhibition can lead to necroptosis and how different molecular complexes (inflammasome, apoptosome, PANoptosome) activate specific caspases.

Experimental Workflow for Live-Cell Tracking of AiP

Diagram 2: Experimental Workflow for Live-Cell Tracking of AiP. This workflow outlines the key steps for investigating apoptosis-induced proliferation, from generating caspase reporter cell lines to integrated data analysis. The process enables simultaneous tracking of caspase activation kinetics, morphological changes, proliferation metrics, and immunogenic cell death markers.

The Scientist's Toolkit: Essential Research Reagents & Solutions

Table 2: Key Research Reagents for Caspase and AiP Studies

Reagent/Solution	Function & Application	Example Use in Protocols
Caspase-3/7 Fluorescent Reporter (DEVD-based)	Detects executioner caspase activity via cleavage of DEVD motif; provides real-time apoptosis monitoring [2]	ZipGFP-based biosensor with constitutive mCherry marker for live-cell imaging of caspase dynamics [2]
Annexin V Conjugates	Binds phosphatidylserine (PS) exposed on outer membrane leaflet during early apoptosis [9]	IncuCyte Annexin V dyes (Red, Green, NIR) for kinetic PS externalization measurement without wash steps [9]
Pan-Caspase Inhibitor (zVAD-FMK)	Irreversible broad-spectrum caspase inhibitor; validates caspase-dependent processes [2]	Control treatment to confirm caspase-specificity of reporter signal or apoptotic phenotypes [2]
Nuclear Labeling Reagents	Labels cell nuclei for proliferation and viability tracking; enables multiplexing with apoptosis assays [2] [9]	IncuCyte Nuclight reagents (e.g., NIR) for concurrent nuclear counting with caspase activation measurement [2]
Proliferation Tracking Dyes	Cell-permanent dyes that dilute with each cell division, enabling proliferation kinetics monitoring [10]	CFSE staining to track proliferation of neighboring cells in response to apoptotic stimuli (AiP) [10]
Caspase-Specific Antibodies	Detect caspase cleavage/activation (Western blot) or spatial localization (immunofluorescence) [2]	Anti-cleaved caspase-3, anti-cleaved PARP for endpoint validation of caspase activation [2]
Calreticulin Antibody	Detects surface calreticulin exposure, a key marker of immunogenic cell death (ICD) [2]	Flow cytometric analysis of CALR exposure following caspase activation and AiP measurements [2]

Apoptosis-induced proliferation (AiP) is a compensatory process where apoptotic cells actively stimulate mitosis in nearby surviving cells through the release of mitogenic factors [1]. This process stands in contrast to general compensatory proliferation (CP), which can be initiated by various mechanisms, including non-apoptotic cell death or mechanical cues, without direct signaling from apoptotic cells [1]. A defining feature of AiP is the involvement of apoptotic caspases, which not only execute cell death but also contribute to AiP by actively releasing growth-promoting signals like Wnt, Hedgehog (Hh), or Prostaglandin E2 (PGE2) to trigger nearby cell proliferation [1]. The key signaling molecules bridging cell death and proliferation include caspases, c-Jun N-terminal Kinase (JNK), and Reactive Oxygen Species (ROS), which have been extensively studied in model organisms like Drosophila and have significant implications for tissue regeneration and tumorigenesis [11].

Core Signaling Pathways in AiP

The ROS-JNK-p38 Signaling Module

Research using Drosophila imaginal discs has revealed that cell death, whether genetically induced or through physical injury, generates a burst of reactive oxygen species (ROS) that propagates to nearby surviving cells [12]. This oxidative burst activates two stress-activated MAP kinases: p38 and JNK. The activation of JNK and p38 results in the expression of cytokines like Unpaired (Upd), which activates the JAK/STAT signaling pathway essential for regenerative growth [12]. This ROS/JNK/p38/Upd stress-responsive module represents one of the earliest responses for imaginal disc regeneration and is crucial for restoring tissue homeostasis.

Table 1: Key Signaling Molecules in Apoptosis-Induced Proliferation

Signaling Component	Role in AiP	Experimental Evidence
Reactive Oxygen Species (ROS)	Early signal generated by dying cells; propagates to surrounding tissue; necessary for repair [12].	Detected via CellROX Green and H2DCFDA in Drosophila imaginal discs; scavenging inhibits regeneration [12].
JNK Signaling	Activated by ROS; induces expression of mitogenic cytokines; required for compensatory proliferation [12] [11].	Transcriptional activation of puckered (puc) and unpaired (upd) in surviving cells near damage [12].
p38 Signaling	Activated alongside JNK by ROS; synergizes with JNK to promote regenerative signaling [12].	Required for the expression of Upd cytokines after cell death induction [12].
Caspases (e.g., Dronc)	Initiator caspases in apoptotic cells actively promote mitogenic signaling [1].	Studies in Drosophila using "undead" models (blocked effector caspases) show excessive mitogenic signaling [1].
Mitogens (Wnt, PGE2, EGF)	Secreted factors that directly stimulate division of neighboring cells [1] [13].	In mammals, apoptotic cells release PGE2, EGF, and other factors to drive repopulation [1] [13].

Caspase-Dependent Mitogenic Signaling

A fundamental aspect of AiP is the non-apoptotic role of caspases. Initiator caspases, such as Dronc in Drosophila, can trigger mitogenic signaling from apoptotic cells [1]. This signaling occurs in two primary models: "genuine" AiP, where apoptotic cells complete death but release signals before their demise, and "undead" models, where cells are kept in an immortalized state by blocking effector caspase activity, leading to sustained and often excessive mitogenic signaling [1]. These mitogenic signals include Wnt, Hedgehog, and Prostaglandin E2 (PGE2), which activate proliferation in surrounding cells [1]. In mammalian systems, apoptotic tumor cells have been shown to release PGE2, stimulating the proliferation of surviving tumor cells after treatments like irradiation, which has significant implications for cancer therapy resistance [1].

The following diagram illustrates the core signaling flow from apoptosis induction to compensatory proliferation:

Quantitative Data in AiP Research

Table 2: Quantitative Effects of ROS Scavenging on Regeneration in Drosophila

Experimental Condition	Regeneration Outcome	Mitotic Count	Key Finding
Cell death induction (control)	Complete wing regeneration	High	ROS is required for normal regenerative growth [12].
Cell death induction + Antioxidants (NAC, Vitamin C, Trolox)	~50% incomplete regeneration	Significantly decreased	Scavenging ROS impairs proliferation and tissue repair [12].
Cell death induction + Enzymatic Scavengers (Sod, Cat)	Impaired regeneration	Decreased	Removal of superoxide or H2O2 disrupts the regenerative signal [12].

Experimental Protocols for Live-Cell Tracking of AiP

Protocol: Real-Time Tracking of Caspase Activation and Proliferation

This protocol utilizes a fluorescent reporter system to dynamically track apoptosis and concomitant proliferation in the same cell population, ideal for investigating AiP [13].

Workflow Overview:

Materials & Reagents:

• Stable reporter cell line expressing a caspase-3/7 biosensor (e.g., ZipGFP-DEVD) and a constitutive fluorescent marker (e.g., mCherry) [13].
• Apoptosis-inducing agent (e.g., chemotherapeutic drug like cisplatin/camptothecin, proteasome inhibitor) [13] [9].
• Fluorescent proliferation dye (e.g., cell trace dye) or nuclear label (e.g., Incucyte Nuclight Reagent) [13] [9].
• Live-cell imaging system (e.g., Incucyte) with environmental control (CO2, temperature) [9].

Detailed Procedure:

• Cell Preparation and Treatment:

  • Seed the stable reporter cells into a multi-well plate suitable for live-cell imaging.
  • Allow cells to adhere and recover overnight.
  • Treat cells with the chosen apoptotic stimulus. Include control groups (vehicle-only) and validation groups co-treated with a pan-caspase inhibitor like zVAD-FMK [13].

• Staining for Proliferation:

  • According to the manufacturer's instructions, add the proliferation dye or nuclear label to the culture medium. This dye will be incorporated into the DNA of dividing cells, allowing for the tracking of proliferation in the surviving cell population [9].

• Image Acquisition:

  • Place the plate in the live-cell analysis system.
  • Program the system to acquire images from multiple positions in each well at regular intervals (e.g., every 2-4 hours) for the duration of the experiment (typically 48-96 hours).
  • Capture fluorescence channels for the caspase sensor (e.g., GFP), the constitutive marker (e.g., mCherry), and the proliferation dye (e.g., Far Red), alongside phase-contrast images [13] [9].

• Data Analysis:

  • Use integrated software to automatically segment and quantify fluorescent objects.
  • Apoptosis Kinetics: Quantify the increase in caspase-dependent GFP fluorescence over time (Green Object Count or Total Green Fluorescence) [9].
  • Proliferation Kinetics: Quantify the increase in the signal from the proliferation dye or the number of nuclei in the constitutive channel (e.g., NIR Object Count) [9].
  • Correlation: Analyze the temporal and spatial relationship between the onset of apoptosis in one cell cohort and the subsequent proliferation in the neighboring, non-apoptotic cells.

Protocol: Monitoring ROS and JNK/p38 Activation in Wound Models

This protocol outlines methods to detect the early ROS and JNK/p38 signals in a physical injury model, such as in Drosophila imaginal discs or mammalian cell monolayers.

Materials & Reagents:

• Experimental tissue (e.g., Drosophila imaginal disc explants, 2D or 3D mammalian cell cultures).
• ROS-sensitive fluorescent probes (e.g., CellROX Green, H2DCFDA) [12].
• Antibodies for phosphorylated (active) JNK and p38 for immunostaining.
• Viability dye (e.g., TO-PRO-3) to distinguish living and dead cells [12].
• Antioxidants (e.g., N-acetyl cysteine (NAC)) for negative controls [12].

Detailed Procedure:

• Tissue Injury:

  • For imaginal discs, perform a precise physical cut using a microsurgical tool.
  • For cell monolayers, create a scratch wound using a sterile pipette tip.

• Detection of ROS:

  • Immediately after injury, incubate the tissue/cells with a ROS-sensitive dye (e.g., CellROX Green) in culture medium.
  • Incubate for a short period (minutes to 1 hour) to allow for dye oxidation.
  • Wash to remove excess dye and image using fluorescence microscopy. High levels of fluorescence will indicate sites of ROS production [12].

• Validation with Scavengers:

  • Pre-treat a separate set of samples with antioxidants like NAC to scavenge ROS. This should significantly reduce the fluorescent signal, confirming the specificity for ROS [12].

• Detection of Pathway Activation:

  • Fix the samples at specific time points post-injury (e.g., 30 mins, 1 hour, 2 hours).
  • Perform immunostaining using antibodies specific to the phosphorylated (active) forms of JNK and p38.
  • Use fluorescently-labeled secondary antibodies and image via confocal microscopy. The signal should be prominent in the nuclei and cytoplasm of cells surrounding the wound [12].

The Scientist's Toolkit: Key Research Reagent Solutions

Table 3: Essential Reagents for Live-Cell AiP Research

Reagent / Tool	Function / Target	Application in AiP Research
Caspase-3/7 Reporter (e.g., ZipGFP-DEVD)	Caspase-3/7 activity [13].	Real-time, specific detection of apoptotic executioner caspase activation at single-cell resolution.
Annexin V Conjugates	Phosphatidylserine (PS) exposure [9].	Early marker of apoptosis; useful for multiplexing with other dyes.
Constitutive Fluorescent Marker (e.g., mCherry)	Cell presence and viability [13].	Serves as a transduction control and aids in cell counting and viability assessment.
Proliferation Dyes (e.g., Cell Trace) / Nuclight Reagents	DNA synthesis / Nuclear labeling [9].	Tracks division history of surviving cells or provides a real-time count of total nuclei.
ROS Probes (CellROX Green, H2DCFDA)	Cellular reactive oxygen species [12].	Detects the ROS burst from dying cells and its propagation to living neighbors.
Phospho-Specific Antibodies (p-JNK, p-p38)	Activated JNK and p38 [12].	Immunostaining to map the spatial activation of these key kinases in response to damage.
Caspase Inhibitors (zVAD-FMK)	Pan-caspase inhibitor [13].	Validates the caspase-dependence of observed phenomena, including AiP signals.
Antioxidants (NAC)	Scavenges ROS [12].	Tool to functionally test the necessity of ROS in initiating the AiP signaling cascade.

In the fields of developmental biology, regeneration, and cancer research, the phenomenon where cell death stimulates subsequent cell division is well-established. However, the terminology describing these processes has often been used inconsistently, leading to conceptual confusion. Two specific terms—Compensatory Proliferation (CP) and Apoptosis-Induced Proliferation (AiP)—are frequently conflated despite describing fundamentally distinct biological phenomena [6]. This conceptual framework aims to establish a clear distinction between these processes, providing researchers with precise definitions, mechanistic insights, and methodological approaches for their study within the context of live-cell apoptosis research.

The distinction is not merely semantic; it carries significant implications for understanding tissue homeostasis, regenerative mechanisms, and cancer therapy resistance. AiP represents a specialized form of proliferation induction where apoptotic cells actively secrete mitogenic signals to stimulate division in neighboring cells [6] [14]. In contrast, CP encompasses a broader category of responses where surviving cells autonomously initiate proliferation in response to tissue loss or damage, potentially independent of apoptotic signaling [6]. Clarifying this distinction enables more precise communication and experimental design in cell death research.

Conceptual Distinctions: Defining Key Characteristics

Core Definitions and Comparative Analysis

The following table outlines the fundamental differences between CP and AiP based on their definitions, initiating signals, and functional characteristics:

Characteristic	Compensatory Proliferation (CP)	Apoptosis-Induced Proliferation (AiP)
Definition	Proliferation of surviving cells in response to tissue loss or damage [6]	Proliferation stimulated by active signaling from apoptotic cells [6] [14]
Initiating Signal	Tissue loss, mechanical cues, systemic factors [6]	Caspase activity in dying cells [6]
Role of Apoptosis	May be associated, but not required [6]	Essential and integral to the process [6]
Signaling Origin	Surviving cells (autonomous) [6]	Dying or undead cells (non-autonomous) [6] [14]
Primary Function	Tissue size restoration, homeostasis [6]	Tissue regeneration, wound healing [14]
Dysregulation Consequences	Possible overgrowth	Chronic overgrowth, tumorigenesis [14]

Biological Context and Significance

AiP ensures that tissues continue to develop or regenerate even when a significant proportion of cells undergo apoptosis [6]. This process has been extensively studied in Drosophila imaginal discs, where activation of apoptotic caspases triggers mitogenic signaling from apoptotic cells [6] [14]. CP, however, operates through different principles, exemplified in systems like the liver, where partial hepatectomy triggers proliferation of remaining hepatocytes without significant apoptosis [6].

The pathological implications of these processes differ substantially. AiP has significant implications in cancer, where after treatments like irradiation, apoptotic tumor cells can release signals that stimulate proliferation of surviving tumor cells, potentially contributing to tumor regrowth [6]. This mechanism could substantially impact cancer therapy strategies. Furthermore, tumor cells can exhibit properties similar to "undead" cells in AiP, where apoptotic signals intended to induce cell death paradoxically promote further cell growth [6].

Molecular Mechanisms: Signaling Pathways and Experimental Models

Distinct Signaling Pathways in AiP

Two well-characterized AiP pathways have been identified, primarily through Drosophila studies, which differ based on the developmental state of the affected tissue and the specific caspases involved:

In proliferating tissues such as the eye and wing imaginal discs, the initiator caspase Dronc coordinates cell death and compensatory proliferation through JNK signaling and p53 activation [15]. This pathway involves a complex feedback loop where Dronc activation triggers production of extracellular reactive oxygen species (ROS) through the NADPH oxidase Duox [16] [14]. These ROS activate macrophage-like hemocytes, which in turn trigger JNK activity in epithelial cells through TNF/Eiger signaling, creating an amplification loop that drives epithelial overgrowth [16] [14].

In differentiating eye tissues, a distinct pathway operates where the effector caspases DrICE and Dcp-1 activate the Hedgehog signaling pathway to induce compensatory proliferation [15]. This demonstrates that different caspases can activate AiP depending on the cellular and developmental context.

Experimental Models for AiP Research

The following table summarizes key experimental models and their applications in AiP research:

Experimental Model	Description	Applications	Key Readouts
'Undead' Model (Drosophila)	Co-expression of pro-apoptotic genes (hid/reaper) with effector caspase inhibitor p35 [16] [14]	Study of initiator caspase signaling without cell death execution [14]	Tissue overgrowth, mitogen expression, JNK activation [16]
Genuine AiP Model (Drosophila)	Transient induction of apoptosis without blocking execution [6]	Study of AiP in physiological regeneration contexts [6]	Compensatory proliferation without overgrowth [6]
3D Culture Systems (Mammalian)	Spheroids or organoids with caspase reporters [13] [2]	Study of AiP in physiologically relevant human models [2]	Caspase activation, proliferation markers [2]
ZipGFP Reporter System	Stable cell lines with caspase-3/7 biosensor [13] [2]	Real-time visualization of caspase dynamics [13]	GFP fluorescence upon caspase activation [13]

Methodological Approaches: Live-Cell Tracking and Quantitative Analysis

Advanced Reporter Systems for Real-Time Apoptosis Monitoring

The ZipGFP-based caspase-3/7 reporter represents a significant advancement in live-cell imaging of apoptosis dynamics [13] [2]. This system utilizes a genetically engineered, caspase-activatable fluorescent biosensor based on a split-GFP architecture where the GFP molecule is divided into two parts tethered via a flexible linker containing a caspase-3/7-specific DEVD cleavage motif [13]. Under basal conditions, the forced proximity of the β-strands prevents proper folding and chromophore maturation, resulting in minimal background fluorescence. Upon caspase-3/7 activation during apoptosis, cleavage at the DEVD site separates the β-strands, allowing spontaneous refolding into the native β-barrel structure of GFP, leading to efficient chromophore formation and rapid fluorescence recovery [13]. This system provides a highly specific, irreversible, and time-accumulating signal for caspase activation, enabling persistent marking of apoptotic events at the single-cell level [13].

This platform has been successfully adapted to both 2D and 3D culture systems, including organoids, allowing dynamic tracking of apoptotic events and viability loss at single-cell resolution [2]. When combined with proliferation dyes, this system enables detection of apoptosis-induced proliferation in neighboring cells [2]. Furthermore, the incorporation of a constitutive mCherry marker provides internal normalization for cell presence, though it should be noted that due to the inherent long half-life of the mCherry protein (approximately 24-30 h in mammalian cells), mCherry fluorescence is not suitable for direct, real-time assessment of cell viability following acute cell death [13].

Integrated Experimental Workflow for AiP Research

The following diagram illustrates a comprehensive experimental workflow for investigating AiP using live-cell imaging approaches:

Quantitative Measures and Pharmacological Analysis

Advanced live-cell analysis systems such as Incucyte enable kinetic quantification of apoptotic activity through caspase-3/7 activation or Annexin V binding [9]. These systems facilitate high-throughput investigation of apoptosis in response to compound treatments, allowing researchers to generate concentration-response curves and determine potency metrics for pro-apoptotic compounds [9]. The ability to perform multiplexed measurements of proliferation and apoptosis is particularly valuable for AiP research, as it enables simultaneous tracking of cell death induction and subsequent proliferative responses in the same population [9].

For example, in experiments with HT-1080 fibrosarcoma cells labeled with nuclear markers and treated with camptothecin in the presence of caspase-3/7 dye, integrated software can automatically mask fluorescence and quantify both cell proliferation and cell death [9]. This approach reveals kinetic concentration-dependent apoptotic and anti-proliferative effects, providing a multi-parametric analysis of compound effects [9].

Research Reagent Solutions: Essential Tools for AiP Investigation

The following table catalogues key reagents and their applications in AiP research:

Research Tool	Type/Function	Application in AiP Research	Example Sources/References
ZipGFP Caspase-3/7 Reporter	Genetically encoded biosensor with DEVD cleavage motif [13]	Real-time visualization of executioner caspase activation [13] [2]	Lentiviral delivery system for stable cell lines [13]
Incucyte Caspase-3/7 Dyes	Cell-permeable, fluorogenic caspase substrates [9]	Kinetic quantification of apoptosis in live cells [9]	Commercially available assays [9]
Incucyte Annexin V Dyes	Fluorescently labeled Annexin V for PS exposure [9]	Detection of early apoptotic events [9]	Multiple fluorophore options available [9]
Proliferation Dyes	Cell tracking dyes (e.g., CFSE, proliferation dyes) [2]	Identification of dividing cells following apoptotic stimuli [2]	Compatible with live-cell imaging platforms [2]
Pan-Caspase Inhibitors (zVAD-FMK)	Broad-spectrum caspase inhibitor [13]	Validation of caspase-dependent processes [13]	Confirmation of AiP specificity [13]
NADPH Oxidase Inhibitors	Duox/Nox pathway inhibitors [16]	Investigation of ROS-dependent AiP mechanisms [16]	Genetic (RNAi) and pharmacological approaches [16]

The distinction between AiP and CP carries significant implications for both basic research and therapeutic development. In cancer biology, AiP may contribute to tumor repopulation following chemotherapy or irradiation, as apoptotic tumor cells release mitogenic signals that stimulate proliferation of surviving cells [6] [14]. Understanding these mechanisms could inform novel therapeutic approaches that simultaneously induce apoptosis while inhibiting subsequent proliferative responses.

Future research directions should focus on elucidating the complete signaling networks governing different forms of AiP, identifying direct caspase substrates involved in mitogen production, and developing more specific inhibitors that can selectively block pro-proliferative caspase signaling without affecting apoptotic execution [14]. The development of more sophisticated reporter systems that can simultaneously track multiple aspects of cell death and proliferation in real-time will further enhance our understanding of these complex biological processes.

As research in this field advances, maintaining clear conceptual distinctions between AiP and CP will be essential for accurate communication and effective experimental design. The integrated approaches outlined in this framework provide a foundation for rigorous investigation of these biologically and therapeutically important processes.

The precise balance between cell death and proliferation is fundamental to maintaining tissue integrity. While apoptosis has long been recognized as a mechanism for eliminating unwanted cells, pioneering research has revealed that dying cells can actively stimulate the proliferation of their neighbors through a process termed apoptosis-induced proliferation (AiP) [14]. This paradoxical phenomenon represents a crucial regenerative mechanism that promotes tissue repair following injury but, when dysregulated, can contribute to tumor repopulation and therapy resistance [1] [14]. Understanding the precise molecular mechanisms governing AiP is therefore essential for developing novel regenerative medicines and more effective cancer therapeutics. This application note provides a structured framework for studying AiP, integrating current conceptual distinctions with practical experimental protocols suitable for both basic research and drug discovery applications.

Conceptual Framework: Distinguishing Compensatory Proliferation from Apoptosis-Induced Proliferation

A critical source of confusion in the field has been the conflation of general compensatory proliferation with the specific phenomenon of AiP. The table below clarifies the fundamental distinctions between these two interrelated processes.

Table 1: Key Differences Between Compensatory Proliferation and Apoptosis-Induced Proliferation

Feature	Compensatory Proliferation (CP)	Apoptosis-Induced Proliferation (AiP)
Definition	Proliferation of surviving cells in response to tissue loss or damage [1]	A specialized form of CP where apoptotic cells actively stimulate neighboring cell mitosis [1]
Initiating Signal	Direct detection of tissue damage, mechanical cues, or systemic factors by surviving cells [1]	Mitogenic signals (e.g., growth factors) actively released by apoptotic cells [1]
Role of Apoptosis/Caspases	Can occur entirely independently of apoptosis [1]	Dependent on apoptotic caspases (e.g., Dronc, caspase-3/7) which generate mitogenic signals [1] [14]
Cellular Mechanism	Cell-autonomous response of healthy cells [1]	Non-autonomous signaling from dying or "undead" cells to healthy neighbors [1] [14]
Key Signaling Pathways	JAK/STAT, Hippo [1]	JNK, ROS, Wnt, Hedgehog, PGE2, EGFR [1] [14]
Primary Biological Role	Tissue homeostasis and regeneration [1]	Tissue regeneration, but also tumor repopulation and therapy resistance [1] [14]

AiP itself can be further categorized into distinct experimental models. The "undead" model, where the execution of apoptosis is blocked, leads to sustained and often excessive proliferative signaling [1] [14]. In contrast, the "genuine" AiP model involves cells that complete the apoptotic process but still release mitogens during their death, representing a more physiologically relevant scenario for most regenerative contexts [1].

Methodological Approaches for Tracking AiP

Investigating AiP requires tools that can dynamically capture cell death events, track subsequent proliferative outcomes, and identify the signaling molecules that connect them. The following section outlines key reagents and workflows for this purpose.

Research Reagent Solutions for AiP Tracking

A multiparametric approach is essential for dissecting the complex relationship between apoptosis and proliferation. The following table catalogues critical reagents for monitoring these interconnected processes.

Table 2: Essential Reagents for Multiparametric Analysis of Apoptosis-Induced Proliferation

Reagent Category	Specific Examples	Function and Application in AiP Research
Caspase Activity Reporters	ZipGFP-based DEVD biosensor [13], CellEvent Caspase-3/7 [17], PhiPhiLux G1D2 [17], FLICA [17]	Enable real-time, live-cell imaging of executioner caspase activation, the initiating trigger for AiP [13].
Proliferation Trackers	CellTrace Violet [18], Bromodeoxyuridine (BrdU) [18], CFSE-like dyes [18]	Label dividing cells to quantify and trace the proliferative response induced by apoptotic neighbors.
Cell Death & Viability Probes	Annexin V (for Phosphatidylserine exposure) [18] [17], Propidium Iodide (membrane integrity) [18] [17], Covalent Viability Probes [17]	Distinguish between stages of cell death (early/late apoptosis, necrosis) and quantify overall viability loss.
Mitochondrial Function Indicators	JC-1 [18]	Measure mitochondrial membrane potential (ΔΨm), linking early apoptotic triggers in the intrinsic pathway to downstream outcomes.
Immunogenic Cell Death Markers	Antibodies against Surface Calreticulin [13]	Assess a key "eat-me" signal for phagocytes, connecting AiP to the broader immune response, which can influence the tissue microenvironment [13].

Integrated Experimental Workflow for AiP Detection

A robust protocol for studying AiP involves simultaneously monitoring caspase activation, subsequent proliferation in neighboring cells, and key signaling pathway components. The workflow below integrates these elements into a cohesive experimental strategy.

Diagram 1: Integrated workflow for live-cell tracking of AiP.

Protocol: Real-Time Tracking of AiP Using a Caspase Biosensor

This detailed protocol describes how to utilize a stable fluorescent reporter system to dynamically monitor caspase activation and subsequent proliferation in a live-cell setting.

Table 3: Step-by-Step Protocol for Live-Cell AiP Tracking

Step	Procedure	Purpose and Critical Parameters
1. Cell Model Preparation	Generate stable reporter cells (e.g., via lentiviral transduction) expressing a caspase-3/7 biosensor (ZipGFP-DEVD) and a constitutive fluorescent marker (mCherry). Adapt cells to relevant culture models (2D, 3D, organoids) [13].	Ensures consistent, specific reporting of caspase activity. The mCherry signal normalizes for cell presence and transduction efficiency [13].
2. Proliferation Dye Labeling	Label cells with a fluorescent proliferation tracker like CellTrace Violet according to manufacturer's protocol. This dye dilutes by half with each cell division [18].	Enables quantitative tracking of cell divisions in bystander cells following apoptosis induction in a neighboring population.
3. Apoptosis Induction & Live-Cell Imaging	Apply apoptotic stimulus (e.g., carfilzomib, oxaliplatin, γ-irradiation). For controls, include untreated cells and cells co-treated with a pan-caspase inhibitor (zVAD-FMK). Place culture in a live-cell imager and acquire images every 2-4 hours for 3-5 days [13].	Captures the dynamic sequence of caspase activation (GFP signal) followed by proliferation (dye dilution) in the same sample over time. zVAD-FMK confirms caspase dependence [13].
4. Image and Data Analysis	Use automated analysis software to: a) Quantify the increase in GFP fluorescence over time. b) Track the number of mCherry-positive viable cells. c) Analyze CellTrace Violet dilution in the mCherry-positive, GFP-negative (bystander) cell population.	Objectively quantifies the kinetics of apoptosis and the resulting proliferative output. Correlating spatial data (GFP+ cells next to dividing cells) strengthens evidence for AiP.
5. Endpoint Validation	Harvest cells for endpoint validation via flow cytometry using Annexin V/PI staining and analysis of cleaved PARP or caspase-3 by western blot [18] [17].	Validates the apoptosis data obtained from the live-cell reporter and provides additional information on the stage of cell death.

The AiP Signaling Network

The core molecular machinery of AiP involves a complex interplay between caspases, stress kinases, and mitogenic signaling pathways. The following diagram and table deconstruct this network.

Diagram 2: Core molecular pathways of apoptosis-induced proliferation.

Table 4: Molecular Mediators of AiP and Their Roles

Molecule/Pathway	Role in AiP	Experimental Notes
Caspases (Dronc, Casp-3/7)	Initiators & Executors: Cleave cellular substrates to initiate apoptosis; also directly or indirectly trigger production of mitogenic signals [1] [14].	Use specific inhibitors (zVAD-FMK) and caspase-specific reporters (DEVD-based) to confirm necessity [13] [14].
JNK Pathway	Key Signal Amplifier: Activated in apoptotic/"undead" cells; essential for transcription of multiple mitogen genes [14].	A central node; can be inhibited pharmacologically or genetically to block most forms of AiP [14].
Reactive Oxygen Species (ROS)	Secondary Messenger & Recruiter: Extracellular ROS (eROS) gradients recruit immune cells which amplify JNK signaling via TNF [14].	Detectable with dyes like DHR or DCFDA; antioxidants can be used to inhibit this arm [18].
Secreted Mitogens (Wnt, PGE2, etc.)	Proliferative Signal: Directly stimulate cell division in neighboring, surviving cells [1] [14].	Can be measured in supernatant (ELISA); pathway-specific inhibitors can identify the key mitogen in a context.
Immune Cells (e.g., Macrophages)	Signal Amplifiers: Recruited to site of apoptosis, where they produce additional signals (e.g., TNF/Eiger) that sustain proliferative signaling [14].	Use conditioned media or co-culture experiments to demonstrate their role in enhancing AiP.

AiP represents a double-edged sword, serving as a vital mechanism for tissue restoration while also posing a significant threat as a driver of tumor recurrence. The experimental frameworks and tools detailed in this application note provide a solid foundation for dissecting the complexities of AiP in both physiological and pathological contexts. By employing robust live-cell imaging reporters, multiparametric flow cytometry, and a clear understanding of the underlying signaling networks, researchers can systematically investigate strategies to promote beneficial AiP for regenerative medicine and develop novel therapeutics to block its deleterious effects in cancer.

Advanced Live-Cell Imaging and Biosensors for Real-Time AiP Tracking

The real-time tracking of apoptotic events at single-cell resolution is a fundamental requirement for modern research into apoptosis-induced proliferation (AIP), a process where dying cells actively stimulate the division of their neighbors. This dynamic feedback mechanism poses a significant challenge in cancer therapy, as it can contribute to tumor repopulation following treatment [2]. Central to the execution of apoptosis are the effector caspases-3 and -7, which recognize the tetrapeptide sequence DEVD (aspartate-glutamate-valine-aspartate) [19] [20] [21]. Genetically encoded fluorescent reporters that harness this specific cleavage activity have thus become indispensable tools for visualizing and quantifying cell death within living systems, allowing researchers to directly correlate caspase activation with subsequent proliferative outcomes in AIP studies [2].

This application note details the principles and protocols for two primary classes of these biosensors: conventional DEVD-based reporters and the advanced ZipGFP system. We provide a structured comparison of their performance characteristics and detailed methodologies for their application in both 2D and 3D cell culture models, with a specific focus on their integration into longitudinal live-cell imaging workflows for AIP research.

Biosensor Design Principles and Performance Comparison

Core Mechanism of DEVD-Based Reporters

Most fluorescent reporters for caspase-3/7 are built around the central principle of separating a fluorophore from its functional state via an intervening DEVD-containing sequence. In their intact form, the biosensor is non-fluorescent. During apoptosis, activated caspase-3 or -7 cleaves the DEVD motif, leading to a conformational change that restores fluorescence. This design creates a permanent, time-accumulating signal that marks cells that have passed the critical point of caspase activation [19] [2] [20]. This irreversible signaling is particularly valuable in AIP studies, as it allows researchers to track the fate of a cell that has undergone apoptosis and its potential influence on the surrounding viable cell population.

Comparison of Reporter Systems

The following table summarizes the key characteristics of available caspase-3/7 biosensor systems, highlighting their suitability for AIP research.

Table 1: Performance Characteristics of Fluorescent Caspase-3/7 Reporters

Reporter System	Core Mechanism	Key Feature	Background Fluorescence	Best-Suited Application	Compatibility with AIP Studies
FRET-Based [19]	Cleavage separates donor/acceptor fluorophores.	Rationetric measurement.	Moderate (requires signal calculation)	Kinetic studies of caspase activation.	Moderate (signal can be affected by morphology).
Cyclized C3AI (e.g., VC3AI) [19]	Cyclized protein linearized by cleavage, restoring fluorescence.	Very low background pre-cleavage.	Very Low	Long-term tracking in 2D & 3D cultures.	High (clear signal over noise for cell tracking).
Translocation-Based (e.g., pCasFSwitch) [20]	Cleavage releases GFP from membrane to nucleus.	Spatial information (nuclear translocation).	High (in non-apoptotic cells).	Confirmation of apoptosis via subcellular localization.	Low (high background can obscure early events).
Bright-to-Dark Mutant GFP [22]	Caspase cleavage disrupts the GFP β-barrel.	Loss of fluorescence upon apoptosis.	High (until cleavage occurs).	Not recommended for AIP (marks survival).	Low (tracking loss of signal is challenging).
ZipGFP [2]	Split-GFP fragments reassemble after DEVD cleavage.	Minimal background; high signal-to-noise.	Very Low	High-content screening & 3D models (Organoids).	Excellent (stable marking of apoptotic events).

Detailed Experimental Protocols

Protocol 1: Implementing the ZipGFP Reporter for Real-Time Apoptosis and AIP Tracking

This protocol is adapted from a recent 2025 study demonstrating integrated real-time imaging of caspase dynamics and AIP [2].

Generation of Stable ZipGFP Reporter Cell Lines

• Lentiviral Transduction:

  • Utilize a lentiviral vector encoding the ZipGFP caspase-3/7 reporter, which is typically designed with a constitutive promoter (e.g., EF1α) driving the expression of the biosensor and a co-expressed red fluorescent protein (e.g., mCherry) for normalization and cell presence tracking [2].
  • Produce lentiviral particles in a packaging cell line (e.g., HEK293T). Transduce your target cells (e.g., MiaPaCa-2, HUVECs, or patient-derived organoids) with the viral supernatant in the presence of polybrene (e.g., 4-8 µg/mL).
  • 48-72 hours post-transduction, begin selection with an appropriate antibiotic (e.g., 1-2 µg/mL puromycin) for 5-7 days.

• Fluorescence-Activated Cell Sorting (FACS):

  • Harvest the selected cell population and use FACS to isolate a pure population of mCherry-positive cells. This ensures uniform reporter expression across experiments [2].
  • Expand the sorted cells for downstream applications.

Live-Cell Imaging of Apoptosis and Concomitant Proliferation

• Cell Plating and Treatment:

  • Plate the stable reporter cells in an appropriate imaging-compatible microplate (e.g., 96-well black-walled, clear-bottom plate) at a density conducive to single-cell analysis.
  • For AIP Assay: Prior to apoptosis induction, label the cells with a fluorescent proliferation dye (e.g., CellTrace dye) according to the manufacturer's instructions. This dye dilutes with each cell division, allowing you to quantify the proliferation of surviving cells adjacent to apoptotic ones [2].
  • Introduce the apoptotic stimulus (e.g., chemotherapeutic agent like carfilzomib at ~10 nM or oxaliplatin). Include controls with a pan-caspase inhibitor (e.g., 20 µM Z-VAD-FMK) to confirm caspase-specific signal [2].

• Image Acquisition:

  • Place the plate in a live-cell imaging system (e.g., IncuCyte or equivalent) maintained at 37°C and 5% CO₂.
  • Acquire images every 1-3 hours for 48-120 hours. Capture images in the following channels:
    • Green Channel (e.g., 488/520 nm): For ZipGFP signal (caspase activation).
    • Red Channel (e.g., 561/600 nm): For mCherry signal (cell presence/viability).
    • Far-Red Channel (e.g., 640/670 nm): For the proliferation dye [2].

• Data Analysis:

  • Caspase Activation: Quantify the Green Fluorescent Protein (GFP) positive objects per frame or normalize the total green fluorescence intensity to the total red (mCherry) intensity to account for changes in cell confluence.
  • Viability: Use the constitutive mCherry signal with automated cell counting algorithms (e.g., the IncuCyte AI Cell Health Module) to estimate viable cell counts. Note that due to the long half-life of mCherry, this is a surrogate marker and should be interpreted alongside the GFP signal [2].
  • AIP Quantification: Identify GFP-positive (apoptotic) cells. In the surrounding mCherry-positive, GFP-negative cells, measure the dilution of the proliferation dye over time. A significant increase in dye dilution in treated samples versus control indicates apoptosis-induced proliferation [2].

Protocol 2: Application in 3D Spheroid and Organoid Models

The ZipGFP system is highly effective in physiologically relevant 3D models [2].

• 3D Culture Setup:

  • Generate spheroids from reporter cells using low-adhesion round-bottom plates or by embedding cells in a 3D matrix like Cultrex or Matrigel.
  • For patient-derived organoids (PDOs), establish cultures as per standard protocols and transduce with the ZipGFP reporter lentivirus.

• Treatment and Imaging:

  • Once 3D structures are formed, add treatments directly to the culture medium.
  • Image using a confocal microscope or a high-content imaging system capable of acquiring z-stacks. To image through the depth of the structure, collect multiple z-slices at each time point.

• Analysis:

  • Reconstruct 3D projections from z-stacks. Quantify the total GFP fluorescence intensity within the entire spheroid/organoid volume and normalize it to the mCherry intensity.
  • Analyze the spatial distribution of apoptosis, noting whether it occurs on the periphery or in the hypoxic core.

Table 2: Essential Research Reagent Solutions for Caspase Reporter Assays

Reagent / Material	Function / Purpose	Example Product / Note
ZipGFP Caspase-3/7 Reporter Plasmid	Genetically encoded biosensor for detecting caspase-3/7 activity.	Available from commercial suppliers or academic repositories [2].
Lentiviral Packaging System	For generating viral particles to create stable cell lines.	e.g., psPAX2, pMD2.G plasmids.
Polybrene	Increases transduction efficiency of lentiviral particles.	Typically used at 4-8 µg/mL.
Puromycin	Antibiotic for selecting successfully transduced cells.	Working concentration is cell line-dependent (e.g., 1-2 µg/mL).
Apoptosis Inducer (e.g., Carfilzomib)	Positive control for inducing apoptosis and reporter activation.	Proteasome inhibitor; use at nanomolar concentrations [2].
Pan-Caspase Inhibitor (Z-VAD-FMK)	Control to confirm caspase-dependence of the fluorescent signal.	Use at ~20 µM to inhibit reporter activation [2].
Fluorescent Proliferation Dye	To track cell division in AIP co-culture assays.	e.g., CellTrace Violet or CFSE.
Matrigel / Cultrex	Basement membrane extract for 3D cell culture and organoid growth.	Essential for 3D model setup [2].

Visualizing Workflows and Signaling Pathways

Biosensor Activation Pathway

Diagram 1: Core biosensor activation pathway.

ZipGFP Mechanism and AIP Assay

Diagram 2: ZipGFP mechanism and AIP application.

Experimental Protocol Workflow

Diagram 3: Live-cell AIP assay workflow.

The study of apoptosis-induced proliferation (AiP) requires technologies that can dynamically track cell death and the subsequent compensatory proliferation of neighboring cells over time, without perturbing the native biological system. AiP is a process where apoptotic cells actively stimulate mitosis in nearby surviving cells, a phenomenon with significant implications for tissue regeneration, cancer therapy resistance, and tumor repopulation [2] [6]. Label-free live-cell imaging, combined with advanced deep learning segmentation, provides an ideal methodological platform for these investigations by eliminating the phototoxicity and cellular disruption associated with fluorescent labels, thereby preserving authentic cell behavior and signaling [23].

This protocol details the integration of phase-contrast microscopy, differential interference contrast (DIC) microscopy, and deep-learning-based computational analysis to recognize, segment, and track individual live cells within the context of AiP research. These label-free modalities enable researchers to capture high-contrast images of living cells, while modern convolutional neural networks (CNNs) transform these images into quantitative, single-cell data for analyzing dynamic processes such as caspase activation, cell division, and migration [23] [24]. The application of this label-free approach is particularly powerful for longitudinal studies of AiP, allowing for the continuous observation of the entire process from initial apoptosis to the resulting proliferation wave in surrounding tissue.

Fundamental Principles and Comparative Analysis

Two primary label-free imaging techniques are commonly used for live-cell analysis: phase-contrast microscopy and differential interference contrast (DIC) microscopy. Both techniques enhance the contrast of transparent, unstained biological specimens by exploiting interactions between light and cellular components, but they operate on different optical principles and offer distinct advantages and limitations [23].

Phase-contrast microscopy transforms subtle variations in the optical path length—caused by differences in cell thickness and refractive index—into detectable contrasts in image intensity. This is achieved through a condenser annulus and a phase plate that work in concert to visualize subcellular structures with high clarity. While exceptionally useful for live-cell imaging, a known artifact of this technique is the characteristic bright halo that can appear at cell boundaries, which can sometimes obscure fine details [23].

DIC microscopy, also known as Nomarski microscopy, produces a pseudo-three-dimensional image with a distinctive shadow-cast effect. It utilizes polarized light and Nomarski or Wollaston prisms to detect the optical path length gradient (the rate of change of optical path) rather than its absolute magnitude. This results in images with reduced halo artifacts compared to standard phase-contrast and provides superior optical sectioning capabilities, which is beneficial for observing thicker specimens. However, a significant limitation is its incompatibility with standard plastic tissue culture vessels due to optical disturbances caused by their birefringent properties [23].

Table 1: Comparison of Primary Label-Free Imaging Modalities for Live-Cell Analysis

Feature	Brightfield Microscopy	Phase-Contrast Microscopy	DIC Microscopy
Working Principle	Light absorption by the specimen [23]	Conversion of phase shifts to intensity changes [23]	Detection of optical path length gradients [23]
Image Quality	Low contrast for transparent cells [23]	High contrast, but with halo artifacts [23]	High contrast, pseudo-3D, reduced halo [23]
Compatibility with Standard Vessels	Yes [23]	Yes [23]	No (requires strain-free objectives, specialized vessels) [23]
Optical Sectioning	Limited [23]	Good for thin specimens [23]	Superior, good for thicker specimens [23]
Key Artifact	N/A	Haloing [23]	Anisotropy effects [23]

The Scientist's Toolkit: Research Reagent Solutions

The following table outlines key materials and tools essential for implementing the label-free live-cell recognition and AiP tracking protocols described in this document.

Table 2: Essential Research Reagents and Tools for Label-Free AiP Assays

Item Name	Function/Description	Application Context
Incucyte Caspase-3/7 Dye	Cell-permeable, non-fluorescent substrate that becomes fluorescent upon cleavage by activated caspase-3/7, enabling real-time apoptosis tracking [9].	Kinetic quantification of apoptosis in 2D or 3D cultures without the need for wash steps [9].
Incucyte Annexin V Dye	Binds to phosphatidylserine (PS) exposed on the outer leaflet of the plasma membrane, an early marker of apoptosis [9].	Real-time detection of apoptosis onset; can be multiplexed with caspase assays [9].
Incucyte Nuclight Reagents	Lentiviral reagents for constitutive fluorescent labeling of nuclear histone proteins [9].	Provides a stable marker for cell presence and enables multiplexed tracking of proliferation and apoptosis [9].
LIVECell-CLS Dataset	A public benchmark dataset containing over 1.6 million label-free phase-contrast images across 8 cell lines [24].	Training and validating deep learning models for label-free cell classification and instance segmentation [24].
ZipGFP Caspase-3/7 Reporter	A genetically encoded, stable reporter based on split-GFP; fluorescence reconstitutes upon caspase-mediated cleavage at the DEVD motif [2].	Specific, irreversible marking of apoptotic events at single-cell resolution in 2D, 3D spheroids, and organoids [2].
Pan-Caspase Inhibitor (zVAD-FMK)	A cell-permeable compound that potently inhibits the activity of a broad range of caspases [2] [25].	Used as a control to confirm the caspase-dependent nature of an observed apoptotic signal or AiP phenomenon [2] [25].

Deep-Learning Segmentation for Label-Free Cell Analysis

Model Architectures and Performance

The advent of deep learning has dramatically advanced the ability to extract quantitative information from label-free microscopy images. Instance segmentation, which assigns a distinct mask to each individual cell, is a critical task for single-cell tracking and behavioral analysis [23]. Models based on convolutional neural networks (CNNs), such as EfficientNet and ResNet, have shown strong performance, leveraging their inherent locality inductive biases which are well-suited for analyzing cellular images [24]. More recently, architectures like Vision Transformers (ViTs) and MLP-Mixers have also been applied, though CNNs and hybrid models like Swin-Transformers often maintain an edge in balanced accuracy and F1-score on this data type [24].

Innovative approaches are further boosting model performance. For instance, incorporating connectome-inspired modules, such as Tensor Networks, into standard model backbones has been demonstrated to improve the latent representation prior to classification, yielding gains of up to 4 percentage points in test accuracy [24]. The best-performing model reported on the LIVECell-CLS dataset, Elegans-EfficientNetV2-M, achieved a test accuracy of 90.35% and an F1-score of 94.82% [24]. Explainable AI (XAI) techniques applied to these models reveal that accuracy gains correspond to enhanced feature separability, allowing the models to make more precise decisions, particularly when distinguishing between morphologically similar cell lines [24].

Experimental Protocol: Implementing a Label-Free AiP Assay

This protocol outlines the steps for setting up a longitudinal experiment to track AiP using label-free imaging and deep-learning segmentation.

Workflow Overview:

Step-by-Step Procedure:

• Cell Preparation and Seeding:

  • Seed caspase reporter cells (e.g., stably expressing ZipGFP caspase-3/7 sensor and constitutive mCherry) [2] or wild-type cells into multi-well imaging plates at an appropriate density (e.g., 2,000-5,000 cells per well for a 96-well plate) to facilitate single-cell tracking.
  • Allow cells to adhere fully and resume normal growth under standard culture conditions (e.g., 37°C, 5% CO₂) for at least 18-24 hours.

• Apoptosis Induction and Experimental Setup:

  • Prepare working concentrations of the apoptotic inducer (e.g., carfilzomib, cisplatin, camptothecin) in pre-warmed culture medium [2] [9].
  • For control groups, replace medium with fresh culture medium or vehicle control (e.g., DMSO).
  • Optional: To confirm caspase dependence of observed phenotypes, include a treatment group co-administered with a pan-caspase inhibitor like zVAD-FMK (e.g., 20-40 µM) [2] [25].

• Longitudinal Image Acquisition:

  • Place the imaging plate into a live-cell analysis system (e.g., Incucyte) or an environmentally controlled microscope stage.
  • Program the acquisition software to capture label-free (phase-contrast or DIC) images from multiple non-overlapping fields per well at regular intervals (e.g., every 2-4 hours) for the desired experiment duration (e.g., 72-120 hours) [9].
  • If using a fluorescent reporter: Configure additional channels to capture fluorescence (e.g., GFP for caspase activation, mCherry for cell presence) [2].

• Computational Image Analysis and Segmentation:

  • Training a Model: If using a custom model, train a CNN (e.g., VGG-16, EfficientNet) or Swin-Transformer architecture on a dataset like LIVECell-CLS for cell instance segmentation [24]. Apply data augmentation techniques to improve model generalizability.
  • Inference on Time-Lapse Data: Process the acquired image sequence using the trained deep learning model to generate instance segmentation masks for every frame. Each mask should uniquely identify every single cell.
  • Feature Extraction: For each segmented cell in each frame, extract morphological features (e.g., size, perimeter, shape descriptors, texture) and, if applicable, fluorescence intensity.

• Single-Cell Tracking and Phenotype Classification:

  • Link the instance segmentation masks across consecutive frames using a tracking algorithm to generate single-cell trajectories.
  • Classify cellular events based on the extracted features:
    • Apoptosis: Characterized by cell shrinkage, membrane blebbing (visible in phase-contrast/DIC), and/or activation of a caspase reporter [9] [26].
    • Proliferation: Identified by cell division events within a tracked lineage.

• Data Integration and AiP Quantification:

  • Correlate the spatial and temporal data to identify AiP events. A positive AiP event is recorded when a proliferation event (cell division) occurs in a viable cell that is in close spatial proximity to a recently apoptosed cell and within a defined time window after the apoptosis event [6].
  • Key Metrics: Calculate the AiP index (number of proliferation events associated with apoptosis / total number of apoptosis events) and analyze the distance and timing relationships between apoptotic and proliferating cells.

Signaling Pathways in Apoptosis-Induced Proliferation

Understanding the molecular signaling that bridges cell death and proliferation is crucial for interpreting data from label-free assays. AiP is a specialized form of compensatory proliferation where dying cells actively send mitogenic signals to their neighbors [6]. The following diagram and table detail the core pathways involved.

Key Signaling Pathways in AiP:

Table 3: Key Signaling Molecules in Apoptosis-Induced Proliferation

Signaling Pathway / Molecule	Role in AiP	Experimental Insight
Caspases (e.g., Caspase-3/-7)	Executioner enzymes that, upon activation during apoptosis, cleave specific substrates to initiate the release of mitogenic signals [2] [6].	Inhibition with zVAD-FMK blocks both apoptosis and subsequent AiP, confirming the pathway's caspase-dependence [2] [25].
Prostaglandin E2 (PGE2)	A key lipid mediator released by apoptotic cells that binds to EP receptors on surviving cells to stimulate proliferation [6].	Identified as a critical AiP signal in tumor repopulation following radiotherapy; its inhibition can reduce regenerative growth [6].
Wnt & Hedgehog (Hh)	Evolutionarily conserved morphogens secreted by apoptotic cells that activate proliferative programs in neighboring cells [6].	Studies in Drosophila imaginal discs have shown that caspase activation in apoptotic cells is necessary for the production of these mitogens [6].
c-Jun N-terminal Kinase (JNK)	A stress-activated kinase pathway that is often upregulated in dying cells and contributes to the production of mitogenic signals [11] [6].	JNK signaling can promote a pro-proliferative state in both the dying cell and the surrounding tissue microenvironment [11].
Reactive Oxygen Species (ROS)	Signaling molecules that can amplify apoptotic cues and contribute to the activation of pro-proliferative pathways like JNK [11].	ROS are involved in the interplay between apoptosis, AiP, and other processes like dedifferentiation in regenerative models [11].

The integration of label-free live-cell imaging with deep-learning segmentation provides a powerful, unbiased framework for investigating complex dynamic biological processes like apoptosis-induced proliferation. The methodologies outlined in this application note—from the selection of the appropriate imaging modality (Phase Contrast or DIC) to the implementation of a robust computational pipeline for single-cell tracking and event classification—enable researchers to quantify AiP with high spatial and temporal resolution. This approach maintains cells in a near-physiological state, ensuring that the observed behaviors, from caspase activation to subsequent compensatory divisions, are authentic and not artifacts of staining procedures. By applying these protocols, researchers in drug development and cancer biology can gain deeper insights into the mechanisms of tumor repopulation and therapy resistance, ultimately informing the development of more effective therapeutic strategies.

The study of Apoptosis-Induced Proliferation (AIP)—where dying cells actively stimulate the division of their neighbors—requires tools that can capture dynamic, multicellular communication over time. Modern live-cell analysis platforms have transformed this research by moving beyond single time-point measurements to kinetic, single-cell resolution tracking. This Application Note details the integrated use of two powerful platforms: the open-source Cell-ACDC software for high-accuracy single-cell segmentation and tracking, and the Sartorius Incucyte Live-Cell Analysis System with its integrated AI for automated, multiplexed assays within a standard incubator. When combined, they create a robust workflow for quantifying the complex signaling dynamics of AIP, a process with critical implications for cancer therapy resistance, tissue regeneration, and developmental biology [2] [27].

Platform Capabilities and Comparative Analysis

The choice of analysis platform depends on the experimental needs, ranging from fully automated, high-throughput compound screening to deep, single-cell phenotypic investigation. The table below summarizes the core capabilities of Cell-ACDC and Incucyte in the context of AIP research.

Table 1: Platform Comparison for AIP Research

Feature	Cell-ACDC	Sartorius Incucyte
Core Function	Open-source GUI for segmentation, tracking, and cell cycle analysis [28] [29]	Automated live-cell imaging and analysis system inside a tissue culture incubator [30] [9]
Key Strength	Flexibility, high-accuracy correction, and multi-generational pedigree tracking [29]	Label-free and fluorescent multiplexed assays with integrated protocols and reagents [30]
AIP-Ready Assays	Requires user-implemented biosensors and fluorescent markers [29]	Integrated Caspase-3/7 and Annexin V apoptosis assays; multiplexing with Nuclight proliferation reagents [30] [9]
Throughput	Adapted for detailed analysis of complex movies, including 3D/4D data [29]	Designed for high-throughput kinetic studies in 96- and 384-well microplates [30]
Analysis Core	State-of-the-art deep learning models (Cellpose, YeaZ, StarDist) [29]	Integrated AI (e.g., AI Confluence Analysis, AI Cell Health Module) [30] [2]
Data Output	Single-cell tables with fluorescence quantification, volume, and pedigree data [29]	Kinetic metrics like Confluence, Fluorescent Object Count, and Apoptotic Index [30] [9]

Incucyte AI for Integrated AIP Workflows

The Incucyte system is tailored for kinetic, multiplexed data collection. Its key advantage in AIP research is the ability to simultaneously track proliferation and apoptosis in the same well over time. This is achieved by combining Incucyte Nuclight Reagents (for fluorescent nuclear labeling and cell counting) with Incucyte Caspase-3/7 Reagents or Incucyte Annexin V Reagents (for apoptosis detection) [30] [9]. The integrated software provides tools like the AI Cell Health Module to automatically segment and classify viable and dead cells, directly quantifying the apoptotic index and correlating it with confluence or nuclear count [2]. This allows researchers to directly observe the anti-proliferative effects of a compound alongside its pro-apoptotic activity and, crucially, to detect any compensatory proliferation in surviving cells [9].

Cell-ACDC for Deep Single-Cell Phenotyping

Cell-ACDC complements this by providing a framework for deep-dive analysis, especially in complex models like epithelial monolayers or yeast colonies. Its GUI allows researchers to achieve near-perfect accuracy in segmentation and tracking by visualizing and manually correcting errors, with changes automatically propagated through the timeline [28] [29]. This is vital for AIP studies, as it ensures the correct assignment of proliferative events to the specific daughter cells of an apoptotic cell's neighbors. Furthermore, its built-in workflow for budding yeast cell cycle annotation provides a label-free method to determine cell cycle phases, which can be adapted to other organisms [29]. This enables the correlation of AIP events with specific cell cycle stages across multiple generations.

Experimental Protocols for AIP Research

Protocol: Multiplexed Kinetic AIP Assay Using Incucyte

This protocol is designed to quantify the dynamic interplay between apoptosis and proliferation in a cancer cell line treated with a cytotoxic agent.

Research Reagent Solutions Table 2: Essential Materials for Incucyte AIP Assay

Item	Function	Example
Nuclight Lentivirus Reagent	Labels nuclei for direct, kinetic cell counting [30]	Incucyte Nuclight Green (Sartorius)
Caspase-3/7 Apoptosis Dye	Detects executioner caspase activity; marker of early apoptosis [9]	Incucyte Caspase-3/7 Green Dye (Sartorius)
Apoptosis Inducer	Triggers apoptosis to initiate the AIP response [2]	Carfilzomib, Cisplatin, or Oxaliplatin
Caspase Inhibitor (Control)	Confirms caspase-specific signal in validation experiments [2]	zVAD-FMK (pan-caspase inhibitor)
Appropriate Cell Line	Model system for AIP study [2]	HT-1080 fibrosarcoma, A549, or other relevant cancer lines

Methodology

• Cell Preparation: Generate a stable cell line expressing a nuclear-restricted fluorescent label (e.g., Incucyte Nuclight Green) [30].
• Seeding and Treatment: Seed cells into a 96-well plate at an optimal density (e.g., 2,000-4,000 cells/well for HT-1080). Allow cells to adhere for 6-18 hours.
• Assay Setup: Add the cytotoxic compound (e.g., a serial dilution of Camptothecin) and the Incucyte Caspase-3/7 Green Dye directly to the media. Use a caspase inhibitor (zVAD-FMK) as a control to confirm the specificity of the apoptosis signal [2] [9].
• Live-Cell Imaging: Place the microplate in the Incucyte instrument inside the tissue culture incubator. Program the software to acquire high-definition phase-contrast and fluorescence images from multiple non-overlapping fields per well every 2-4 hours for 72-120 hours.
• Automated Analysis:
  • Proliferation: Use the integrated software to quantify the Nuclight Green Object Count per well over time.
  • Apoptosis: Use the software to quantify the Caspase-3/7 Green Object Count (fluorescent nuclei) per well over time.
  • Data Integration: Plot both metrics kinetically. AIP may be indicated by an initial wave of apoptosis followed by a recovery or stabilization of the nuclear count, suggesting proliferation in the surviving population [9].

Protocol: Single-Cell AIP Dynamics Using Cell-ACDC

This protocol is for analyzing AIP dynamics at the single-cell level, particularly suited for 2D monolayer studies.

Methodology

• Live-Cell Imaging: Perform time-lapse imaging of cells expressing fluorescent biosensors for apoptosis (e.g., a ZipGFP-based caspase-3/7 reporter [2]) and a constitutive marker (e.g., mCherry). Include a proliferation dye or marker if needed.
• Data Conversion: Convert raw microscopy files to TIFF format using the Bio-Formats library integrated into Cell-ACDC [29].
• Segmentation and Tracking:
  • Load the image sequence into Cell-ACDC and select an appropriate deep learning model (e.g., Cellpose for mammalian cells) for initial segmentation.
  • Run the segmentation and tracking algorithms. The software will generate masks and assign unique IDs to each cell across frames.
• Manual Correction and Annotation:
  • Use the Cell-ACDC GUI to visually inspect and correct any segmentation or tracking errors. The software allows for easy propagation of corrections to adjacent frames.
  • If studying asymmetric division or in yeast, use the cell cycle annotation mode to mark key events (e.g., bud emergence, division) [29].
• Signal Quantification: Cell-ACDC automatically extracts single-cell data, including fluorescence intensity (for the caspase sensor and constitutive marker), cell volume, and morphology.
• AIP Analysis: In downstream analysis (e.g., using R or Python), link the apoptosis event of a single cell (a spike in caspase reporter fluorescence) to the subsequent proliferation kinetics of its immediate neighbors, as tracked by their IDs and changes in volume or signal.

Visualization of the AIP Workflow and Signaling

The following diagrams, generated with Graphviz, illustrate the core experimental workflow and the underlying signaling pathway of AIP.

AIP Experimental Workflow

Core AIP Signaling Pathway

Apoptosis-induced proliferation (AiP) is a compensatory mechanism where apoptotic cells actively stimulate the proliferation of neighboring surviving cells through the release of mitogenic factors such as epidermal growth factors (EGF) and interleukin-6 (IL-6). This process is increasingly recognized as a driver of tumour repopulation following cytotoxic therapies, contributing to therapy resistance, tumour recurrence, and metastatic dissemination [2]. While traditional two-dimensional (2D) cell cultures have provided fundamental insights into AiP mechanisms, they cannot accurately capture the complex physiological characteristics of tissues and tumour microenvironments. The transition to three-dimensional (3D) culture systems, including organoids, spheroids, and other complex models (collectively termed 3D-oids), represents a critical advancement for AiP research as these models better maintain native tissue architecture and cell-cell interactions [31].

However, conducting AiP assays in 3D systems presents significant technical challenges, including limitations in high-resolution three-dimensional imaging, penetration of reagents and dyes, and the development of accessible 3D analysis platforms. This application note provides detailed methodologies and integrated workflows for adapting AiP investigation from 2D to physiologically relevant 3D model systems, leveraging recent advancements in live-cell reporters, artificial intelligence (AI)-driven imaging, and automated analysis pipelines [2] [31] [32].

Integrated Real-Time AiP Reporter Platform for 2D and 3D Cultures

Stable Caspase-3/-7 Reporter System with Constitutive Viability Marker

We have developed a lentiviral-based, stable reporter system that enables real-time visualization of caspase-3/-7 activity—the key executioner caspases in apoptosis—alongside a constitutive fluorescent marker for assessing cell presence [2]. The core components of this system include:

• ZipGFP-based Caspase-3/-7 Reporter: A genetically engineered, caspase-activatable fluorescent biosensor based on a split-GFP architecture. The GFP molecule is divided into two parts (β-strands 1-10 and the eleventh β-strand) tethered via a flexible linker containing a caspase-3/-7-specific DEVD cleavage motif. Under basal conditions, minimal background fluorescence occurs due to prevented proper folding. Upon caspase-3/-7 activation during apoptosis, cleavage at the DEVD site separates the β-strands, allowing spontaneous refolding into the native GFP structure with efficient chromophore formation and rapid fluorescence recovery [2].

• Constitutive mCherry Marker: Provides internal normalization for cell presence and transduction efficiency. Note: Due to the inherent long half-life of mCherry protein (approximately 24-30 h in mammalian cells), mCherry fluorescence is not suitable for direct, real-time assessment of cell viability following acute cell death, but serves primarily as a normalization control for fluorescence-based assays [2].

Table 1: Core Components of the Fluorescent Reporter Platform

Component	Function	Detection Method	Key Characteristics
ZipGFP caspase-3/-7 reporter	Specific detection of apoptosis execution phase	Fluorescence imaging (GFP channel)	DEVD cleavage motif; low background; irreversible signal upon activation
Constitutive mCherry	Cell presence and normalization marker	Fluorescence imaging (RFP/TRITC channel)	Stable expression; suitable for normalization but not acute viability assessment
Proliferation dye	Tracking cell division in neighboring cells	Fluorescence imaging	Cell membrane-permeable dyes that dilute with each division cycle

Validation in 2D and 3D Culture Systems

The reporter system has been validated across multiple culture models, demonstrating robust apoptosis tracking capability:

In 2D cultures, treatment with proteasome inhibitor carfilzomib (1 μM) induced a significant increase in GFP fluorescence within 12-24 hours, which was abrogated by co-treatment with the pan-caspase inhibitor zVAD-FMK (20 μM), confirming caspase-dependent reporter activation. Western blot analysis corroborated these findings with increased levels of cleaved PARP and cleaved caspase-3 [2].

In 3D models, including endothelial spheroids and patient-derived pancreatic ductal adenocarcinoma (PDAC) organoids, the system enabled dynamic tracking of apoptotic events at single-cell resolution. MiaPaCa-2 cell-derived spheroids embedded in Cultrex exhibited a time-dependent increase in GFP signal following apoptosis induction, with fluorescence normalization to mCherry intensity ensuring accurate interpretation independent of viability changes [2].

Comprehensive Protocol for 3D AiP Assay Implementation

Generation of Reporter-Expressing 3D Cultures

Materials Required:

• Stable caspase-3/-7 reporter cell line (generated via lentiviral transduction)
• Organoid culture extracellular matrix (e.g., Cultrex, Matrigel)
• Appropriate complete medium with growth factors
• 384-well U-bottom cell-repellent plates for spheroid formation
• AI-driven micromanipulator system (e.g., SpheroidPicker) for 3D-oid selection [31]

Procedure:

• Harvesting Reporter Cells: Culture stable caspase-3/-7 reporter cells in appropriate 2D conditions until 70-80% confluency. Harvest using standard trypsinization protocol and centrifuge at 300×g for 5 minutes [33].

• 3D Culture Setup:

  • For spheroids: Resuspend cell pellet in complete medium and seed in 384-well U-bottom cell-repellent plates at optimized densities (e.g., 100-500 cells/well depending on cell type). Centrifuge plates at 100×g for 2 minutes to aggregate cells in well bottoms. Incubate for 48-72 hours until compact spheroids form [31].
  • For organoids: Mix cells with extracellular matrix according to manufacturer's instructions (typically 5,000-10,000 cells/50 μL dome). Plate as domes in culture plates and polymerize at 37°C for 30 minutes before adding complete medium [2].

• Quality Control: Use AI-driven systems like SpheroidPicker for morphological pre-selection of uniform 3D-oids. Research indicates that inter-operator variability can cause significant heterogeneity in 3D-oid size and shape, even when following identical protocols [31].

AiP Induction and Live-Cell Imaging

Apoptosis Induction:

• Apply apoptosis-inducing agents (e.g., carfilzomib 1 μM, oxaliplatin IC50 concentration, doxorubicin 1 μM) directly to culture medium [2] [33].
• Include control wells with vehicle (DMSO) only and caspase inhibitor controls (zVAD-FMK 20 μM) where appropriate.
• Incubate for determined time periods (typically 24-120 hours depending on treatment and model system).

Proliferation Tracking:

• Following apoptosis induction, add proliferation tracking dye (e.g., CellTrace dyes) according to manufacturer's instructions.
• Incubate for 15-30 minutes at 37°C, then replace with fresh medium to remove excess dye.

Live-Cell Imaging Setup:

• Transfer 3D cultures to appropriate imaging chambers if necessary.
• For high-content screening, utilize automated systems like HCS-3DX with AI-driven selection of imaging positions [31].
• Acquire time-lapse images every 2-6 hours for up to 120 hours using confocal or light-sheet fluorescence microscopy (LSFM) systems.
• Maintain environmental control at 37°C with 5% CO2 throughout imaging.

Table 2: Optimal Imaging Parameters for 3D AiP Assays

Parameter	2D Culture Setting	3D Culture Setting	Notes
Imaging frequency	Every 15-30 minutes	Every 2-6 hours	Balance between temporal resolution and phototoxicity
Z-stack intervals	Not required	2-5 μm	Essential for 3D reconstruction
Objectives	10x-20x air	5x-20x water immersion	Water immersion preferred for 3D deep imaging
Laser power	5-15%	15-30%	Higher power needed for 3D penetration but monitor phototoxicity
Imaging duration	Up to 72 hours	Up to 120 hours	Longer cultures possible with optimized conditions

Multiparametric Endpoint Analyses

Following live-cell imaging, cultures can be processed for endpoint analyses to validate AiP observations:

Immunogenic Cell Death (ICD) Assessment:

• Harvest 3D cultures using appropriate dissociation methods.
• Stain for surface calreticulin exposure—a key damage-associated molecular pattern (DAMP) in ICD—using fluorochrome-conjugated anti-calreticulin antibodies.
• Analyze by flow cytometry, gating on viable (Annexin V-/PI-) and apoptotic (Annexin V+/PI-) populations [2].

Flow Cytometry-Based Apoptosis Quantification:

• Implement dual staining with Annexin V-FITC and propidium iodide (PI) according to established protocols [33]:
  • Harvest cells and wash with PBS containing 25 mM CaCl₂
  • Resuspend in 100 μL Annexin staining solution (5 μL Annexin V-FITC in 1 mL binding buffer)
  • Incubate 15 minutes at room temperature in dark
  • Add PI to final concentration of 1 μg/mL and incubate additional 15 minutes
  • Analyze by flow cytometry, acquiring ≥10,000 events per sample

AI-Driven Image Analysis for 3D AiP Quantification

Multi-Scale Segmentation Pipeline

The analysis of AiP in 3D cultures requires sophisticated segmentation approaches to quantify apoptotic and proliferative events at multiple scales. We recommend an integrated pipeline incorporating:

Nuclear Segmentation:

• Utilize DeepStar3D, a pretrained convolutional neural network (CNN) based on StarDist principles, specifically fine-tuned for 3D nuclei segmentation across diverse image qualities [32].
• The network demonstrates robust performance (F1IoU50 score >0.5) across various resolutions, staining procedures, and imaging modalities.

Cellular Segmentation:

• Apply grayscale 3D watershed approach incorporating nuclear contours as seeds based on actin or membrane stain images.
• Generate cell surfaces enabling single-cell resolution analysis within 3D structures.

Organoid-Level Segmentation:

• Implement fine-tuned thresholding and morphological mathematics filtering to extract complete organoid contours.
• Enable whole-organoid scale analysis of AiP phenomena.

Automated AiP Metric Extraction

The 3DCellScope software platform provides a user-friendly interface for extracting key AiP parameters without requiring programming expertise [32]:

• Apoptotic Index: Percentage of GFP-positive cells within defined regions
• Proliferation Correlation: Spatial relationship between apoptotic cells and dye-diluted proliferating cells
• Neighborhood Analysis: Quantification of cell-to-cell and cell-to-neighborhood organization changes following apoptosis induction
• Morphological Signatures: Deformation descriptors at nuclear, cellular, and organoid levels

Research Reagent Solutions for AiP Assays

Table 3: Essential Research Reagents for AiP Investigation

Reagent Category	Specific Examples	Function in AiP Assay	Application Notes
Caspase activity reporters	ZipGFP-based DEVD biosensor [2]	Real-time visualization of caspase-3/7 activation	Stable expression via lentiviral transduction; minimal background fluorescence
Constitutive fluorescent markers	mCherry, H2B-mNeonGreen [2] [32]	Cell presence normalization and segmentation reference	Long half-life limits acute viability assessment
Proliferation tracking dyes	CellTrace dyes, EdU/BrdU incorporation assays [34]	Detection of cell division in neighboring cells	Membrane-permeable formats preferred for 3D cultures
Extracellular matrix systems	Cultrex, Matrigel [2]	3D culture support for organoids and spheroids	Batch-to-batch variability requires optimization
Apoptosis-inducing agents	Carfilzomib, oxaliplatin, doxorubicin [2] [33]	Induction of initial apoptotic stimulus	Concentration and timing require empirical optimization per model
Caspase inhibitors	zVAD-FMK [2]	Specificity controls for caspase-dependent apoptosis	Use at 20-50 μM for effective inhibition
Immunogenic cell death markers	Anti-calreticulin antibodies [2]	Endpoint detection of immunogenic cell death	Surface exposure indicates immunogenic potential

Signaling Pathways and Experimental Workflows

The adaptation of AiP assays from 2D to 3D culture systems represents a critical advancement in apoptosis research, enabling more physiologically relevant investigation of cell death-mediated proliferative responses. The integrated platform described herein—combining stable fluorescent reporters for real-time caspase activity monitoring, AI-driven 3D segmentation, and automated analysis pipelines—provides researchers with a comprehensive toolkit for quantifying AiP dynamics in complex culture models. These methodologies offer significant potential for enhancing our understanding of tumor repopulation following therapy, potentially identifying novel therapeutic targets to disrupt this resistance mechanism.

Regulated cell death (RCD) plays a central role in tissue homeostasis, disease progression, and therapeutic responses. Within this framework, apoptosis-induced proliferation (AIP) represents a critical compensatory mechanism where apoptotic cells actively stimulate the proliferation of neighboring surviving cells. This process has significant implications for tumor repopulation following therapy, contributing to treatment resistance and disease recurrence [35]. Advancements in live-cell tracking technologies now enable the integrated analysis of cell death execution, subsequent proliferative events, and immunogenic signaling, providing a comprehensive view of dynamic cellular responses. This application note details methodologies for multiplexed tracking of caspase activation, cell cycle status, and immunogenic markers within the context of AIP research.

The Scientific Framework: Key Biological Processes

Core Signaling Pathways

The experimental approach is built on the interplay of three key biological processes, illustrated in the pathway diagram below.

Key Research Reagent Solutions

The following table catalogues essential reagents and tools for implementing multiplexed assays in AIP research.

Table 1: Research Reagent Solutions for Multiplexed AIP Assays

Reagent / Tool	Function / Target	Key Features & Applications
ZipGFP-based Caspase-3/7 Reporter [36] [35]	Detection of executioner caspase activity	DEVD cleavage motif; split-GFP design minimizes background; irreversible signal marks apoptotic events.
Constitutive mCherry Reporter [36] [35]	Cell presence & viability normalization	Stable expression marks transduced cells; internal control for fluorescence assays.
Proliferation Dyes (e.g., CFSE) [35]	Tracking cell division	Dilution of dye in daughter cells indicates proliferation; used to detect AIP.
Anti-Calreticulin Antibody [35] [37]	Detection of immunogenic cell death (ICD)	Flow cytometry endpoint to measure surface CALR exposure, a key "eat-me" signal for ICD.
Annexin V / Propidium Iodide [35]	Apoptosis & necrosis validation	Standard flow cytometry method to confirm phosphatidylserine exposure and membrane integrity.
Phospho-Histone H3 Antibody [38]	Mitosis & cell cycle marker	Immunofluorescence marker for mitotic cells; part of immunogenic cell injury panels.
Caspase Inhibitor (zVAD-FMK) [35]	Pan-caspase inhibition	Control to confirm caspase-dependence of reporter activation and cell death phenotypes.

Experimental Workflow & Quantitative Assay Parameters

A generalized protocol for establishing and using the stable reporter system in 2D and 3D cultures is outlined below.

Detailed Protocol: Multiplexed AIP and ICD Assay

Step 1: Generation of Stable Caspase-3/7 Reporter Cell Line

• Methodology: Utilize a lentiviral delivery system to stably express a ZipGFP-based DEVD caspase-3/7 biosensor alongside a constitutive mCherry marker in your target cell line (e.g., MCF-7, MiaPaCa-2, HUVECs) [36] [35].
• Validation: Confirm reporter functionality via treatment with a known apoptosis inducer (e.g., 1 µM Carfilzomib for 24-48 hours) and concurrent GFP fluorescence increase. Specificity should be validated using the pan-caspase inhibitor zVAD-FMK (20 µM) to abrogate the signal [35].

Step 2: Culture and Experimental Setup

• 2D Monolayers: Plate reporter cells in multi-well imaging plates.
• 3D Models: For spheroids or Patient-Derived Organoids (PDOs), embed cells in Cultrex or other ECM substitutes to form 3D structures [35]. Ensure the system is compatible with high-resolution confocal microscopy.

Step 3: Treatment with Modulators

• AIP Induction: Treat cells with an ICD-inducing agent (e.g., 1 µM Carfilzomib, 10 µM Doxorubicin, or 100 µM Oxaliplatin) [35] [37].
• Proliferation Tracking: Prior to treatment, label cells with a proliferation tracking dye (e.g., 5 µM CFSE) according to the manufacturer's protocol.
• Essential Controls: Include vehicle (DMSO) and caspase-inhibited (e.g., 20 µM zVAD-FMK) conditions.

Step 4: Real-Time Live-Cell Imaging and Analysis

• Imaging Parameters: Acquire images every 30-60 minutes for 72-120 hours using an incubator-equipped live-cell imaging system. Capture both GFP (caspase activity) and mCherry (cell presence) channels [35].
• Quantitative Analysis:
  • Caspase Activation: Calculate the ratio of GFP to mCherry fluorescence intensity over time to quantify caspase activation kinetics.
  • AIP Detection: Identify mCherry-positive, GFP-negative (viable) cells that show dilution of the proliferation dye, indicating division events in response to neighboring apoptosis [35].
  • Viability Loss: Use automated cell counting algorithms on the mCherry channel to track the decrease in viable cell numbers.

Step 5: Endpoint Analysis of Immunogenic Markers

• Sample Preparation: Harvest supernatant and cells at a predetermined endpoint (e.g., 48 hours post-treatment).
• Surface Calreticulin Exposure: Detach cells gently without trypsin (e.g., using EDTA), stain with an anti-calreticulin antibody, and analyze by flow cytometry. Surface CALR is a key determinant of immunogenic cell death adjuvanticity [35] [37].
• Other DAMPs: Supernatants can be analyzed for released ATP (e.g., using luciferase-based assays) and HMGB1 (e.g., by ELISA) [37] [39].

The following table consolidates key quantitative findings and optimal parameters from validated studies using this approach.

Table 2: Quantitative Assay Parameters and Expected Outcomes

Assay Readout	Measurement Method	Example Data & Kinetics	Key Interpretation
Caspase-3/7 Dynamics	GFP/mCherry fluorescence ratio (Live imaging)	>5-fold GFP increase over 24-48h with Carfilzomib (1 µM); signal suppressed by zVAD-FMK [35].	Robust, caspase-dependent apoptosis. MCF-7 cells (caspase-3 null) show significant signal, confirming caspase-7 activity [35].
Apoptosis-Induced Proliferation (AIP)	Proliferation dye dilution in viable (mCherry+) cells [35].	Quantifiable increase in dye-negative, mCherry+ cell population in treated vs. control samples.	Direct evidence of compensatory proliferation triggered by apoptotic stimuli.
Immunogenic Cell Death (ICD)	Surface Calreticulin exposure (Flow cytometry)	Significant increase in CALR+ population; note: in ferroptosis, CALR exposure is minimal and transient [35] [39].	Strong CALR exposure is a reliable biomarker for functional, immunogenic apoptosis [37].
Cell Viability	Automated count of mCherry+ objects (Live imaging) [35].	Decrease in viable cell count correlates with GFP activation timeline.	Provides complementary viability data alongside caspase activity.
Model System Application	Fluorescence imaging in 3D	Localized GFP signal in organoid structures post-treatment [35].	Confirms platform utility in physiologically relevant 3D models like PDOs.

The integrated platform described herein enables the simultaneous monitoring of initial apoptotic insult, subsequent proliferative feedback, and immunogenic potential. This multiplexed approach is particularly powerful for dissecting the tumor-repopulating effects of AIP and for screening therapeutic agents that may modulate this process. A critical insight from related research is that not all cell death is equivalently immunogenic. For instance, while immunogenic apoptosis robustly exposes calreticulin, ferroptosis—a form of iron-dependent cell death—fails to do so effectively and negatively impacts dendritic cell function, thereby failing to elicit protective immunity [39]. This underscores the necessity of directly measuring immunogenic markers like CALR rather than inferring them from cell death morphology.

This protocol, validated in both 2D and complex 3D models, provides a robust framework for high-content screening and the mechanistic dissection of cell death and its functional consequences. By combining real-time kinetic data with endpoint immunogenic profiles, researchers can gain a systems-level understanding of treatment responses, accelerating the development of more effective cancer therapies that overcome resistance mediated by AIP.

Overcoming Technical Hurdles in AiP Live-Cell Imaging and Data Analysis

Optimizing Signal-to-Noise Ratio in Fluorescent Biosensors and Probes

Within the context of live-cell tracking of apoptosis-induced proliferation (AIP), the clarity of the data is paramount. AIP is a compensatory process where dying cells stimulate the proliferation of their neighbors, a dynamic that is asynchronous and occurs within complex cellular environments. Fluorescent biosensors are indispensable tools for studying such processes, but their utility is entirely dependent on a high signal-to-noise ratio (SNR). This document provides detailed application notes and protocols for optimizing SNR in fluorescent biosensors, with a specific focus on methodologies enabling AIP research. We will explore the principles of biosensor design, quantitative performance metrics of relevant sensors, and step-by-step protocols for their application in advanced experimental models.

Biosensor Design Principles and Quantitative Performance

The core of SNR optimization lies in the fundamental design of the biosensor. Key strategies include the use of FRET-based conformational sensors and the implementation of split-FP systems that minimize background fluorescence.

The table below summarizes the performance characteristics of two advanced biosensor types critical for AIP research:

Table 1: Performance Characteristics of Representative Fluorescent Biosensors

Biosensor Name	Biosensor Type / Target	Key Structural Features	Dynamic Range (ΔF/F or Δτ)	Optimal Excitation/ Emission	Primary Application Context
PTEN Conformation Sensor [40]	FRET/FLIM (Conformational change)	mEGFP-sREACh flanking N/C termini of PTEN; truncated linkers	Fluorescence Lifetime Change (Δτ): ~0.33 ns (TBB-induced opening) [40]	2P excitation for FLIM	Monitoring PTEN activity state in live cells and intact brain tissue
ZipGFP Caspase-3/7 Reporter [2]	Split-FP (Caspase-3/7 activity)	Split-GFP with DEVD cleavage motif; constitutive mCherry	Fluorescence Intensity: Robust, irreversible signal upon cleavage [2]	Standard GFP/mCherry channels	Real-time, irreversible marking of apoptotic events in 2D & 3D cultures

Detailed Experimental Protocols

Protocol 1: Monitoring PTEN Activity with a FRET-FLIM Biosensor in Live Cells

This protocol is optimized for tracking PTEN conformational dynamics, a key signaling pathway, using Fluorescence Lifetime Imaging Microscopy (FLIM) to achieve a robust SNR independent of sensor concentration.

I. Materials and Reagents

• Cell lines (e.g., HEK293, primary neurons)
• PTEN FRET-FLIM biosensor (mEGFP-PTEN-sREACh) [40]
• Microscope equipped with two-photon laser and FLIM detection capabilities
• Imaging chamber with controlled environment (37°C, 5% CO₂)
• Pharmacological agents: Tetrabromobenzotriazole (TBB, CK2 inhibitor), Epidermal Growth Factor (EGF)

II. Methodology

• Cell Preparation and Transfection:
  • Culture cells in appropriate growth medium.
  • Transfect with the PTEN FRET-FLIM biosensor construct using a method suitable for your cell line (e.g., lipofection, electroporation).
  • Allow 24-48 hours for expression before imaging.

• FLIM Data Acquisition:

  • Transfer transfected cells to an imaging chamber.
  • Using a two-photon microscope, select a field of view with healthful, expressing cells.
  • Acquire fluorescence lifetime images of the mEGFP donor. Collect sufficient photons per pixel (typically >1000) to ensure accurate lifetime fitting.
  • Set the acquisition settings (laser power, dwell time) to minimize photobleaching.

• Pharmacological Perturbation (Kinetics Assay):

  • Acquire a stable baseline by recording lifetime images for 5-10 minutes.
  • Without moving the field of view, carefully add TBB (e.g., 50 µM) to inhibit CK2 and induce PTEN activation.
  • Continue time-lapse FLIM acquisition for 60+ minutes to track the increase in fluorescence lifetime (decrease in FRET).
  • For reversal or inhibition studies, follow TBB washout with EGF application.

• Data Analysis:

  • Fit fluorescence decay curves for each pixel to calculate the mean fluorescence lifetime (τ).
  • Generate lifetime maps and plot τ over time for regions of interest (ROIs) encompassing individual cells.
  • Calculate the change in lifetime (Δτ) between baseline and post-stimulation conditions.

Protocol 2: Real-Time Tracking of Apoptosis and Consequent Proliferation in 3D Cultures

This protocol leverages a stable, fluorescent reporter system to simultaneously track caspase activation (apoptosis) and subsequent AIP in physiologically relevant 3D models.

I. Materials and Reagents

• Stable reporter cell line expressing ZipGFP-Caspase-3/7 sensor and constitutive mCherry [2]
• Apoptosis inducer: Carfilzomib (1-10 µM) or Oxaliplatin (50-100 µM)
• Pan-caspase inhibitor: zVAD-FMK (20-50 µM) for control
• Proliferation dye: e.g., CellTrace dyes
• 3D Culture Matrix: Cultrex or Matrigel
• Live-cell imaging system (e.g., IncuCyte or confocal microscope with environmental control)

II. Methodology

• 3D Spheroid/Organoid Generation:
  • Mix reporter cells with the 3D culture matrix according to manufacturer instructions.
  • Plate the cell-matrix suspension in µ-plates to form domes or use hanging-drop techniques to generate spheroids.
  • Culture for 48-72 hours to allow for structure formation.

• Apoptosis Induction and Live-Cell Imaging:

  • Pre-label a separate population of cells with a proliferation dye according to the manufacturer's protocol. These will be used to detect AIP.
  • Add the apoptosis inducer (e.g., Carfilzomib) to the 3D culture medium.
  • For controls, co-treat with Carfilzomib and zVAD-FMK.
  • Place the culture in the live-cell imager. Acquire GFP (apoptosis) and mCherry (cell presence/viability) channels every 2-4 hours for 72-120 hours.

• Detecting Apoptosis-Induced Proliferation (AIP):

  • After 24-48 hours of apoptosis induction, introduce the pre-labeled, proliferation-dye-positive cells to the culture system.
  • Continue time-lapse imaging, adding a channel for the proliferation dye.
  • Monitor for a decrease in the proliferation dye intensity in the co-cultured cells, indicating cell division (AIP) in response to apoptotic signals from the reporter cells.

• Data Analysis:

  • Apoptosis Kinetics: Quantify the GFP intensity (normalized to mCherry) over time for entire spheroids or individual cells within organoids.
  • AIP Quantification: Measure the dilution of the proliferation dye in the responder cell population via flow cytometry or fluorescence intensity analysis, comparing conditions with and without apoptosis induction.

The Scientist's Toolkit: Essential Reagents and Materials

The following table lists key reagents and their critical functions for implementing the protocols described above.

Table 2: Research Reagent Solutions for Biosensor-Based AIP Studies

Reagent / Material	Function / Application	Key Characteristics	Example Use Case
FRET-FLIM Biosensor (PTEN) [40]	Reports protein conformational state/activity	mEGFP donor, sREACh acceptor; minimal perturbation design	Monitoring PTEN activation/inhibition kinetics in live neurons
ZipGFP Caspase-3/7 Reporter [2]	Detects executioner caspase activation	Split-GFP with DEVD motif; low background, irreversible signal	Real-time tracking of apoptotic events in tumor organoids for AIP studies
Diacyllipid-DNA Conjugate [41]	Enables facile membrane anchoring of biosensors	Hydrophobic tails for membrane insertion; PEG linker	Engineering cell-surface sensors for extracellular ion detection
Two-Photon FLIM System	Enables deep-tissue, quantitative FRET imaging	Resolves fluorescence lifetime; reduces background & phototoxicity	In vivo imaging of biosensor dynamics in the intact mouse brain [40]
Pharmacological Inhibitors (TBB, zVAD-FMK) [40] [2]	Validates biosensor specificity and modulates pathways	TBB: CK2 inhibitor; zVAD-FMK: pan-caspase inhibitor	Control experiments to confirm signal origin (e.g., caspase-specific cleavage)

Live-cell imaging within three-dimensional (3D) models—such as spheroids, organoids, and patient-derived explants—is revolutionizing our understanding of complex biological processes like apoptosis-induced proliferation (AiP) in fields spanning cancer biology, regenerative medicine, and drug development [42]. These 3D systems effectively mimic in vivo microenvironments, including cell-cell interactions, nutrient gradients, and tissue-specific architecture, providing more physiologically relevant data than traditional 2D cultures [42] [43]. However, extracting high-fidelity, quantitative information from deep within these living samples presents significant technical challenges related to poor penetration of light and reagents, structural and signal heterogeneity, and phototoxicity and photobleaching [43]. This Application Note provides detailed protocols and analytical frameworks to overcome these hurdles, specifically contextualized for researchers tracking dynamic AiP signaling in live 3D systems.

Core Challenges and Quantitative Comparisons

The table below summarizes the primary constraints in 3D live-cell imaging and their specific impact on AiP research.

Table 1: Core Challenges in 3D Live-Cell Imaging for AiP Studies

Challenge	Impact on 3D Imaging	Specific Impact on AiP Research
Light Scattering & Penetration	Causes image blurring, signal attenuation, and loss of resolution at depth; limits imaging depth to ~100-200 µm in non-cleared samples [43].	Obscures detection of caspase activation waves and the spatial coordination of apoptotic signals with proliferative niches [2] [27].
Sample Heterogeneity	Creates variability in nutrient/O2 gradients, cell density, and proliferation/death zones, complicating quantitative analysis [42] [43].	Hampers accurate quantification of AiP dynamics; necessitates single-cell resolution tracking to distinguish signal-originating cells [2] [44].
Phototoxicity	Cumulative light exposure from optical sectioning damages cells, altering biology and causing artifacts; tolerable light doses can be as low as ~10 J/cm² for fluorescently labeled samples [43].	Disrupts the delicate signaling kinetics of AiP, as the process relies on precise caspase activity and subsequent paracrine communication [2] [14].
Photobleaching	Fluorophore degradation leads to signal loss over time, preventing long-term kinetic studies and quantitative measurements [43].	Prevents continuous, long-term tracking of executioner caspase dynamics (e.g., via Caspase-3/7 biosensors) and subsequent proliferation markers [2].

Experimental Protocols for AiP Research in 3D Models

Protocol: Real-Time Tracking of AiP Using a Stable Fluorescent Reporter Platform

This protocol enables real-time visualization of apoptosis and concomitant proliferation in 3D models, leveraging a genetically encoded biosensor [2].

Key Research Reagent Solutions: Table 2: Essential Reagents for AiP Reporter Assays

Reagent / Tool	Function in AiP Experiment
ZipGFP-based Caspase-3/7 Reporter	Caspase-activatable biosensor providing irreversible, time-accumulating fluorescent signal upon cleavage at DEVD motif [2].
Constitutively Expressed mCherry	Labels all successfully transduced cells, enabling cell presence normalization and viability assessment [2].
Proliferation Dye (e.g., CellTrace)	Labels cell membranes; dilution in daughter cells allows detection of apoptosis-induced proliferation [2].
Holographic Optical Tweezers (HOT)	For non-contact, all-optical manipulation and 3D imaging of suspended live cells [45].
Cultrex or Matrigel	Natural ECM-based scaffold for embedding and growing 3D spheroids and organoids [42] [2].

Methodology:

• Cell Line Engineering: Generate a stable cell line (e.g., using lentiviral delivery) expressing the dual reporter construct containing the ZipGFP-based DEVD caspase-3/7 sensor and a constitutive mCherry marker [2].
• 3D Model Generation:
  • Spheroids: Use scaffold-free methods like liquid overlay or agitation-based approaches to form self-assembled aggregates of reporter cells [42] [43].
  • Organoids: Embed reporter cells in a Cultrex or Matrigel dome for scaffold-supported growth of patient-derived or stem cell-derived organoids [42] [2].
• Experimental Setup: Treat 3D models with the apoptotic stimulus (e.g., chemotherapeutic agent carfilzomib or oxaliplatin) and a vehicle control. Include conditions with a pan-caspase inhibitor (e.g., zVAD-FMK) to confirm caspase-specific signaling [2].
• Live-Cell Imaging:
  • Microscope: Use a confocal or light sheet fluorescence microscope (LSFM) equipped with an environmental chamber for temperature and CO₂ control.
  • Acquisition: Capture z-stacks of the entire 3D structure over a time course (e.g., 0-80 hours post-treatment). For the proliferation assay, pre-stain cells with a proliferation dye before model assembly [2].
• Image and Data Analysis:
  • Apoptosis Quantification: Calculate the GFP/mCherry fluorescence ratio over time to normalize for caspase activation independent of cell loss.
  • AiP Quantification: Identify mCherry-positive cells that show dilution of the proliferation dye, indicating division events. Correlate the spatial location of these proliferating cells with regions of prior GFP (caspase activity) signal [2].

Protocol: Deep-Tissue 3D Imaging with Minimal Photodamage

This protocol optimizes imaging parameters to mitigate photobleaching and phototoxicity during long-term AiP kinetics studies [43].

Methodology:

• Microscope Selection: Prefer Light Sheet Fluorescence Microscopy (LSFM). LSFM illuminates only the plane in focus, reducing out-of-focus light exposure and allowing ~100 layers to be imaged at non-phototoxic doses, compared to ~20 layers with confocal laser scanning microscopy (CLSM) [43].
• Imaging Parameter Optimization:
  • Wavelength: Use the longest wavelength possible for excitation to reduce light scattering and energy deposition.
  • Intensity: Use the lowest laser power that provides a sufficient signal-to-noise ratio.
  • Detection: Employ ultra-sensitive cameras (e.g., sCMOS) to detect weak signals from deep layers.
  • Temporal Resolution: Balance the acquisition frequency with the need to minimize cumulative light exposure, especially for slow processes like AiP [43].
• Sample Mounting for LSFM: For optimal imaging, mount samples in a vertical orientation embedded in a transparent hydrogel (e.g., 1% low-melting-point agarose) within a dedicated sample holder or micro-capillary [43].
• Optical Clearing (Fixed Samples Only): If endpoint analysis is sufficient and viability is not required, apply refractive index matching optical clearing techniques (e.g., based on fructose or urea) to achieve penetration depths greater than 0.5 mm [43].

Protocol: Single-Cell Resolution Segmentation in Complex 3D Tissues

This protocol details a computational pipeline for achieving accurate 3D segmentation of individual cells, which is crucial for analyzing heterogeneous AiP signaling [44].

Methodology:

• Sample Preparation and Imaging:
  • Labeling: Use a membrane-bound fluorescent marker (e.g., Ubi-GFP-CAAX).
  • Mounting: Use Cell-Tak to immobilize the tissue (e.g., Drosophila wing disc or a spheroid) in a culture dish.
  • Acquisition: Image on a multiphoton microscope with a high-NA water immersion objective. Acquire z-stacks with appropriate spacing (e.g., 0.5 µm) to cover the entire tissue volume [44].
• AI-Assisted 3D Segmentation with Human-in-the-Loop:
  • Initial Segmentation: Run the acquired 3D image stack through Cellpose using a pre-trained model (e.g., cyto3) to get an initial segmentation mask [44].
  • Manual Correction: Manually correct the segmentation errors in each 2D slice using a tool like Napari.
  • 3D Stitching Correction: Use TrackMate to automatically and then manually correct any errors in connecting cells across adjacent z-slices.
  • Model Re-training: Use the corrected segmentation as "ground truth" to re-train the Cellpose model, improving its performance on similar datasets.
  • Iteration: Repeat this process for new images to continuously improve segmentation accuracy [44].

Visualization of AiP Signaling and Experimental Workflow

The following diagrams illustrate the core signaling pathway of AiP and the integrated experimental workflow for its investigation in 3D models.

AiP Signaling Pathway

Integrated Experimental Workflow for 3D AiP Imaging

The integration of advanced 3D cell models, genetically encoded biosensors for real-time apoptosis tracking, and gentle, high-resolution imaging technologies provides a powerful and holistic framework for dissecting the complex dynamics of apoptosis-induced proliferation. By systematically addressing the challenges of penetration, heterogeneity, and photobleaching with the detailed protocols and tools outlined in this document, researchers can achieve unprecedented insights into the spatial and temporal coordination of cell death and regeneration. This approach is poised to significantly advance our fundamental understanding of tissue homeostasis and repair, as well as the role of AiP in disease pathologies such as cancer recurrence and therapy resistance.

Correcting Segmentation and Tracking Errors in Dense Cell Populations

This application note provides a detailed protocol for correcting segmentation and tracking errors in dense cell populations, a common challenge in live-cell imaging studies of apoptosis-induced proliferation (AIP). The methods leverage recent advances in error-prediction algorithms and interactive validation tools to ensure accurate lineage tracking, which is crucial for quantifying cell fate decisions in AIP research. By implementing these procedures, researchers can achieve high-confidence tracking data necessary for reliable analysis of cell death and proliferation dynamics.

The study of apoptosis-induced proliferation (AIP) requires precise tracking of individual cells across multiple generations to quantify how apoptotic events stimulate neighboring cell division. In dense 3D cultures like organoids and spheroids, accurate cell segmentation and tracking present significant challenges due to rapid cell movement, close cell packing, and complex nuclear morphologies during division [46]. Traditional tracking methods output a single solution without confidence measures, making it impossible to assess the statistical reliability of resulting AIP metrics [46]. This protocol addresses these limitations by integrating an error-prediction algorithm with an interactive validation workflow, enabling researchers to efficiently obtain high-fidelity cell lineage data from dense populations while focusing manual curation efforts on the most error-prone tracking events.

Quantitative Performance of Cell Tracking Methods

Table 1: Comparison of cell tracking performance characteristics

Method	Error Rate	Key Innovation	Manual Curation Time	Applicable Model Systems
OrganoidTracker 2.0 [46]	<0.5% per cell per frame	Statistical physics-based error probability	Hours (for 60h movie)	Intestinal organoids, mouse blastocysts, C. elegans
LEVER 3-D [47]	Requires full manual correction	Stereoscopic 3-D visualization and editing	Days (for similar datasets)	Neural stem cells in 3D explant cultures

Table 2: Segmentation and detection accuracy under challenging conditions

Condition	Detection Accuracy	Primary Challenge	Mitigation Strategy
Poor signal-to-noise (>50h imaging) [46]	95%	Signal degradation	Adaptive distance maps
Deep imaging (>40μm) [46]	95%	Signal attenuation	Improved training data augmentation
Densely packed nuclei [46]	99% (baseline)	Undersegmentation	Adaptive distance mapping

Experimental Protocols

Protocol 1: Automated Tracking with Integrated Error Prediction

This protocol utilizes OrganoidTracker 2.0 to achieve automated cell tracking with built-in error probability assessment, enabling researchers to identify and focus manual correction efforts on low-confidence tracking segments [46].

Materials

• Biological Materials: Intestinal organoids, 3D spheroids, or similar dense cell cultures expressing fluorescent nuclear markers (e.g., H2B-mCherry)
• Imaging Equipment: Confocal or multiphoton microscope with environmental control (37°C, 5% CO₂)
• Software: OrganoidTracker 2.0 [46]

Procedure

• Sample Preparation and Imaging

  • Culture organoids or spheroids in glass-bottomed dishes with appropriate media.
  • Image samples using time-lapse microscopy with Z-stacks (recommended: 25×1μm steps) collected at 20-minute intervals for 16-60 hours [47].
  • Maintain focus on cell viability by controlling temperature and CO₂ throughout imaging.

• Cell Detection with Adaptive Distance Maps

  • Input 3D time-lapse data into OrganoidTracker 2.0.
  • Apply the 3D U-Net neural network to generate adaptive distance maps that prevent undersegmentation of closely packed nuclei [46].
  • Validate detected cell centers against nuclear morphology.

• Linking Graph Construction

  • Allow the software to construct a probabilistic graph where nodes represent cells and links represent possible connections between frames.
  • The algorithm will automatically cull links representing unrealistically large displacements (>7μm) [46].

• Neural Network-Based Linking and Division Prediction

  • The software employs specialized neural networks to:
    • Calculate link probabilities between cells in consecutive frames.
    • Identify division events based on nuclear morphology, including metaphase plate detection [46].
  • These predictions are expressed as "link energies" and "division energies" where lower energies indicate higher probability.

• Track Assembly and Error Probability Calculation

  • The integer flow solver identifies the most probable set of cell tracks by minimizing total energy [46].
  • Context-aware error probabilities are computed for each tracking step using statistical physics concepts.
  • Export error probabilities for downstream analysis.

• Targeted Manual Validation

  • Review tracking steps with high error probabilities (>10%) in the interactive interface.
  • Use the stereoscopic 3-D visualization to verify challenging tracking events [47].
  • Corrections are automatically propagated to related tracking segments.

Protocol 2: Integrated AIP Analysis with Caspase Activity Monitoring

This protocol enables simultaneous tracking of apoptosis and proliferation events by combining cell tracking with a caspase activation reporter system, allowing direct observation of AIP dynamics.

Materials

• Reporter Cell Line: Stable caspase-3/-7 reporter cells expressing ZipGFP (DEVD-based biosensor) and constitutive mCherry [2]
• AIP Induction Agents: Carfilzomib (1-10μM), oxaliplatin, or other apoptosis-inducing compounds
• Proliferation Marker: Cell proliferation dye (e.g., CellTrace) [2]

Procedure

• Reporter System Validation

  • Treat reporter cells with apoptosis inducers (e.g., carfilzomib 1-10μM) and confirm caspase-dependent GFP activation.
  • Verify specificity using pan-caspase inhibitor zVAD-FMK (10-20μM) [2].
  • Confirm constitutive mCherry expression as a cell presence marker.

• Time-Lapse Imaging of AIP

  • Image reporter cells in 2D or 3D culture before and after apoptosis induction.
  • Simultaneously capture GFP (caspase activity), mCherry (cell presence), and brightfield channels every 20-30 minutes for 48-80 hours [2].
  • Include proliferation dye imaging if tracking division events directly.

• Integrated Tracking and AIP Quantification

  • Process time-lapse data using Protocol 1 to generate cell tracks and lineages.
  • Identify caspase activation events as sustained GFP fluorescence increases.
  • Quantify proliferation events in cells neighboring apoptotic cells.
  • Calculate AIP metrics: proliferation rate in apoptosis-proximal vs. distal cells.

Research Reagent Solutions

Table 3: Essential research reagents for AIP and cell tracking studies

Reagent	Function	Application Example
Caspase-3/-7 Reporter (ZipGFP) [2]	Caspase activity detection via DEVD cleavage	Real-time apoptosis tracking in live cells
Constitutive mCherry [2]	Cell presence and transduction marker	Normalization control for cell numbers
H2B-mCherry [46]	Nuclear labeling	Cell segmentation and tracking
Cell Proliferation Dyes [2]	Division tracking	Quantifying apoptosis-induced proliferation
Pan-caspase inhibitor zVAD-FMK [2]	Caspase activity inhibition	Specificity controls for apoptosis assays
Apoptosis inducers (carfilzomib, oxaliplatin) [2]	Experimental AIP induction	Stimulating apoptotic events in reporter systems

Workflow Visualization

Discussion

The integration of error-prediction algorithms with AIP research addresses a critical methodological gap in live-cell imaging studies. OrganoidTracker 2.0's ability to assign confidence values to tracking data enables researchers to distinguish reliable AIP observations from potential artifacts [46]. When combined with caspase reporter systems [2], this approach provides a robust framework for quantifying the spatial and temporal relationships between apoptosis and subsequent proliferation events. The MEM algorithm [48] offers additional capability for quantitative cell population characterization that could be integrated with tracking data to provide multidimensional analysis of cell identity changes during AIP. For researchers studying drug responses in tumor models, these methods offer particular value by enabling precise quantification of how therapeutic agents alter the balance between cell death and compensatory proliferation.

Apoptosis-induced proliferation (AiP) is a paradoxical phenomenon where dying cells actively release mitogenic signals that stimulate the division of surrounding surviving cells [49]. This process is driven specifically by apoptotic caspases, which not only execute cell death but also trigger the production of proliferative factors like Wingless (Wnt), prostaglandin E2 (PGE2), and interleukins [49] [6]. In live-cell tracking of AiP, a fundamental challenge arises: how can researchers conclusively demonstrate that observed proliferative effects are directly attributable to caspase-dependent apoptosis rather than other forms of cell death or stress responses?

The necessity for rigorous controls is underscored by compelling evidence demonstrating that caspase-independent cell death (CICD) does not elicit a comparable proliferative response [50]. In fact, CICD may even slightly inhibit proliferation in some experimental contexts [50]. This distinction carries profound implications for cancer therapy, where apoptotic stimuli from treatments can paradoxically stimulate tumor repopulation through AiP mechanisms [49] [6]. Without proper controls, researchers risk misattcribing proliferation signals or overlooking crucial aspects of caspase-specific signaling. This application note provides detailed protocols and analytical frameworks to ensure specificity when investigating AiP using live-cell imaging platforms, enabling researchers to distinguish true caspase-mediated proliferative effects from caspase-independent phenomena.

Key Concepts and Definitions

Apoptosis-Induced Proliferation (AiP) vs. Compensatory Proliferation

A critical foundation for ensuring specificity in AiP research lies in precisely defining the phenomenon under investigation and distinguishing it from related processes:

• Apoptosis-Induced Proliferation (AiP): A specialized form of proliferation specifically triggered by apoptotic caspases within dying cells, which actively secrete mitogens to stimulate neighboring cell division [6]. AiP can be further categorized into "genuine" AiP (where cells complete apoptosis) and "undead" models (where execution is blocked but signaling occurs) [6].

• Compensatory Proliferation (CP): A broader category where surviving cells detect tissue loss or damage through various mechanisms, including non-apoptotic cell death, mechanical cues, or systemic factors, and proliferate to restore tissue mass [6]. Unlike AiP, CP does not necessarily rely on apoptotic signaling.

Table 1: Distinguishing Features of AiP vs. Compensatory Proliferation

Feature	Apoptosis-Induced Proliferation (AiP)	Compensatory Proliferation (CP)
Initiating Signal	Active signaling from apoptotic cells	Tissue loss, damage, or mechanical cues
Dependence on Apoptosis	Absolute requirement for apoptotic caspases	Can occur independently of apoptosis
Key Signaling Molecules	Caspases, PGE2, Wnt, JNK	Growth factors, JAK/STAT, Hippo signaling
Cellular Source of Mitogens	Dying apoptotic cells	Surviving cells or systemic factors
Experimental Models	Undead models, genuine apoptosis	Partial hepatectomy, irradiation injury

The Caspase Specificity Challenge in AiP

The core specificity challenge in AiP research stems from several experimental complexities:

• Transient Caspase Activation: Caspase activity is often brief and asynchronous within cell populations, creating difficulty in correlating timing between death and subsequent proliferation [2] [51].

• Multiple Cell Death Pathways: Cells can undergo various death modalities (apoptosis, necrosis, CICD) simultaneously or sequentially in response to stimuli, each with different signaling consequences [50].

• Threshold Effects: Evidence suggests AiP may require higher caspase activation thresholds than apoptosis itself, creating potential for false negatives [49].

• Spatiotemporal Dynamics: AiP signaling involves complex paracrine interactions that are difficult to track with endpoint assays [2].

Experimental Design for Controlling Caspase-Independent Effects

Strategic Framework

To conclusively establish caspase-dependent AiP, researchers must implement a multi-layered control strategy that simultaneously captures caspase activity, cell death, and proliferation dynamics while systematically excluding caspase-independent mechanisms.

Core Principle: Caspase Inhibition and CICD Controls

The most definitive approach for establishing caspase dependence involves combining caspase inhibition with induction of caspase-independent cell death as a negative control:

• Caspase Inhibition: Complete ablation of caspase activity (pharmacologically or genetically) during apoptosis induction should abrogate both AiP signaling and effector caspase activation while still permitting CICD [50].

• CICD Control: Induction of CICD provides a critical negative control that establishes the baseline proliferative response to non-apoptotic cell death, which should be significantly lower than apoptotic stimulation [50].

Methodologies and Protocols

Protocol 1: Establishing Caspase-Independent Cell Death Controls

This protocol adapts established methods from Höck et al. [50] to generate definitive CICD controls for AiP experiments.

Materials and Reagents

Table 2: Essential Reagents for CICD Induction

Reagent	Function	Concentration/Details
Doxycycline-inducible BAX vector	Induces mitochondrial apoptosis	Stable expression system
Q-VD-OPh pan-caspase inhibitor	Inhibits caspase activation	10-20 µM [50]
APAF1 knockout cells	Genetic caspase blockade	CRISPR/Cas9 generated
SYTOX Green	Cell death marker	50-500 nM [50]
PGE2 ELISA kit	Quantifies AiP mitogen	Commercial assay
IncuCyte Live-Cell Imager	Kinetic tracking	Compatible with multiwell plates

Step-by-Step Procedure

• Cell Line Preparation:

  • Generate stable WM115 or 501Mel melanoma cell lines expressing doxycycline-inducible BAX (or alternative inducible pro-apoptotic Bcl-2 proteins).
  • Confirm inducible expression via Western blotting for BAX following 24-48 hours of 1 µg/mL doxycycline treatment.
  • Optional: Create APAF1 knockout variants using CRISPR/Cas9 to enable genetic caspase inhibition.

• Experimental Groups Setup:

  • Plate cells in 96-well or 384-well plates at 5,000-10,000 cells/well and allow to adhere for 24 hours.
  • Establish four critical experimental conditions:
    • Group A (Untreated control): No doxycycline, no inhibitor
    • Group B (Apoptosis): 1 µg/mL doxycycline + vehicle control
    • Group C (CICD): 1 µg/mL doxycycline + 20 µM Q-VD-OPh
    • Group D (Inhibitor control): No doxycycline + 20 µM Q-VD-OPh

• Conditioned Media Collection:

  • Treat cells according to experimental groups for 24 hours.
  • Collect supernatant and centrifuge at 500 × g for 5 minutes to remove cellular debris.
  • Aliquot and store conditioned media at -80°C or use immediately for proliferation assays.

• Proliferation Assay:

  • Seed reporter cells (H2B-mCherry labeled) in 96-well plates at 3,000 cells/well.
  • After 24 hours, replace media with 50% fresh media + 50% conditioned media from step 3.
  • Monitor proliferation kinetically using IncuCyte imaging system, quantifying mCherry-positive objects every 2-4 hours for 72-96 hours.

• Validation Measurements:

  • Cell Death Validation: Parallel plates should be stained with SYTOX Green (50 nM) to confirm equivalent cell death induction between Groups B and C at the 24-hour timepoint.
  • Caspase Activity Validation: Confirm caspase activation (Group B) and inhibition (Group C) using DEVD-based caspase assays (see Protocol 2).
  • Mitogen Measurement: Quantify PGE2 levels in conditioned media using ELISA to confirm caspase-dependent mitogen production.

Expected Results and Interpretation

• Successful CICD Induction: Group B (apoptosis) should show rapid SYTOX Green uptake within 12-24 hours, while Group C (CICD) should exhibit delayed but ultimately equivalent cell death by 48-72 hours [50].
• Specific AiP Response: Conditioned media from Group B should stimulate significant proliferation in reporter cells (150-200% of control), while media from Group C should show no proliferative effect (90-110% of control) [50].
• Mitogen Correlation: PGE2 should be significantly elevated in Group B conditioned media but not in Group C, establishing the molecular mechanism of caspase-dependent AiP.

Protocol 2: Live-Cell Multiplexed Caspase and Proliferation Tracking

This protocol utilizes fluorescent reporter systems for simultaneous monitoring of caspase activation and proliferation dynamics in real time, adapted from integrated imaging approaches [2] [13].

Materials and Reagents

Table 3: Live-Cell Tracking Reagents

Reagent	Function	Detection Method
ZipGFP caspase-3/7 reporter	Caspase activation sensor	GFP fluorescence upon DEVD cleavage
Constitutive mCherry	Cell presence normalization	Red fluorescence
NucView488 caspase-3/7 substrate	Alternative caspase detection	Fluorogenic DNA binding
Proliferation dyes (CFSE, CellTrace)	Division tracking	Fluorescence dilution
IncuCyte Caspase-3/7 Dye	Commercial caspase detection	Green/red fluorescence

Step-by-Step Procedure

• Reporter Cell Line Generation:

  • Create stable cell lines expressing ZipGFP-based caspase-3/7 reporter with constitutive mCherry marker using lentiviral transduction [2].
  • Alternatively, use commercial IncuCyte Caspase-3/7 reagents (NucView488-based) for flexible endpoint caspase detection without requiring stable lines [52] [51].
  • Validate reporter functionality using known apoptosis inducers (1 µM camptothecin or 100 µM etoposide) and caspase inhibitors (20 µM Z-VAD-FMK).

• Multiplexed Live-Cell Imaging Setup:

  • Plate reporter cells in 96-well imaging plates at optimal density for proliferation tracking (2,000-5,000 cells/well).
  • If using non-integrating caspase detection, add IncuCyte Caspase-3/7 dye at recommended concentration (typically 1:1000 dilution) [52].
  • For proliferation tracking, pre-label cells with CellTrace Violet or CFSE according to manufacturer protocols.
  • Treat cells with apoptotic stimuli and appropriate controls (including caspase inhibitors).

• Real-Time Data Acquisition:

  • Place plates in IncuCyte or comparable live-cell imaging system maintained at 37°C, 5% CO₂.
  • Program automated image acquisition every 2-4 hours for 72-96 hours across multiple channels:
    • Phase contrast for morphology
    • GFP channel (500-550 nm) for caspase activation
    • Red channel (570-630 nm) for mCherry/constitutive marker
    • Violet/blue channel for proliferation dye dilution

• Image and Data Analysis:

  • Quantify caspase activation events as GFP-positive objects per well or per image field over time.
  • Track proliferation through quantification of mCherry-positive object count increases and proliferation dye dilution in daughter cells.
  • Calculate temporal correlation between caspase wave and subsequent proliferation onset.

Expected Results and Quality Control

• Caspase Activation Kinetics: Apoptotic stimuli should produce a wave of GFP-positive cells typically peaking 12-36 hours post-treatment, completely abolished by co-treatment with caspase inhibitors [2].
• Proliferation Correlation: Increased proliferation should follow caspase activation by 12-48 hours, with spatial correlation between caspase-active regions and subsequent proliferation hotspots.
• Specificity Validation: Caspase inhibitor conditions should show equivalent cell death (by phase contrast morphology) but no subsequent proliferation wave.

Protocol 3: AiP-Specific Pharmacological and Genetic Controls

This protocol provides specific approaches for using pharmacological inhibitors and genetic tools to establish caspase dependence in AiP.

Pharmacological Inhibition Approach

• Caspase Inhibitor Titration:

  • Perform dose-response with pan-caspase inhibitors (Z-VAD-FMK or Q-VD-OPh) from 1-100 µM alongside apoptosis induction.
  • Identify minimal concentration that completely abolishes DEVD cleavage activity while maintaining cell death induction (confirmed by SYTOX Green uptake).
  • Include specific caspase-3/7 inhibitors (DEVD-FMK) at 10-50 µM to test executioner caspase requirement.

• Mitogen Pathway Inhibition:

  • Test PGE2 pathway inhibitors (COX-2 inhibitors like celecoxib 10 µM) to validate specific AiP mechanisms [50].
  • Utilize JNK inhibitors (SP600125 10-20 µM) to assess requirement for this signaling pathway in AiP [49].

Genetic Approaches

• APAF1 Knockout Models:

  • Generate APAF1-deficient cells using CRISPR/Cas9 to disrupt apoptosome formation.
  • Validate by Western blotting and failure to activate caspase-3 upon apoptotic stimulation.
  • Compare AiP responses between APAF1 proficient and deficient cells.

• Caspase-Specific Knockouts:

  • Create caspase-3/7 double knockout cells using sequential CRISPR editing.
  • Test retention of AiP capacity, as caspase-7 may compensate for caspase-3 in some systems [2].

Data Analysis and Interpretation Framework

Key Validation Metrics

To conclusively demonstrate caspase-specific AiP, datasets should satisfy these critical validation metrics:

Table 4: Essential Validation Criteria for Caspase-Specific AiP

Validation Criterion	Experimental Approach	Acceptance Threshold
Caspase Dependence	Caspase inhibition + apoptosis induction	≥80% reduction in proliferation vs. apoptosis alone
CICD Specificity	CICD conditioned media vs. apoptotic media	No significant proliferation above control
Temporal Correlation	Live-cell caspase & proliferation tracking	Proliferation wave follows caspase activation
Mitogen Production	PGE2/Wnt measurement in conditioned media	Significant elevation in apoptotic media only
Genetic Validation	Caspase/APAF1 KO models	Abrogated AiP in knockout background

Troubleshooting Common Specificity Issues

• Incomplete Caspase Inhibition: If proliferation persists despite caspase inhibition, verify complete caspase blockade using DEVD cleavage assays and increase inhibitor concentration or use alternative inhibitors (Q-VD-OPh generally superior to Z-VAD-FMK).

• Unexpected CICD Proliferation: If CICD controls show significant proliferation, verify true caspase-independence by confirming absence of caspase activation and consider alternative CICD inducers (e.g., caspase-independent death inducers).

• Weak AiP Signal: If proliferative responses are weak despite clear caspase activation, consider increasing apoptotic stimulus intensity or testing alternative cell systems with demonstrated AiP capacity.

Research Reagent Solutions

Table 5: Essential Reagents for Controlling Caspase-Independent Effects

Reagent Category	Specific Products	Application & Function
Caspase Inhibitors	Q-VD-OPh, Z-VAD-FMK	Pan-caspase inhibition to test caspase dependence
Caspase Reporters	ZipGFP-DEVD, NucView488, IncuCyte Caspase-3/7 Dyes	Real-time visualization of caspase activation
Cell Death Inducers	Doxycycline-inducible BAX, chemotherapeutics (etoposide, camptothecin)	Controlled apoptosis induction
Proliferation Reporters	H2B-mCherry, CellTrace dyes, CFSE	Tracking and quantifying cell division
CICD Tools	APAF1 KO cells, caspase KO lines	Genetic models of caspase-independent death
Key Assay Kits	PGE2 ELISA, COX-2 inhibitors, Annexin V assays	Validating AiP mechanisms and specificity
Live-Cell Imagers	IncuCyte systems with environmental control	Kinetic monitoring of apoptosis and proliferation

Establishing specificity for caspase-dependent effects in AiP research requires a comprehensive strategy combining pharmacological inhibition, genetic controls, and appropriate CICD comparators. The protocols detailed herein provide a rigorous framework for distinguishing true caspase-mediated proliferation from caspase-independent phenomena, enabling researchers to draw definitive conclusions about AiP mechanisms. Proper implementation of these controls is particularly crucial in therapeutic contexts where misattribution of proliferative signals could lead to incorrect conclusions about treatment efficacy or resistance mechanisms. Through systematic application of these specificity controls, researchers can advance our understanding of the complex dialogue between cell death and proliferation with greater confidence and precision.

Application Note: Core Challenges in Live-Cell AIP Research

Long-term live-cell imaging is essential for studying dynamic processes like apoptosis-induced proliferation (AIP), where apoptotic cells stimulate the proliferation of their neighbors through the release of mitogenic factors such as epidermal growth factors (EGF) and interleukin-6 (IL-6). Capturing these events requires maintaining cell health and imaging precision over days while automatically quantifying apoptosis and subsequent proliferation [2]. This application note details best practices for overcoming primary challenges in these experiments: preserving cell viability, mitigating focus drift, and ensuring strict environmental control.

Key Challenges and Quantitative Comparisons

The table below summarizes the core challenges and the technological solutions required to address them for successful AIP research.

Table 1: Core Challenges and Technical Solutions for Long-Term AIP Imaging

Challenge	Impact on AIP Experiments	Recommended Solution	Key Performance Metrics
Cell Viability & Health	Compromised cell health alters apoptotic kinetics and proliferative responses, yielding unreliable AIP data [2].	Integrated incubation chambers (CO₂, temperature, humidity) [53] [54] [55].	Temperature: 37°C ± 0.5°C; CO₂: 5% ± 0.2%; Humidity: >90% [55].
Phototoxicity	Excessive light exposure induces aberrant apoptosis, confounding the study of genuine AIP mechanisms [56].	Adaptive illumination, low-light detectors, long-wavelength fluorophores [56] [54].	Use of H2B-mRFPruby (far-red) for nuclear labeling to minimize damage [56].
Focus Drift	Loss of focus over days corrupts cell tracking and lineage tracing, essential for AIP [56].	Automated focus stabilization systems (hardware or software-based) [53] [54].	Precise thermal regulation to mitigate thermal Z-drift [53].
Temporal Resolution	Infrequent imaging misses rapid caspase activation or early cell divisions in AIP [2].	Automated scheduling for high-frequency imaging without user intervention [54].	Imaging intervals of 20 minutes for reliable cell tracking over 5-10 days [56].

Protocol: Multiplexed Kinetic AIP Assay

Experimental Workflow for AIP Detection

This protocol enables the real-time tracking of apoptosis and the subsequent proliferation of neighboring cells.

Materials and Reagents

Table 2: Research Reagent Solutions for AIP Assays

Reagent / Solution	Function in AIP Experiment	Example Application
Caspase-3/7 Dye (DEVD-based) [9] [52]	Irreversibly labels nuclei upon caspase-3/7 activation, identifying apoptotic cells.	Kinetic quantification of initial apoptotic event in AIP cascade.
Annexin V Dye [9] [52]	Binds to externalized phosphatidylserine (PS), an early marker of apoptosis.	Confirming apoptosis via a second pathway; multiplexing with caspase-3/7 dye.
Nuclight Reagents (Lentivirus) [9] [52]	Constitutively labels all nuclei with a fluorescent protein (e.g., NIR, green).	Automated counting of total and proliferating cell populations.
ZipGFP Caspase Reporter [2]	Genetically encoded biosensor that fluoresces upon caspase-3/7 cleavage.	Stable cell line generation for long-term, background-free apoptosis tracking in 2D and 3D.
Proliferation Dye (e.g., CFSE)	Labels cell cytoplasm upon division, enabling tracking of proliferative bursts.	Directly identifying and quantifying proliferation in cells neighboring apoptosis.

Step-by-Step Methodology

• Cell Preparation: Generate a stable cell line expressing a constitutive nuclear label (e.g., Incucyte Nuclight NIR) for robust cell counting and tracking [9] [52]. For studies in 3D models, adapt these lines to spheroid or organoid culture [2].
• Assay Setup:
  • Plate cells in a 96-well or 384-well plate at an optimal density for proliferation (e.g., 2,000 cells/well for A549 cells) [9].
  • Prepare treatment compounds (e.g., Camptothecin, Cisplatin) in serial dilutions.
  • Add the Incucyte Caspase-3/7 Green Dye (1:1000 dilution) directly to the media. No wash steps are required [9] [52].
• Imaging Configuration:
  • Place the plate into the automated live-cell imaging system (e.g., Incucyte) inside a standard tissue culture incubator or a system with a built-in environmental chamber [9] [52].
  • Environmental Control: Activate and verify precise control of temperature (37°C), CO₂ (5%), and humidity (>90%) to ensure normal cell metabolism and development [54] [55].
  • Acquisition Schedule: Program a time-lapse method with regular intervals (e.g., every 2-4 hours) over a minimum of 72 hours to capture the entire AIP sequence [9].
  • Focus Management: Engage the automated focus stabilization system to compensate for thermal drift during the extended acquisition [53] [54].
• Data Analysis:
  • Use integrated software to automatically segment and quantify green fluorescent objects (apoptotic cells) and red/blue fluorescent nuclei (total cells) in each well at every time point [9].
  • Generate kinetic plots of apoptotic counts and total nuclear counts.
  • To analyze AIP, correlate the time course and location of apoptotic signals with subsequent increases in proliferation in neighboring, non-apoptotic cells [2].

Signaling Pathways in Apoptosis-Induced Proliferation

The following diagram illustrates the core signaling relationship between apoptosis and the induction of proliferation in neighboring cells, which is the focal point of this research.

Validating AiP Phenomena and Comparative Analysis Across Biological Contexts

In the field of live-cell tracking of apoptosis-induced proliferation (AIP), endpoint validation techniques are crucial for confirming the molecular events suggested by dynamic imaging. AIP is a paradoxical process where apoptotic cells actively stimulate the proliferation of their neighboring surviving cells, playing critical roles in development, regeneration, and tumor repopulation after therapy [13] [6]. While real-time reporters like the ZipGFP caspase biosensor allow for dynamic observation of apoptosis, flow cytometry provides essential, quantitative validation of specific death markers at the population level [13] [2]. This application note details robust flow cytometry protocols for detecting two key endpoints: phosphatidylserine externalization via Annexin V and immunogenic cell death marked by calreticulin exposure, enabling researchers to contextualize their AIP findings within well-defined cell death frameworks.

Core Principles and Signaling Pathways

The Role of Endpoint Assays in AIP Research

In AIP research, endpoint assays anchor the interpretation of live-cell imaging data. The core principle involves caspase-activated apoptotic cells releasing mitogenic signals such as Wnt, Hedgehog, or Prostaglandin E2 (PGE2), which drive compensatory proliferation in surrounding tissues [6]. Flow cytometry provides snapshot validation of cell death initiation and immunogenic signaling, confirming that the observed proliferative responses originate from bona fide apoptotic events. Calreticulin exposure is a particularly significant endpoint as it represents a key "eat-me" signal that bridges mere apoptosis to immunogenic cell death, a process with substantial implications for anticancer therapy [13] [57].

Key Signaling Pathways in Apoptosis and Immunogenic Cell Death

The following diagram illustrates the central signaling pathways in apoptosis and immunogenic cell death, connecting key molecular events to the detectable markers used for validation.

Quantitative Data and Caspase Specificity

Caspase Cleavage Specificities for DEVD-Based Reporters

The DEVD peptide sequence used in many apoptosis reporters demonstrates varying susceptibility to different caspases, which is crucial for interpreting both live-cell imaging and endpoint validation data.

Table 1: Caspase Specificity for DEVD Cleavage Motif

Caspase	Cleaves DEVD	Preferred Motif	Function / Role
Caspase-3	+++ (Strong)	DEVD	Executioner (apoptosis)
Caspase-7	+++ (Strong)	DEVD	Executioner (apoptosis)
Caspase-8	++ (Weak)	LETD, XEXD	Initiator (extrinsic pathway)
Caspase-9	+ (Very Weak)	LEHD, WEHD	Initiator (intrinsic pathway)
Caspase-2	+ (Very Weak)	VDVAD, XDEVD	Apoptotic / stress response
Caspase-6	++ (Weak)	VQVD, VEVD	Executioner (apoptosis)
Caspase-1	- (No)	WEHD, YVHD	Inflammatory (IL-1β activation)
Caspase-4/5	- (No)	LEVD, WEHD-like	Inflammatory (LPS sensing)

Source: Adapted from [13]

Experimental Readouts from Integrated Apoptosis Platforms

Recent integrated platforms combining real-time reporters with endpoint validation have generated key quantitative metrics that demonstrate the relationship between caspase activation and downstream events.

Table 2: Experimental Readouts from Integrated Apoptosis Platforms

Experimental Model	Treatment	Key Apoptosis Readout	AIP/ICD Corollary
2D Cell Culture (Stable Reporter Line)	Carfilzomib (Proteasome Inhibitor)	>5-fold increase in ZipGFP fluorescence (caspase-3/7 activation) [13]	Concurrent proliferation dye dilution in neighboring cells [2]
3D Patient-Derived Organoids (PDAC)	Carfilzomib	Localized GFP fluorescence in heterogeneous structures [2]	N/D
MCF-7 (Caspase-3 Deficient)	Carfilzomib	Significant GFP signal (caspase-7 mediated) [13]	Confirms caspase-7 sufficient for AIP signaling
Sea Cucumber Regeneration Model	zVAD (Apoptosis Inhibitor)	39-60% reduction in apoptosis (TUNEL assay) [25]	Decreased cell proliferation (BrdU incorporation) in rudiment [25]

Detailed Experimental Protocols

Annexin V/Propidium Iodide Staining Protocol for Apoptosis Detection

The Annexin V/PI staining protocol provides a reliable method for distinguishing between early apoptotic, late apoptotic, and necrotic cell populations based on phosphatidylserine exposure and membrane integrity [58] [59].

Materials Needed

• Cells: Cultured cells or cell suspension from tissues (0.5-1 × 10⁶ cells per sample)
• Annexin V Conjugate: Fluorochrome-labeled (FITC, PE, APC, or similar)
• Propidium Iodide (PI): Stock solution (50 µg/mL) or 7-AAD as alternative
• Binding Buffer: 10 mM HEPES, 140 mM NaCl, 2.5 mM CaCl₂, pH 7.4
• Flow Cytometer equipped with appropriate lasers and filters
• Controls: Unstained cells, single-stained controls (Annexin V-only, PI-only), apoptosis-induced positive control

Step-by-Step Procedure

• Cell Preparation

  • Harvest cells gently using non-enzymatic dissociation methods for adherent cells to preserve membrane integrity.
  • Wash cells twice in cold PBS and once in 1X Binding Buffer.
  • Resuspend cell pellet in 1X Binding Buffer at 1-5 × 10⁶ cells/mL.

• Staining

  • Transfer 100 µL of cell suspension to flow cytometry tube.
  • Add 5 µL of fluorochrome-conjugated Annexin V.
  • Add 5 µL of PI solution (50 µg/mL).
  • Gently vortex tubes to mix and incubate for 15 minutes at room temperature in the dark.

• Analysis

  • Within 1 hour of staining, add 400 µL of 1X Binding Buffer to each tube.
  • Analyze samples by flow cytometry using FITC (Annexin V) and PE/Pero-CP (PI) channels.
  • Include single-stained controls for proper compensation.

Data Interpretation

• Viable Cells: Annexin V negative / PI negative
• Early Apoptotic Cells: Annexin V positive / PI negative
• Late Apoptotic/Necrotic Cells: Annexin V positive / PI positive
• Necrotic Cells: Annexin V negative / PI positive (less common)

Critical Notes: Avoid EDTA-containing buffers as Annexin V binding is calcium-dependent. Include a viability dye when working with fixed cells or performing intracellular staining [60].

Surface Calreticulin Staining Protocol for Immunogenic Cell Death Detection

Surface exposure of calreticulin is a definitive marker for immunogenic cell death (ICD) and can be detected by flow cytometry following specific staining protocols [57].

Materials Needed

• Cells: Treated and untreated controls (0.5-1 × 10⁶ cells per sample)
• Primary Antibody: Anti-calreticulin antibody (clone FMC 75 or equivalent)
• Secondary Antibody: Fluorochrome-conjugated species-specific antibody (if needed)
• Staining Buffer: PBS with 1% BSA or FBS
• Fixation Buffer: 2-4% formaldehyde (if fixation is required)
• Flow Cytometer with appropriate laser and filter setup

Step-by-Step Procedure

• Cell Harvest and Washing

  • Harvest cells gently to preserve surface antigen integrity.
  • Wash cells twice with cold staining buffer.

• Surface Staining

  • Resuspend cell pellet in 100 µL staining buffer.
  • Add optimized concentration of primary anti-calreticulin antibody.
  • Incubate for 30 minutes at 4°C in the dark.
  • Wash twice with staining buffer to remove unbound antibody.
  • If using secondary antibody, add appropriate dilution and incubate for 30 minutes at 4°C in the dark, then wash twice.

• Analysis

  • Resuspend cells in 300-500 µL staining buffer.
  • Analyze by flow cytometry within 4 hours or fix with 2% formaldehyde for later analysis.
  • Include isotype control and unstained cells for gating background fluorescence.

Data Interpretation

• Calreticulin-positive populations indicate cells undergoing immunogenic cell death.
• In cancer cells, surface calreticulin serves as a pro-phagocytic signal through interaction with LRP receptors on phagocytic cells [57].
• Combine with Annexin V staining to correlate calreticulin exposure with apoptotic progression.

The Scientist's Toolkit: Essential Research Reagents

Table 3: Essential Research Reagents for Apoptosis and AIP Studies

Reagent/Category	Specific Examples	Function/Application
Caspase Reporters	ZipGFP DEVD-based biosensor [13]	Real-time visualization of caspase-3/7 activation in live cells
Constitutive Markers	mCherry (lentiviral expression) [2]	Normalization control for cell presence and transduction efficiency
Apoptosis Inducers	Carfilzomib, Oxaliplatin, Staurosporine [13] [58]	Positive controls for inducing apoptotic cell death
Caspase Inhibitors	zVAD-FMK (pan-caspase inhibitor) [13] [25]	Validation of caspase-dependent apoptosis
Proliferation Tracking	Cell Trace dyes, BrdU/EdU kits [2] [25]	Detection of apoptosis-induced proliferation in neighboring cells
Flow Cytometry Kits	Annexin V/PI detection kits [60] [59]	Quantitative endpoint measurement of apoptosis stages
ICD Detection	Anti-calreticulin antibodies [57]	Detection of immunogenic cell death marker
3D Culture Systems	CultrexTM, organoid culture media [2]	Physiologically relevant models for apoptosis studies

Workflow Integration for AIP Research

The following diagram illustrates a comprehensive experimental workflow that integrates live-cell imaging with endpoint flow cytometry validation for the study of apoptosis-induced proliferation.

The integration of endpoint flow cytometry validation with real-time live-cell imaging creates a powerful framework for investigating apoptosis-induced proliferation. The Annexin V/PI protocol provides essential quantification of apoptosis progression, while calreticulin detection confirms immunogenic cell death—a critical aspect of the tumor microenvironment and therapy response. When contextualized within AIP research, these techniques enable researchers to move beyond correlation to establish causative relationships between apoptotic events and subsequent proliferative responses. The standardized protocols and reagent toolkit presented here offer a foundation for robust, reproducible investigation of this biologically significant and therapeutically relevant phenomenon.

Within live-cell research focusing on Apoptosis-Induced Proliferation (AiP), a critical step is the unequivocal confirmation that the observed compensatory proliferation is a direct consequence of caspase-mediated apoptotic signaling [13] [2]. AiP is a compensatory process where apoptotic cells actively stimulate the proliferation of neighboring surviving cells, a phenomenon increasingly recognized as a driver of tumour repopulation following cytotoxic therapies [13] [2]. Pharmacological inhibition using the pan-caspase inhibitor zVAD-FMK provides a powerful tool for this validation. This application note details the integration of zVAD-FMK into experimental workflows featuring real-time, live-cell imaging to confirm the caspase dependence of AiP.

zVAD-FMK (carbobenzoxy-valyl-alanyl-aspartyl-[O-methyl]-fluoromethylketone) is a cell-permeant, irreversible pan-caspase inhibitor that binds to the catalytic site of caspase proteases, thereby preventing the induction of apoptosis [61] [62]. Its function is to block the activation of pro-caspases, such as pro-caspase-3, rather than directly inhibiting the proteolytic activity of the already-activated enzyme [62]. In the context of AiP, its application allows researchers to dissect whether the proliferative signals originate from the caspase activation phase of apoptosis or from earlier, caspase-independent events.

The AiP Signaling Pathway and zVAD-FMK Inhibition

The following diagram illustrates the core signaling pathway of Apoptosis-Induced Proliferation and the specific point of inhibition by zVAD-FMK.

Key Reagents and Experimental Setup

Research Reagent Solutions

The following table details the essential reagents required for implementing this protocol.

Reagent / Tool	Function / Role in the Experiment
zVAD-FMK	Cell-permeant, irreversible pan-caspase inhibitor used to confirm the caspase-dependence of AiP by blocking caspase activation [13] [61].
Caspase-3/-7 Reporter (e.g., ZipGFP-DEVD)	Fluorescent biosensor that undergoes fluorescence reconstitution upon cleavage by caspase-3 or -7, enabling real-time visualization of apoptosis [13] [2].
Constitutive Fluorescent Marker (e.g., mCherry)	Provides a persistent marker for successful reporter transduction, cell presence, and normalization for fluorescence-based assays [13] [2].
Proliferation Dye	A fluorescent cell tracking dye (e.g., CellTrace) used to quantify the proliferation of neighboring surviving cells [13] [2].
Apoptosis Inducer	A chemical agent (e.g., Carfilzomib, Oxaliplatin) used to trigger the intrinsic apoptotic pathway in the experimental system [13] [2].

Quantitative Data from Key Experiments

The table below summarizes quantitative findings from foundational experiments utilizing zVAD-FMK to inhibit caspase-dependent processes, providing a reference for expected outcomes.

Experimental Context	Treatment	Key Measured Outcome	Effect of zVAD-FMK
Real-time Caspase-3/-7 Tracking [13]	Oxaliplatin vs. Oxaliplatin + zVAD-FMK	GFP fluorescence (caspase activity) over 120 hours	Suppressed reporter activation; progressive GFP increase with oxaliplatin alone was abrogated.
Caspase-3 Deficient MCF-7 Cells [13] [2]	Carfilzomib	GFP signal from caspase-7 mediated DEVD cleavage	Significant GFP signal still detected, confirming caspase-7 is sufficient for reporter activation.
Necroptosis Induction (L929 cells) [63]	TNF-α	Viability via necrotic cell death	Increased vulnerability to TNF-α-induced necrosis, illustrating a switch in cell death modality.
T Cell Proliferation [62]	Anti-CD3/CD28 costimulation	General T cell proliferation	Dose-dependent inhibition, suggesting caution for long-term/co-stimulation assays.

Detailed Experimental Protocol

Workflow for zVAD-FMK in AiP Validation

The integrated experimental workflow for confirming caspase-dependent AiP, from cell preparation to final analysis, is outlined below.

Step-by-Step Methodology

Cell Line Generation and Culture

• Stable Reporter Generation: Generate stable cell lines expressing a lentiviral-delivered caspase-3/-7 reporter (e.g., ZipGFP with a DEVD cleavage motif) alongside a constitutive fluorescent marker like mCherry [13] [2]. The mCherry serves as a marker for cell presence and transduction success, though its long half-life makes it less suitable for real-time viability assessment post-death [13] [2].
• Culture Conditions: Maintain reporter cells in appropriate 2D monolayers or adapt them to more physiologically relevant 3D culture systems, such as spheroids or patient-derived organoids (PDOs), to study AiP in a complex tissue context [13] [2].

Inhibitor Preparation and Treatment

• zVAD-FMK Reconstitution: Resuspend zVAD-FMK in anhydrous DMSO to a stock concentration of 20 mM. Aliquot and store at -20°C [61] [62].
• Application in Experiment: For AiP assays, add zVAD-FMK to the cell culture medium at a final concentration of 20 µM [61]. To ensure effective caspase inhibition prior to apoptosis induction, pre-incubate cells with zVAD-FMK for 1-2 hours before adding the apoptotic stimulus [13].

Induction of Apoptosis and Proliferation Labeling

• Apoptosis Induction: Following the pre-incubation period, induce apoptosis using a suitable agent such as the proteasome inhibitor carfilzomib or oxaliplatin [13] [2]. Include control groups treated with the vehicle (e.g., DMSO) and groups treated with the inducer in the absence of zVAD-FMK.
• Proliferation Tracking: Prior to imaging, label cells with a fluorescent proliferation dye (e.g., CellTrace Violet) according to the manufacturer's instructions. This dye dilutes with each cell division, allowing for the quantification of proliferation in neighboring, surviving cells [13] [2].

Live-Cell Imaging and Kinetic Analysis

• Image Acquisition: Subject the plates to time-lapse live-cell imaging for an extended period (typically 80-120 hours) using a high-content imaging system (e.g., IncuCyte) [13] [64]. Acquire images of the GFP (caspase activity), mCherry (cell presence), and proliferation dye channels at regular intervals (e.g., every 2-3 hours).
• Kinetic Analysis: Use integrated software (e.g., IncuCyte AI Cell Health Module) to automatically quantify the GFP-positive apoptotic cells and the mCherry-positive viable cell count over time [13] [2]. The simultaneous tracking of caspase activation and viability loss provides single-cell resolution of apoptotic kinetics.

Endpoint Analysis of AiP and Immunogenic Markers

• Proliferation Quantification: At the endpoint of the experiment, harvest the cells and analyze the dilution of the proliferation dye in the caspase-negative (GFP-negative) cell population via flow cytometry. A significant reduction in proliferation dye intensity in the group treated with the apoptosis inducer alone—but not in the group co-treated with zVAD-FMK—confirms that the proliferation is caspase-dependent [13] [2].
• Supplementary Assays: The platform also allows for simultaneous endpoint detection of immunogenic cell death (ICD) markers, such as the surface exposure of calreticulin, by flow cytometry, providing additional insights into the immunogenic properties of the cell death triggered [13] [2].

Troubleshooting and Key Considerations

• zVAD-FMK Solubility and Stability: zVAD-FMK is soluble in DMSO but insoluble in water or ethanol. Avoid repeated freeze-thaw cycles of the stock solution. For prolonged assays, verify inhibitor stability in culture medium [62].
• Concentration Optimization: While 20 µM is a standard working concentration, titrate zVAD-FMK (e.g., 10-50 µM) for specific cell lines and apoptosis inducers to ensure complete inhibition without off-target effects [62].
• Context-Dependent Cell Death: Inhibition of caspases can sometimes lead to a shift in the mode of cell death, for instance, from apoptosis to necroptosis [63] [65]. Include controls and assays to monitor for alternative cell death pathways if caspase inhibition is incomplete or the death stimulus is strong.
• Proliferation Assay Controls: Always include a non-induced, proliferation dye-labeled control to establish the baseline proliferation rate. This is crucial for accurately attributing any increase in proliferation to the AiP mechanism.

The maintenance of tissue homeostasis is a fundamental process in multicellular organisms, requiring a delicate balance between cell death and cell proliferation. Apoptosis, a form of programmed cell death, serves not only to eliminate unwanted or damaged cells but also actively participates in signaling processes that maintain tissue integrity. A key phenomenon bridging these processes is Apoptosis-Induced Proliferation (AiP), a compensatory mechanism where dying cells actively stimulate mitosis in their surviving neighbors [1] [6]. This process ensures that tissues can continue to develop or regenerate even when significant cell loss occurs, maintaining homeostasis despite apoptotic insults.

The study of AiP has been revolutionized by genetic models, particularly in Drosophila melanogaster, where the 'undead' cell system has enabled detailed dissection of the underlying mechanisms. In parallel, advances in mammalian model systems and real-time imaging technologies have provided critical insights into the conservation and pathophysiological relevance of AiP. This article explores the conceptual framework, experimental methodologies, and key findings from these genetic models, providing researchers with practical tools for investigating AiP in both Drosophila and mammalian contexts, with particular emphasis on live-cell tracking approaches essential for contemporary AIP research.

Conceptual Framework and Definitions

Distinguishing Compensatory Proliferation and Apoptosis-Induced Proliferation

A critical conceptual foundation for AiP research lies in distinguishing it from the broader phenomenon of compensatory proliferation (CP). While these terms have historically been conflated, recent clarifications establish clear distinctions:

• Compensatory Proliferation (CP): Describes a process where surviving cells detect tissue damage or loss and proliferate to restore normal organ size and function [1] [6]. CP can be initiated through multiple distinct mechanisms, including non-apoptotic forms of cell death, mechanical cues from disrupted tissue architecture, or systemic factors sensing overall tissue mass reduction. Crucially, CP can occur entirely independently of apoptotic signaling.
• Apoptosis-Induced Proliferation (AiP): Represents a specialized form of CP where apoptotic cells—instead of undergoing passive clearance—actively stimulate mitosis in nearby surviving cells [1] [6]. A defining feature of AiP is the involvement of apoptotic caspases, which not only execute cell death but also contribute to AiP by actively releasing growth-promoting signals.

Table 1: Key Characteristics of Compensatory Proliferation and Apoptosis-Induced Proliferation

Characteristic	Compensatory Proliferation (CP)	Apoptosis-Induced Proliferation (AiP)
Initiating Signal	Tissue damage/loss, mechanical cues, systemic factors	Apoptotic cells
Role of Apoptosis	Non-essential; can occur independently	Essential and defining
Caspase Involvement	Not required	Required for signal production
Signaling Source	Surviving cells	Apoptotic or undead cells
Biological Outcome	Tissue homeostasis restoration	Tissue repair, regeneration, potential overgrowth

The 'Undead' Cell Model

A cornerstone of AiP research involves the 'undead' cell model, primarily established in Drosophila. In this experimental system, cells are triggered to initiate apoptosis through genetic means (e.g., expression of pro-apoptotic proteins like Hid, Reaper, or Grim) but are prevented from completing the death process through concurrent expression of caspase inhibitors like P35 [15] [66]. This creates a population of 'undead' cells that persist in a state of continuous apoptotic signaling without being eliminated, resulting in sustained secretion of mitogenic factors that can produce dramatic overgrowth phenotypes [15]. These 'undead' cells have been instrumental in identifying key signaling pathways and caspases involved in AiP.

Drosophila Genetic Models of AIP

Fundamental Mechanisms and Key Findings

Genetic studies in Drosophila have revealed that distinct mechanisms of AiP are employed in apoptotic tissues of different developmental states, involving different caspases and signaling pathways [15] [67]:

• Dronc-Dependent AiP in Proliferating Tissues: In proliferating eye and wing imaginal discs, the initiator caspase Dronc coordinates cell death and compensatory proliferation through the Jun N-terminal kinase (JNK) pathway and p53 [15]. This process leads to induction of the mitogens Decapentaplegic (Dpp, a BMP homolog) and Wingless (Wg, a Wnt homolog).
• Effector Caspase-Dependent AiP in Differentiating Tissues: In differentiating eye tissues posterior to the morphogenetic furrow, the effector caspases DrICE and Dcp-1 activate the Hedgehog (Hh) signaling pathway to induce compensatory proliferation [15] [67]. This mechanism can trigger cell-cycle reentry of cells that had previously exited the cell cycle.

Table 2: Distinct AiP Mechanisms in Drosophila Tissues

Tissue Context	Key Caspase	Signaling Pathways	Mitogens Produced	Developmental State
Proliferating tissues (wing disc, eye anterior to MF)	Dronc (initiator)	JNK, p53	Dpp, Wg	Proliferating
Differentiating tissues (eye posterior to MF)	DrICE, Dcp-1 (effector)	Hedgehog	Hedgehog	Differentiating

Drosophila AiP Signaling Pathways

Apoptosis-Induced Apoptosis (AiA) and TNF Signaling

Beyond AiP, research in Drosophila has revealed another form of apoptotic communication: Apoptosis-Induced Apoptosis (AiA). This phenomenon occurs when apoptotic cells produce Eiger, the Drosophila TNF homolog, which activates the JNK pathway in neighboring cells and induces them to die [66]. This mechanism helps explain the coordinated "communal death" of cell populations observed during development and under pathological conditions, demonstrating that apoptotic signaling can propagate beyond initially affected cells.

Experimental Protocol: Establishing Drosophila 'Undead' Cell System

Objective: Generate 'undead' cells in Drosophila imaginal discs to study AiP mechanisms.

Materials:

• Drosophila strains: Engrailed-Gal4 (or other tissue-specific Gal4 drivers), UAS-hid (or UAS-rpr), UAS-p35
• Standard Drosophila culture equipment and media
• Fixation and dissection tools for imaginal discs
• Antibodies for immunofluorescence: anti-caspase-3 (activated), anti-Wg, anti-Dpp, anti-Hh, anti-phospho-Histone H3 (mitosis marker)

Procedure:

• Genetic Cross Setup: Cross Engrailed-Gal4 (en-Gal4) females with UAS-hid, UAS-p35 males to generate progeny expressing both hid and p35 in the posterior compartment of wing imaginal discs.
• Larval Collection and Rearing: Collect progeny larvae and rear at 25°C until third instar stage.
• Tissue Dissection: Dissect wing imaginal discs from third instar larvae in PBS.
• Fixation and Staining: Fix discs in 4% paraformaldehyde and process for immunofluorescence using relevant antibodies.
• Imaging and Analysis: Image discs using confocal microscopy. Analyze patterns of caspase activation, mitogen expression, and proliferation markers.

Expected Results: 'Undead' cells in the posterior compartment will show elevated activated caspase-3 staining, induce expression of Wg and Dpp, and stimulate non-autonomous proliferation. Additionally, AiA may be observed as caspase activation in the anterior compartment [66].

Mammalian Systems and Real-Time Tracking of AIP

Conservation of AIP Mechanisms in Mammalian Systems

While initially characterized in Drosophila, AiP mechanisms show significant conservation in mammalian systems. Key findings include:

• Caspase-Dependent Mechanisms: As in Drosophila, apoptotic caspases in mammalian systems contribute to compensatory proliferation signals, with caspase-3 playing a particularly important role [13] [11].
• Mitogenic Signaling: Apoptotic mammalian cells release growth factors such as prostaglandin E2 (PGE2), Wnts, and hedgehog proteins that stimulate proliferation of neighboring cells [1] [6].
• Pathophysiological Relevance: In mammals, AiP has been implicated in tissue regeneration, wound healing, and cancer recurrence following therapy [1] [6]. For example, after irradiation, apoptotic tumor cells can release PGE2 that stimulates proliferation of surviving tumor cells, potentially contributing to treatment resistance.

Advanced Real-Time Tracking Methodologies

Recent technological advances have enabled real-time tracking of AiP dynamics in mammalian systems, providing unprecedented temporal resolution and mechanistic insights:

ZipGFP Caspase-3/7 Reporter System: This innovative platform utilizes a genetically engineered caspase-activatable fluorescent biosensor based on a split-GFP architecture [13] [2]. The GFP molecule is divided into two parts tethered via a flexible linker containing a caspase-3/7-specific DEVD cleavage motif. Under basal conditions, minimal background fluorescence is observed. Upon caspase-3/7 activation during apoptosis, cleavage at the DEVD site allows spontaneous refolding into functional GFP, producing a fluorescent signal that serves as a specific, irreversible, and time-accumulating marker of caspase activation.

SPARKL (Single-Cell and Population-Level Analyses Using Real-Time Kinetic Labeling): This integrated workflow combines high-content live-cell imaging with automated detection and analysis of fluorescent reporters of cell death [68]. SPARKL enables zero-handling, non-disruptive protocols for detailing cell death mechanisms and proliferation profiles, offering superior sensitivity and temporal resolution compared to traditional endpoint assays.

Mammalian AiP Tracking Workflow

Experimental Protocol: Real-Time AIP Tracking in Mammalian 3D Cultures

Objective: Monitor AiP dynamics in real-time using caspase reporter systems in 3D spheroid/organoid models.

Materials:

• Stable caspase-3/7 reporter cell lines (ZipGFP-based system with constitutive mCherry marker)
• Apoptosis inducers: carfilzomib (1-10 µM), oxaliplatin (10-100 µM), or other context-appropriate agents
• Caspase inhibitor: zVAD-FMK (20-50 µM) for control experiments
• Cell proliferation dye: eFluor 670, CFSE, or similar
• Live-cell imaging compatible plates and imaging system (e.g., IncuCyte)
• 3D culture matrix: Cultrex, Matrigel, or similar
• Flow cytometry equipment for calreticulin exposure analysis

Procedure:

• Reporter Cell Culture: Maintain stable caspase-3/7 reporter cells in appropriate medium. Validate reporter functionality using known apoptosis inducers and caspase inhibitors [13] [2].
• 3D Spheroid/Organoid Formation:
  • For spheroids: Seed reporter cells in ultra-low attachment plates or embed in 3D culture matrix.
  • For patient-derived organoids (PDOs): Transduce with lentiviral caspase reporter and culture in appropriate 3D matrix.
• Treatment and Live-Cell Imaging:
  • Treat 3D cultures with apoptosis inducers alone or in combination with zVAD-FMK.
  • Add proliferation dye to track division of surviving cells.
  • Transfer to live-cell imaging system and acquire images every 2-4 hours for 72-120 hours.
• Endpoint Immunogenic Cell Death (ICD) Analysis:
  • Harvest cells after live imaging for flow cytometric analysis of surface calreticulin exposure.
  • Stain with anti-calreticulin antibody and appropriate secondary antibodies.
• Data Analysis:
  • Quantify GFP fluorescence intensity over time to track caspase activation kinetics.
  • Analyze proliferation dye dilution to identify AiP in surviving cells.
  • Correlate caspase activation timing with subsequent proliferation events.
  • Assess calreticulin exposure as a marker of ICD.

Expected Results: Apoptosis induction will trigger time-dependent GFP fluorescence indicating caspase-3/7 activation. Following initial cell death, proliferation dye dilution in non-apoptotic cells will demonstrate AiP. zVAD-FMK co-treatment should suppress both caspase activation and subsequent proliferation, confirming the caspase-dependent nature of the process [13] [2].

Comparative Analysis and Research Applications

The Scientist's Toolkit: Essential Research Reagents

Table 3: Key Research Reagents for AIP Studies

Reagent/Category	Specific Examples	Function/Application	Model Systems
Caspase Reporters	ZipGFP DEVD-based biosensor, FRET-based caspase sensors	Real-time visualization of caspase activation	Mammalian, Drosophila
Cell Death Inducers	Hid, Reaper, Grim (genetic), carfilzomib, oxaliplatin (pharmacological)	Initiate apoptosis and AiP signaling	Drosophila, mammalian
Caspase Inhibitors	P35, p35, zVAD-FMK	Block effector caspase activity, create 'undead' state	Drosophila, mammalian
Proliferation Trackers	eFluor 670, CFSE, phospho-Histone H3 staining	Label and monitor dividing cells	Mammalian, Drosophila
Signaling Pathway Reagents	JNK inhibitors, Wg/Wnt agonists/antagonists, Hh pathway modulators	Dissect specific signaling pathways in AiP	Drosophila, mammalian
Live-Cell Imaging Systems	IncuCyte, spinning disc confocal microscopy	Real-time kinetic monitoring of AiP	Mammalian, Drosophila

Comparative Analysis of Drosophila and Mammalian AIP Models

Table 4: Comparison of Key AIP Features Between Drosophila and Mammalian Systems

Feature	Drosophila Models	Mammalian Models
Genetic Tractability	High; well-established genetic tools, RNAi libraries, CRISPR	Moderate; improving with CRISPR but more complex
'Undead' Cell Paradigm	Well-established using p35 expression	Limited application; primarily pharmacological inhibition
Real-Time Imaging Resolution	Good for tissue-level analysis; challenges for single-cell tracking in intact tissues	Excellent; advanced reporter systems for single-cell tracking in 2D and 3D cultures
Conserved Pathways	JNK, Dpp/Wg (BMP/Wnt), Hh	JNK, BMP/Wnt, Hh, TNF, PGE2
Physiological Relevance	Developmental contexts, tissue regeneration	Tissue regeneration, cancer therapy response, disease models
Throughput Capacity	Moderate; genetic screens feasible but lower throughput than mammalian cellular screens	High; adaptable to high-content screening formats

Genetic models of AiP, particularly the Drosophila 'undead' system and mammalian real-time tracking approaches, have fundamentally advanced our understanding of how apoptotic cells influence their microenvironment. The conserved nature of AiP mechanisms across evolution underscores their fundamental importance in tissue homeostasis and repair. The experimental protocols outlined here provide researchers with robust methodologies for investigating AiP in both genetic and mammalian systems, with particular emphasis on emerging live-cell tracking technologies that offer unprecedented temporal resolution.

Future directions in AiP research will likely focus on integrating these model systems to leverage their respective strengths, developing more sophisticated reporters for parallel tracking of multiple signaling events, and applying single-cell omics approaches to characterize heterogeneous cellular responses to apoptotic signaling. Furthermore, translating these basic research findings into therapeutic applications—particularly in the contexts of regenerative medicine and cancer therapy—represents a promising frontier where inhibiting pathological AiP could prevent tumor recurrence while promoting beneficial AiP could enhance tissue regeneration.

Apoptosis-induced proliferation (AiP) is a conserved process where dying cells activate signaling cascades that stimulate proliferation in their surviving neighbors [49]. This mechanism is crucial for epithelial wound repair and regeneration but also presents a paradoxical challenge in oncology, where therapy-induced cell death may inadvertently fuel tumor repopulation [11] [69] [49]. This Application Note delineates the mechanistic differences between regenerative and tumorigenic AiP and provides detailed protocols for their experimental investigation in live-cell systems. Understanding these contrasting signaling paradigms is essential for developing regenerative therapies that promote healing while avoiding unintended oncogenic consequences.

Core Mechanisms of AiP

Key Signaling Pathways and Molecular Players

Table 1: Comparative Mechanisms of AiP in Physiology vs. Pathology

Feature	Physiological AiP (Epithelial Repair)	Pathological AiP (Tumor Regrowth)
Primary Initiators	Tissue damage, localized apoptosis	Cytotoxic therapy, chronic inflammation
Key Caspases	Initiator caspase Dronc (Drosophila), Caspase-9 (mammals); Effector caspases in specific contexts [69] [49]	Sustained initiator & effector caspase activity [49]
Critical Signaling Nodes	JNK, ROS, specific mitogen production (Wg, Spi, Dpp) [11] [49]	Persistent JNK-ROS-TNF feedback loops, immune cell recruitment [49]
Mitogens Secreted	Wingless (Wnt), Spitz (EGF), Decapentaplegic (BMP/TGF-β) - transient production [49]	Sustained mitogen production, pro-inflammatory cytokines
Cellular Outcome	Controlled proliferation, tissue restoration, homeostasis	Hyperplastic growth, tumor initiation, therapy resistance [69] [49]
Immune Involvement	Limited, transient hemocyte/macrophage recruitment	Extensive, chronic immune cell infiltration with TNF production [49]

Visualizing AiP Signaling Pathways

Experimental Protocols

Protocol 1: Live-Cell Tracking of AiP in Epithelial Repair Models

Objective: Quantify AiP dynamics in regenerating epithelial tissue using label-free live-cell imaging and computational tracking.

Materials & Reagents:

• Drosophila wing imaginal disc culture system or mammalian epithelial organoids
• Rapamycin-based caspase-9 dimerization system (for precise apoptosis induction) [70]
• SnapCyte or similar AI-powered confluency and proliferation analysis platform [71]
• CellPhenTracker or equivalent machine learning-based cell tracker [72]

Procedure:

• Model Preparation: Establish undead model system by co-expressing pro-apoptotic genes (e.g., hid, reaper) with effector caspase inhibitor P35 in Drosophila epithelium [69] [49]. For mammalian systems, use intestinal organoids with inducible caspase systems.
• Apoptosis Induction: Activate apoptotic signaling using 50-100 nM rapamycin dimerizer B/B (AP20187) for 3-4 hours to initiate caspase-9 dimerization [70].
• Live-Cell Imaging: Capture time-lapse brightfield microscopy every 10 minutes for 24-48 hours using 10x objective, maintaining 37°C, 5% CO₂.
• Label-Free Cell Classification: Apply LANCE (Live, Apoptotic, and Necrotic Cell Explorer) convolutional neural network to categorize cell states based on morphology [70].
• Proliferation Tracking: Use CellPhenTracker to simultaneously trace cell lineage, metabolic changes, and cell-type transitions [72].
• Signal Quantification: Measure JNK activation using FRET biosensors and ROS production with CellROX dyes.
• Data Analysis: Calculate AiP index as (number of divisions in surrounding cells)/(number of apoptotic cells) over 24-hour post-induction.

Protocol 2: Monitoring Therapy-Induced Tumor Regrowth

Objective: Investigate AiP in therapy-resistant cancer models and quantify contribution to tumor repopulation.

Materials & Reagents:

• Patient-derived tumor organoids or murine allograft models
• Chemotherapeutic agents (e.g., platinum-based compounds)
• Raman microscopy system with 785 nm laser [73]
• CD8+ T cell suppression assay components

Procedure:

• Therapy Model: Treat tumor organoids with IC50 concentration of chemotherapeutic agent for 24 hours, then wash and maintain in fresh media.
• Cell Death Verification: Confirm apoptosis induction using LANCE classification on brightfield images [70].
• Molecular Fingerprinting: Acquire Raman spectra (500-1800 cm⁻¹ range) pre- and post-therapy to track biomolecular changes associated with AiP [73].
• Single-Cell Analysis: Perform scRNA-seq on treated samples to identify SUMOylation-related genes and other AiP markers [74].
• Immune Modulation Assay: Co-culture treated tumor cells with CD8+ cytotoxic T cells and measure cytotoxicity suppression via AUP1 and CCDC80 expression [74].
• Machine Learning Classification: Apply support vector machine (SVM) algorithms to Raman spectral data for early detection of AiP signatures [73].
• Long-term Tracking: Monitor tumor regrowth weekly for 4 weeks, calculating regrowth velocity and AiP persistence index.

The Scientist's Toolkit: Essential Research Reagents

Table 2: Key Research Reagent Solutions for AiP Investigation

Category	Specific Reagents/Tools	Function in AiP Research	Example Application
Apoptosis Inducers	Rapamycin dimerizers (B/B), UV irradiation, TNF-α + cycloheximide	Controlled initiation of apoptotic signaling	Precise spatiotemporal activation of AiP [70]
Caspase Inhibitors	P35 (effector caspase inhibitor), zVAD-fmk (pan-caspase inhibitor)	Decoupling apoptosis execution from AiP signaling	Establishing "undead" models [69] [49]
AI Analysis Platforms	SnapCyte, CellPhenTracker, LANCE CNN	Automated cell classification and tracking	Label-free quantification of AiP dynamics [71] [70] [72]
Label-Free Imaging	Raman microscopy, brightfield time-lapse	Non-invasive monitoring of cell death and proliferation	Tracking AiP without fluorescent labels [70] [73]
Pathway Reporters	JNK FRET biosensors, ROS-sensitive dyes (CellROX)	Real-time signaling pathway monitoring	Quantifying JNK and ROS activation in AiP [11] [49]
Single-Cell Analysis	scRNA-seq, CopyKAT, Monocle2	Cellular heterogeneity and trajectory analysis	Identifying AiP-associated gene signatures [74]

Visualizing Experimental Workflows

Data Analysis and Interpretation

Quantitative Metrics for AiP Assessment

Table 3: Key Quantitative Parameters for AiP Experiments

Parameter	Calculation Method	Physiological Range (Repair)	Pathological Range (Tumor)
AiP Index	(Proliferating neighbors)/(Apoptotic cells) × 100	150-300%	300-600%+
JNK Activation Duration	Time from caspase activation to JNK signal return to baseline	2-6 hours	12-48 hours+
ROS Persistence	Time of detectable ROS elevation post-apoptosis	1-4 hours	8-24 hours+
Mitogen Secretion Window	Duration of Wg/Wnt and Spitz/EGF detection	4-8 hours	24-72 hours+
Immune Recruitment	Number of hemocytes/macrophages per apoptotic cell	0.5-1.5	2.0-5.0+
Therapy Resistance Score	Viability post-chemotherapy compared to baseline	N/A	40-80% recovery

Technical Considerations and Pitfalls

• Caspase Activity Thresholds: AiP requires different caspase activation thresholds than apoptosis - use titratable systems rather than all-or-nothing approaches [49].

• Temporal Control: AiP signaling is highly time-dependent - ensure precise synchronization of apoptosis induction across samples.

• Model Selection: Drosophila models excel for pathway discovery, while mammalian organoids provide better translational relevance [69] [74].

• Immune Component: Include immune cells in co-culture for physiologically relevant modeling, particularly for tumor AiP [49].

• Label Interference: Fluorescent labels may alter cellular behavior - prioritize label-free methods like LANCE and Raman microscopy when possible [70] [73].

The protocols and analyses outlined herein provide a framework for distinguishing regenerative from tumorigenic AiP, enabling development of therapeutic strategies that promote beneficial tissue repair while inhibiting detrimental tumor repopulation.

The study of Apoptosis-induced Proliferation (AiP) has traditionally focused on how apoptotic cells actively secrete mitogenic signals to stimulate proliferation in their neighbors. However, emerging research reveals crucial intersections between AiP and other regulated cell death modalities, particularly the lytic pathways of pyroptosis and necroptosis. Understanding these intersections is critical for researchers using live-cell tracking systems, as these pathways can coexist, compete, or synergize within the same biological system, potentially influencing AiP dynamics. This protocol framework establishes standardized approaches for investigating these complex interactions, with particular emphasis on real-time imaging platforms that can simultaneously track multiple cell death and proliferation parameters.

The fundamental distinction between AiP and general compensatory proliferation lies in the origin of signaling cues. While Compensatory Proliferation (CP) is initiated by surviving cells detecting tissue loss through various mechanisms (including mechanical cues or systemic factors), AiP is specifically driven by signals originating from apoptotic cells themselves [6]. This distinction becomes particularly significant when inflammatory forms of cell death like pyroptosis and necroptosis occur in the same microenvironment, as they release different profiles of damage-associated molecular patterns (DAMPs) and cytokines that may modulate the AiP response.

Core Concepts and Definitions

Key Cell Death Modalities and Their Characteristics

Table 1: Characteristics of Major Regulated Cell Death Modalities

Feature	Apoptosis	Apoptosis-Induced Proliferation (AiP)	Pyroptosis	Necroptosis
Primary Initiators	Caspase-8, -9	Caspases (Dronc in Drosophila), JNK, ROS	Caspase-1, -4, -5, -11; GSDMD	RIPK1, RIPK3, MLKL
Executioners	Caspase-3, -7	Secreted mitogens (Wnt, Hh, PGE2)	GSDMD pores	MLKL pores
Morphology	Membrane blebbing, chromatin condensation	No direct execution; stimulates neighboring cell division	Osmotic swelling, membrane rupture	Cellular swelling, plasma membrane rupture
Membrane Integrity	Maintained until late stages	Not applicable	Permeabilized via GSDMD pores	Permeabilized via MLKL pores
Immunogenicity	Generally immunologically silent	Context-dependent	Highly immunogenic	Highly immunogenic
Key Signaling Components	Bcl-2 family, cytochrome c	Caspases, JNK, ROS, EGFR	Inflammasomes, gasdermins	RIPK1/RIPK3/MLKL axis
Proliferative Outcome	Can stimulate AiP	Directly stimulates compensatory division	May inhibit or modulate AiP via inflammation	May inhibit or modulate AiP via inflammation

Distinguishing AiP from Compensatory Proliferation

The classification of proliferation responses to cell death requires precise terminology. Compensatory Proliferation (CP) serves as an umbrella term for any proliferation that restores tissue after cell loss, regardless of the initiating mechanism. In contrast, AiP represents a specialized form of CP where apoptotic cells actively drive the proliferative response through specific signaling mechanisms [6]. This distinction is crucial when studying intersections with pyroptosis and necroptosis, as these lytic death forms may trigger CP through different mechanisms, potentially in competition with genuine AiP signals.

Research in Drosophila has identified two principal AiP models: "genuine" AiP, where dying cells complete apoptosis while releasing mitogenic signals, and "undead" models, where cells are prevented from completing death execution but maintain active apoptotic signaling that drives proliferation [6]. Both models involve caspases in non-apoptotic signaling roles, creating potential points of intersection with other death pathways.

Signaling Pathway Crosstalk and Experimental Considerations

Molecular Intersections Between AiP, Pyroptosis, and Necroptosis

Diagram 1: Signaling pathway crosstalk between AiP, pyroptosis, and necroptosis. Note the convergence on compensatory proliferation outcomes and potential modulatory effects.

Key Experimental Considerations for Pathway Integration

When designing experiments to investigate intersections between AiP and lytic cell death pathways, several critical factors must be addressed:

• Temporal Dynamics: AiP signals typically emerge during early apoptosis, while pyroptosis and necroptosis progress more rapidly to lytic stages. Live-cell imaging must capture these divergent timelines [2] [75].

• Spatial Considerations: The proximity of dying cells to potential responders influences AiP efficacy. Lytic deaths may affect broader microenvironments through widespread DAMP release.

• Signal Competition: In mixed death modality environments, inflammatory signals from pyroptosis/necroptosis may override or modify AiP mitogenic signaling.

• Cell Type Variability: Sensitivity to specific death inducers and capacity for AiP signaling varies significantly between cell types and model systems.

Integrated Live-Cell Imaging Protocol for Multi-Modality Death Tracking

Diagram 2: Experimental workflow for integrated live-cell tracking of AiP with pyroptosis and necroptosis intersections.

Detailed Protocol Steps

Step 1: Generation of Stable Reporter Cell Lines

• Lentiviral Transduction: Utilize a lentiviral delivery system to stably express a caspase-3/7 activation reporter based on the ZipGFP platform alongside a constitutive mCherry marker for cell presence normalization [2].
• Reporter Validation: Validate reporter functionality through treatment with known apoptosis inducers (e.g., 1-5 μM carfilzomib for 8-24 hours) followed by caspase inhibition controls (20-50 μM zVAD-FMK) [2].
• 3D Model Adaptation: Adapt reporter cells to 3D culture systems including spheroids and patient-derived organoids to better recapitulate physiological tissue contexts [2].

Step 2: Multi-Parameter Live-Cell Staining

• Membrane Integrity Probes: Implement non-lytic membrane dyes such as FM 1-43FX (1-5 μg/mL) to track early membrane perturbations characteristic of pyroptosis and necroptosis [75].
• Mitochondrial Membrane Potential: Use TMRM (50-100 nM) to monitor mitochondrial commitment, which occurs approximately 18-21 minutes before plasma membrane rupture during pyroptosis [75].
• Lysosomal Integrity Tracking: Employ LysoTracker Red (50-75 nM) to detect lysosome decay, which begins 6-9 minutes before pyroptotic membrane rupture [75].

Step 3: Time-Lapse Imaging of Death Modality Intersections

• Imaging Platform Setup: Configure confocal laser scanning microscope with environmental chamber (37°C, 5% CO₂) for extended time-lapse imaging (24-120 hours) [76] [2].
• Multi-Channel Acquisition: Establish sequential acquisition parameters to minimize crosstalk between GFP (caspase activation), mCherry (cell presence), TMRM (mitochondria), and membrane dye channels [2].
• Death Inducer Titration: Apply specific inducers for each death modality in combination: apoptosis (carfilzomib 1-5 μM), pyroptosis (Nigericin 10-20 μM for NLRP3 activation), and necroptosis (TSZ: TNF-α + SMAC mimetic + zVAD-FMK) [75] [77].

Step 4: Tracking Proliferation Responses

• Cell Division Tracing: Incorporate fluorescent cell tracing dyes such as CFSE (5-10 μM) to track division events in neighboring cells following death induction [2].
• AiP-Specific Markers: Implement immunofluorescence for AiP-associated mitogens (Wnt, PGE2) or their pathway activation (nuclear β-catenin localization) at endpoint [6].
• Spatial Analysis: Correlate proliferation events with proximity to specific death modality cells using radial analysis algorithms.

Step 5: AI-Assisted Morphological Classification and Quantification

• Morphological Training Set: Develop reference images for death classification: apoptotic (membrane blebbing, caspase activation without swelling), pyroptotic (osmotic swelling, GSDMD-mediated pores), and necroptotic (cellular swelling, smooth membrane contours) [78] [75].
• Automated Classification: Implement deep learning models trained on differential interference contrast (DIC) and fluorescence features to classify death modalities in mixed populations [78].
• Kinetic Parameter Extraction: Quantify timing between initial caspase activation, mitochondrial depolarization, lysosomal decay, and membrane rupture for each death modality.

Protocol Validation and Controls

Table 2: Essential Experimental Controls for AiP Intersection Studies

Control Type	Purpose	Implementation	Expected Outcome
Caspase Inhibition	Confirm caspase-dependent events	20-50 μM zVAD-FMK co-treatment	Abrogation of apoptosis and AiP; potential enhancement of necroptosis
GSDMD Knockout	Verify pyroptosis-specific effects	CRISPR/Cas9-mediated GSDMD deletion	Blockade of pyroptosis; preserved apoptosis and necroptosis
MLKL Inhibition	Confirm necroptosis contribution	Necrosulfonamide or MLKL knockout	Specific blockade of necroptosis
Death Receptor Blockade	Isolate specific initiation pathways	Anti-TNF-α or TNF receptor blockade	Inhibition of extrinsic apoptosis and necroptosis
"Undead" AiP Model	Test pure apoptotic signaling without death completion	p35 expression or effector caspase inhibition	Sustained mitogenic signaling without cell elimination

Research Reagent Solutions

Table 3: Essential Research Reagents for Integrated AiP and Cell Death Studies

Reagent Category	Specific Examples	Function/Application	Concentration/Usage
Caspase Reporters	ZipGFP-DEVD caspase-3/7 sensor [2]	Real-time apoptosis tracking in live cells	Lentiviral transduction; excitation/emission: 488/510 nm
Constitutive Markers	mCherry fluorescent protein [2]	Cell presence normalization and viability assessment	Lentiviral co-expression; excitation/emission: 587/610 nm
Death Pathway Inhibitors	zVAD-FMK (pan-caspase) [2], Necrosulfonamide (MLKL) [77], Disulfiram (GSDMD) [79]	Specific pathway blockade for mechanistic studies	20-50 μM (zVAD), 1-5 μM (necrosulfonamide), 10-50 μM (disulfiram)
Membrane Integrity Probes	FM 1-43FX, Sytox Green/Blue [75]	Plasma membrane permeability assessment	1-5 μg/mL (FM 1-43FX), 1-5 μM (Sytox dyes)
Mitochondrial Probes	TMRM, MitoTracker Red CMXRos [75]	Mitochondrial membrane potential and commitment	50-100 nM (TMRM), 50-200 nM (MitoTracker)
Lysosomal Probes	LysoTracker Red, Acridine Orange [75]	Lysosomal integrity and acidification	50-75 nM (LysoTracker), 1-5 μg/mL (acridine orange)
Proliferation Trackers	CFSE, EdU/Click-iT kits [2]	Cell division tracking in neighbor cells	5-10 μM (CFSE), 10 μM EdU with click chemistry
Immunogenic Markers	Anti-calreticulin antibodies, HMGB1 detection [2] [80]	Immunogenic cell death assessment	Manufacturer recommended concentrations
AI-Assisted Analysis Tools	Custom deep learning models [78]	Automated death classification and morphology analysis	Python/TensorFlow implementations

Data Analysis and Interpretation Framework

Quantitative Parameters for Cross-Modality Comparison

Table 4: Key Kinetic Parameters for Death Modality Discrimination

Parameter	Apoptosis	Pyroptosis	Necroptosis	Measurement Method
Caspase Activation to Membrane Rupture	60-180 minutes	30-90 minutes	Not applicable	ZipGFP to Sytox Green interval [2] [75]
Mitochondrial Depolarization Timing	Variable (intrinsic pathway)	18-21 minutes before rupture	Cell type dependent	TMRM signal decay relative to membrane rupture [75]
Lysosomal Permeabilization	Late event	6-9 minutes before rupture	Poorly characterized	LysoTracker loss relative to membrane rupture [75]
Phosphatidylserine Exposure	Early event (before membrane rupture)	3-12 minutes before rupture	Before membrane rupture	Annexin V-FITC timing relative to PI [75]
Cell Detachment Behavior	Late detachment	Maintains attachment until rupture	Early detachment and rounding	Phase contrast/DIC imaging [75]
Proliferation Response Kinetics	24-72 hours post-death	Potentially inhibited or delayed	Potentially inhibited or delayed	CFSE dilution or EdU incorporation [2]

Interpretation Guidelines for Complex Scenarios

When analyzing experiments involving multiple death modalities, consider these interpretive frameworks:

• Dominant Pathway Effects: In mixed death populations, lytic pathways (pyroptosis/necroptosis) may dominate the microenvironment through robust DAMP release, potentially suppressing AiP responses to simultaneous apoptosis.

• Sequential Activation Patterns: Some death inducers trigger sequential pathway activation (e.g., caspase-8 inhibition shifting apoptosis to necroptosis), creating time-dependent effects on proliferation outcomes.

• Threshold Effects: AiP efficacy may demonstrate threshold behavior dependent on the ratio of apoptotic to lytic death cells within a defined spatial neighborhood.

• Cell-Type Specific Modulation: The impact of lytic death on AiP may vary significantly between cell types based on their innate immune signaling capacities and microenvironment context.

This integrated protocol framework provides researchers with comprehensive methodologies for investigating the complex intersections between AiP and inflammatory cell death modalities. The combination of live-cell imaging, multi-parameter tracking, and AI-assisted analysis enables unprecedented resolution of these dynamic biological processes, with significant implications for understanding tissue regeneration, cancer therapy resistance, and therapeutic development.

Conclusion

Live-cell tracking has firmly established Apoptosis-Induced Proliferation (AiP) as a fundamental biological process with profound implications for tissue homeostasis and disease. The integration of advanced biosensors, such as DEVD-based caspase reporters, with sophisticated analytical platforms like Cell-ACDC, provides an unprecedented ability to dissect AiP dynamics at single-cell resolution. A clear understanding of the molecular triggers—particularly the non-apoptotic roles of caspases and the subsequent JNK and ROS signaling—is crucial for manipulating this process. The dual nature of AiP presents a compelling therapeutic paradox: harnessing its regenerative capacity offers promise for healing and regenerative medicine, while inhibiting its aberrant activation in tumors could prevent therapy resistance and repopulation. Future research must focus on developing more specific in vivo imaging probes, elucidating the complex crosstalk between different cell death modalities, and translating these mechanistic insights into targeted strategies that can selectively promote regenerative AiP or block oncogenic AiP in clinical settings.

References

• 1. Decoding the divide: what distinguishes apoptosis-induced ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12247200/]
• 2. Integrated real-time imaging of executioner caspase ... [https://www.nature.com/articles/s41420-025-02662-y]
• 3. Live Cell Imaging, Live Cell Applications, Time-Lapse ... [https://www.moleculardevices.com/applications/live-cell-imaging]
• 4. Caspases as master regulators of programmed cell death [https://pmc.ncbi.nlm.nih.gov/articles/PMC12229594/]
• 5. The multifunctionality of the caspase family of proteases [https://www.sciencedirect.com/science/article/abs/pii/S0098299725000755]
• 6. Decoding the divide: what distinguishes apoptosis-induced ... [https://biosignaling.biomedcentral.com/articles/10.1186/s12964-025-02336-3]
• 7. Caspases: structural and molecular mechanisms and ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12052993/]
• 8. structural and molecular mechanisms and functions in cell ... [https://www.nature.com/articles/s41421-025-00791-3]
• 9. Kinetic quantification of apoptosis using Incucyte® live-cell ... [https://www.news-medical.net/whitepaper/20251027/Kinetic-quantification-of-apoptosis-using-Incucytec2ae-live-cell-imaging-assays.aspx]
• 10. Cell proliferation assays supported by live-cell imaging [https://www.axionbiosystems.com/cell-proliferation-assays-supported-live-cell-imaging]
• 11. Emerging players bridging apoptosis and cell proliferation ... [https://www.sciencedirect.com/science/article/pii/S1084952125000126]
• 12. ROS-Induced JNK and p38 Signaling Is Required for ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC4619769/]
• 13. Integrated real-time imaging of executioner caspase dynamics ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12328661/]
• 14. caspases drive apoptosis-induced proliferation in tissue ... [https://www.nature.com/articles/cdd201747]
• 15. Apoptosis-induced compensatory proliferation. The Cell is ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC2705980/]
• 16. Extracellular Reactive Oxygen Species drive Apoptosis ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC4765900/]
• 17. Multiparametric Analysis of Apoptosis by Flow Cytometry [https://pmc.ncbi.nlm.nih.gov/articles/PMC8063493/]
• 18. From proliferation to mitochondrial membrane potential ... [https://www.nature.com/articles/s41420-025-02391-2]
• 19. Visualization of caspase-3-like activity in cells using a ... [https://www.nature.com/articles/ncomms3157]
• 20. Development of a fluorescence-based cellular apoptosis ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC6372133/]
• 21. Video: Caspase-3/7 Assay: A Luminescence-Based ... [https://www.jove.com/v/30445/caspase-37-assay-luminescence-based-assay-to-quantify-apoptosis]
• 22. Designing an apoptosis reporter by mutagenesis-based ... [https://www.sciencedirect.com/science/article/pii/S2090123225004795]
• 23. Label-free live cell recognition and tracking for biological ... [https://www.nature.com/articles/s44303-024-00046-y]
• 24. Advancing label-free cell classification with connectome ... [https://www.sciencedirect.com/science/article/pii/S0010482525006250]
• 25. Evidence of interactions among apoptosis, cell proliferation ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC11163280/]
• 26. Technological advances in real-time tracking of cell death - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC3037440/]
• 27. Gossiping about death: Apoptosis-induced ERK waves as ... [https://www.sciencedirect.com/science/article/pii/S1084952125000254]
• 28. Cell-ACDC – For those about to analyze microscopy images [https://www.helmholtz-munich.de/en/newsroom/news-all/artikel/cell-acdc-for-those-about-to-analyze-microscopy-images]
• 29. Segmentation, tracking and cell cycle analysis of live-cell ... [https://bmcbiol.biomedcentral.com/articles/10.1186/s12915-022-01372-6]
• 30. Cell Proliferation Assays for Live-Cell Analysis [https://www.sartorius.com/en/applications/life-science-research/live-cell-assays/proliferation]
• 31. HCS-3DX, a next-generation AI-driven automated 3D-oid ... [https://www.nature.com/articles/s41467-025-63955-5]
• 32. Digitalized organoids: integrated pipeline for high-speed 3D ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12165853/]
• 33. Flow cytometry-based quantitative analysis of cellular ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC11260931/]
• 34. AI‐Driven Quality Monitoring and Control in Stem Cell Cultures [https://pmc.ncbi.nlm.nih.gov/articles/PMC12336434/]
• 35. Integrated real-time imaging of executioner caspase dynamics... [https://www.nature.com/articles/s41420-025-02662-y?error=cookies_not_supported&code=997d5d12-8110-4bfe-afc4-0e9db0552642]
• 36. Integrated real-time imaging of executioner caspase dynamics... [https://pubmed.ncbi.nlm.nih.gov/40769969/]
• 37. in cancer: concept and therapeutic implications Immunogenic cell death [https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-023-04017-6]
• 38. An immunogenic cell injury module for the single- ... [https://www.sciencedirect.com/science/article/pii/S0021925822007426]
• 39. Cancer cells dying from ferroptosis impede dendritic ... [https://www.nature.com/articles/s41467-022-31218-2]
• 40. Genetically encoded biosensor for fluorescence lifetime ... [https://www.nature.com/articles/s41592-025-02610-9]
• 41. Cell Membrane-Anchored Biosensors for Real-Time ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC4183634/]
• 42. Harnessing 3D cell models and high-resolution imaging to ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12277333/]
• 43. Challenges in 3D Live Cell Imaging [https://www.mdpi.com/2304-6732/8/7/275]
• 44. Single cell resolution 3D imaging and segmentation within ... [https://www.nature.com/articles/s44303-025-00099-7]
• 45. Optical 3D Imaging of Suspended Live Cells Developed [https://www.technologynetworks.com/analysis/news/researchers-develop-optical-3d-imaging-for-suspended-live-cells-402025]
• 46. Cell tracking with accurate error prediction [https://www.nature.com/articles/s41592-025-02845-6]
• 47. Visualization and correction of automated segmentation ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC4287543/]
• 48. Generating Quantitative Cell Identity Labels with Marker ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC5774653/]
• 49. Killers creating new life: caspases drive apoptosis-induced ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC5520457/]
• 50. Caspase-independent cell death does not elicit a proliferative ... [https://bmcmolcellbiol.biomedcentral.com/articles/10.1186/s12860-018-0164-1]
• 51. Live Cell Imaging of Caspase Activation for High Content Screening - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC3613133/]
• 52. Incucyte® Apoptosis Assays for Live-Cell Analysis | Sartorius [https://www.sartorius.com/en/applications/life-science-research/live-cell-assays/apoptosis]
• 53. Environmental Control and time-lapse Imaging [https://www.moleculardevices.com/technology/environmental-control]
• 54. Advancing Live-Cell and Time-Lapse Imaging with Digital ... [https://www.labx.com/resources/advancing-live-cell-and-time-lapse-imaging-with-digital-microscopy/5472]
• 55. Bruker's Environmental Control Module [https://www.bruker.com/en/products-and-solutions/fluorescence-microscopy/light-sheet-microscopes/lsfm-accessories/environmental-control-module.html]
• 56. Long-term live imaging, cell identification and cell tracking ... [https://elifesciences.org/articles/107534]
• 57. Calreticulin is the dominant pro-phagocytic signal on ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC4126904/]
• 58. Annexin V PI Staining Guide for Apoptosis Detection [https://www.bosterbio.com/blog/post/methods/flow-cytometry-with-annexin-v-pi-staining?srsltid=AfmBOormLMgvH_HlMNxga5x8Jye7bb6OYOaFHZrxqtj704wRYyT-Tn4H]
• 59. Annexin V staining assay protocol for apoptosis [https://www.abcam.com/en-us/technical-resources/protocols/annexin-v-for-apoptosis]
• 60. Annexin V Staining Protocol for Flow Cytometry [https://www.thermofisher.com/us/en/home/references/protocols/cell-and-tissue-analysis/protocols/annexin-v-staining-flow-cytometry.html]
• 61. Caspase Inhibitor Z-VAD-FMK [https://www.promega.com/products/cell-health-assays/apoptosis-assays/caspase-inhibitor-z_vad_fmk/]
• 62. Z-VAD-FMK – Pan-Caspase Inhibitor [https://www.apexbt.com/z-vad-fmk.html]
• 63. Apoptosis: A Comprehensive Overview of Signaling ... [https://www.mdpi.com/2073-4409/13/22/1838]
• 64. Robust high-throughput kinetic analysis of apoptosis with ... [https://www.nature.com/articles/cddis2016332]
• 65. Caspases as master regulators of programmed cell death [https://www.nature.com/articles/s12276-025-01470-9]
• 66. Apoptotic cells can induce non-autonomous apoptosis ... [https://elifesciences.org/articles/01004]
• 67. Distinct Mechanisms of Apoptosis-Induced Compensatory ... [https://www.sciencedirect.com/science/article/pii/S1534580708000312]
• 68. Single-Cell and Population-Level Analyses Using Real ... [https://www.sciencedirect.com/science/article/pii/S1534580719306999]
• 69. The Role of Apoptosis-Induced Proliferation for Regeneration ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC3405855/]
• 70. LANCE: a Label-Free Live Apoptotic and Necrotic Cell ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC10729583/]
• 71. AI-Powered Cell Confluency and Proliferation Analysis in ... [https://www.snapcyte.com/cell-death-research/]
• 72. Lactate controls cancer stemness and plasticity through ... [https://www.sciencedirect.com/science/article/pii/S1550413125000026]
• 73. Machine learning with label-free Raman microscopy to ... [https://www.nature.com/articles/s42003-025-07624-9]
• 74. Integrated machine learning and single-cell analysis reveal ... [https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1577781/full]
• 75. Single-cell analysis of pyroptosis dynamics reveals ... [https://www.nature.com/articles/s41418-018-0106-7]
• 76. Time-lapse live-cell imaging of pyroptosis by confocal ... [https://www.sciencedirect.com/science/article/pii/S2666166723006755]
• 77. Pyroptosis versus necroptosis: similarities, differences, and ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC6294779/]
• 78. High-throughput screening system for immunogenic cell ... [https://www.sciencedirect.com/science/article/pii/S0010482525010789?dgcid=rss_sd_all]
• 79. AI-powered omics-based drug pair discovery for pyroptosis ... [https://www.nature.com/articles/s41467-024-51980-9]
• 80. 综述：急性心肌梗死的分子发病机制、诊断与临床管理 [https://www.ebiotrade.com/newsf/2025-10/20251008002011838.htm]